Contact, publication, and social network information about Harvard faculty and fellows. Harvard Catalyst Profiles
Keywords
Last Name
Institution

Elliott Marshall Antman, M.D.

TitleProfessor of Medicine
InstitutionBrigham and Women's Hospital
DepartmentMedicine
AddressBrigham and Women's Hospital
Cardiovascular
75 Francis St
Boston MA 02115
Phone617/732-7143
Fax617/975-0990
Other Positions
TitleAssociate Dean for Clinical and Translational Research
InstitutionHarvard Medical School
DepartmentClinical and Translational Science Center


 Bibliographic 
 selected publications
Publications listed below are automatically derived from MEDLINE/PubMed and other sources, which might result in incorrect or missing publications. Faculty can login to make corrections and additions.
List All   |   Timeline
  1. Udell JA, Braunwald E, Antman EM, Murphy SA, Montalescot G, Wiviott SD. Prasugrel Versus Clopidogrel in Patients With ST-Segment Elevation Myocardial Infarction According to Timing of Percutaneous Coronary Intervention: A TRITON-TIMI 38 Subgroup Analysis (Trial to Assess Improvement in Therapeutic Outcomes by Optimizing Platelet Inhibition with Prasugrel-Thrombolysis In Myocardial Infarction 38). JACC Cardiovasc Interv. 2014 Jun; 7(6):604-12.
    View in: PubMed
  2. Antman EM. Clinical research and the development of medical therapeutics. Circ J. 2014 May 23; 78(6):1267-71.
    View in: PubMed
  3. Antman EM, Appel LJ, Balentine D, Johnson RK, Steffen LM, Miller EA, Pappas A, Stitzel KF, Vafiadis DK, Whitsel L. Stakeholder discussion to reduce population-wide sodium intake and decrease sodium in the food supply: a conference report from the american heart association sodium conference 2013 planning group. Circulation. 2014 Jun 24; 129(25):e660-79.
    View in: PubMed
  4. Antman EM, Jessup M. Clinical practice guidelines for chronic cardiovascular disorders: a roadmap for the future. JAMA. 2014 Mar 26; 311(12):1195-6.
    View in: PubMed
  5. Bonaca MP, Murphy SA, Miller D, Herrman JP, Gottlieb S, Keltai M, Menozzi A, Nicolau JC, Widimsky P, Antman EM, Wiviott SD. Patterns of Long-term Thienopyridine Therapy and Outcomes in Patients With Acute Coronary Syndrome Treated With Coronary Stenting: Observations From the TIMI-38 Coronary Stent Registry. Clin Cardiol. 2014 May; 37(5):293-9.
    View in: PubMed
  6. Antman E. Data sharing in research: benefits and risks for clinicians. BMJ. 2014; 348:g237.
    View in: PubMed
  7. Antman E, Arnett D, Jessup M, Sherwin C. The 50th Anniversary of the US Surgeon General's Report on Tobacco: What We've Accomplished and Where We Go From Here. J Am Heart Assoc. 2014; 3(1):e000740.
    View in: PubMed
  8. Ruff CT, Giugliano RP, Braunwald E, Hoffman EB, Deenadayalu N, Ezekowitz MD, Camm AJ, Weitz JI, Lewis BS, Parkhomenko A, Yamashita T, Antman EM. Comparison of the efficacy and safety of new oral anticoagulants with warfarin in patients with atrial fibrillation: a meta-analysis of randomised trials. Lancet. 2014 Mar 15; 383(9921):955-62.
    View in: PubMed
  9. Gupta DK, Shah AM, Giugliano RP, Ruff CT, Antman EM, Grip LT, Deenadayalu N, Hoffman E, Patel I, Shi M, Mercuri M, Mitrovic V, Braunwald E, Solomon SD. Left atrial structure and function in atrial fibrillation: ENGAGE AF-TIMI 48. Eur Heart J. 2014 Jun 7; 35(22):1457-65.
    View in: PubMed
  10. Giugliano RP, Ruff CT, Braunwald E, Murphy SA, Wiviott SD, Halperin JL, Waldo AL, Ezekowitz MD, Weitz JI, Špinar J, Ruzyllo W, Ruda M, Koretsune Y, Betcher J, Shi M, Grip LT, Patel SP, Patel I, Hanyok JJ, Mercuri M, Antman EM. Edoxaban versus warfarin in patients with atrial fibrillation. N Engl J Med. 2013 Nov 28; 369(22):2093-104.
    View in: PubMed
  11. Ojeifo O, Wiviott SD, Antman EM, Murphy SA, Udell JA, Bates ER, Mega JL, Sabatine MS, O'Donoghue ML. Concomitant Administration of Clopidogrel With Statins or Calcium-Channel Blockers: Insights From the TRITON-TIMI 38 (Trial to Assess Improvement in Therapeutic Outcomes by Optimizing Platelet Inhibition With Prasugrel-Thrombolysis In Myocardial Infarction 38). JACC Cardiovasc Interv. 2013 Dec; 6(12):1275-81.
    View in: PubMed
  12. Choudhry NK, Glynn RJ, Avorn J, Lee JL, Brennan TA, Reisman L, Toscano M, Levin R, Matlin OS, Antman EM, Shrank WH. Untangling the relationship between medication adherence and post-myocardial infarction outcomes: Medication adherence and clinical outcomes. Am Heart J. 2014 Jan; 167(1):51-58.e5.
    View in: PubMed
  13. Kohli P, Udell JA, Murphy SA, Cannon CP, Antman EM, Braunwald E, Wiviott SD. Discharge Aspirin Dose and Clinical Outcomes in Patients With Acute Coronary Syndromes Treated With Prasugrel Versus Clopidogrel: An Analysis From the TRITON-TIMI 38 Study (Trial to Assess Improvement in Therapeutic Outcomes by Optimizing Platelet Inhibition With Prasugrel-Thrombolysis In Myocardial Infarction 38). J Am Coll Cardiol. 2014 Jan 28; 63(3):225-32.
    View in: PubMed
  14. Mogabgab O, Wiviott SD, Cannon CP, Sloan S, Sabatine MS, Antman EM, Braunwald E, Giugliano RP. Circadian Variation of Stent Thrombosis and the Effect of More Robust Platelet Inhibition: A Post Hoc Analysis of the TRITON-TIMI 38 Trial. J Cardiovasc Pharmacol Ther. 2013 Nov; 18(6):555-9.
    View in: PubMed
  15. Bohula May EA, Bonaca MP, Jarolim P, Antman EM, Braunwald E, Giugliano RP, Newby LK, Sabatine MS, Morrow DA. Prognostic Performance of a High-Sensitivity Cardiac Troponin I Assay in Patients with Non-ST-Elevation Acute Coronary Syndrome. Clin Chem. 2014 Jan; 60(1):158-64.
    View in: PubMed
  16. Kulik A, Desai NR, Shrank WH, Antman EM, Glynn RJ, Levin R, Reisman L, Brennan T, Choudhry NK. Full prescription coverage versus usual prescription coverage after coronary artery bypass graft surgery: analysis from the post-myocardial infarction free Rx event and economic evaluation (FREEE) randomized trial. Circulation. 2013 Sep 10; 128(11 Suppl 1):S219-25.
    View in: PubMed
  17. Antman EM. Bypassing the emergency department to improve the process of care for ST-elevation myocardial infarction: necessary but not sufficient. Circulation. 2013 Jul 23; 128(4):322-4.
    View in: PubMed
  18. Anderson JL, Adams CD, Antman EM, Bridges CR, Califf RM, Casey DE, Chavey WE, Fesmire FM, Hochman JS, Levin TN, Lincoff AM, Peterson ED, Theroux P, Wenger NK, Wright RS, Jneid H, Ettinger SM, Ganiats TG, Philippides GJ, Jacobs AK, Halperin JL, Albert NM, Creager MA, DeMets D, Guyton RA, Kushner FG, Ohman EM, Stevenson W, Yancy CW. 2012 ACCF/AHA focused update incorporated into the ACCF/AHA 2007 guidelines for the management of patients with unstable angina/non-ST-elevation myocardial infarction: a report of the American College of Cardiology Foundation/American Heart Association Task Force on Practice Guidelines. J Am Coll Cardiol. 2013 Jun 11; 61(23):e179-347.
    View in: PubMed
  19. Anderson JL, Adams CD, Antman EM, Bridges CR, Califf RM, Casey DE, Chavey WE, Fesmire FM, Hochman JS, Levin TN, Lincoff AM, Peterson ED, Theroux P, Wenger NK, Wright RS, Jneid H, Ettinger SM, Ganiats TG, Lincoff AM, Philippides GJ, Zidar JP. 2012 ACCF/AHA focused update incorporated into the ACCF/AHA 2007 guidelines for the management of patients with unstable angina/non-ST-elevation myocardial infarction: a report of the American College of Cardiology Foundation/American Heart Association Task Force on Practice Guidelines. Circulation. 2013 Jun 11; 127(23):e663-828.
    View in: PubMed
  20. Mogabgab O, Wiviott SD, Antman EM, Foody JM, Wang TY, Sabatine MS, Cannon CP, Li S, Giugliano RP. Relation between time of symptom onset of ST-segment elevation myocardial infarction and patient baseline characteristics: from the National Cardiovascular Data Registry. Clin Cardiol. 2013 Apr; 36(4):222-7.
    View in: PubMed
  21. Amin ST, Morrow DA, Braunwald E, Sloan S, Contant C, Murphy S, Antman EM. Dynamic TIMI risk score for STEMI. J Am Heart Assoc. 2013 Feb; 2(1):e003269.
    View in: PubMed
  22. Jacobs AK, Kushner FG, Ettinger SM, Guyton RA, Anderson JL, Ohman EM, Albert NM, Antman EM, Arnett DK, Bertolet M, Bhatt DL, Brindis RG, Creager MA, DeMets DL, Dickersin K, Fonarow GC, Gibbons RJ, Halperin JL, Hochman JS, Koster MA, Normand SL, Ortiz E, Peterson ED, Roach WH, Sacco RL, Smith SC, Stevenson WG, Tomaselli GF, Yancy CW, Zoghbi WA. ACCF/AHA clinical practice guideline methodology summit report: a report of the American College of Cardiology Foundation/American Heart Association Task Force on Practice Guidelines. Circulation. 2013 Jan 15; 127(2):268-310.
    View in: PubMed
  23. Jacobs AK, Kushner FG, Ettinger SM, Guyton RA, Anderson JL, Ohman EM, Albert NM, Antman EM, Arnett DK, Bertolet M, Bhatt DL, Brindis RG, Creager MA, DeMets DL, Dickersin K, Fonarow GC, Gibbons RJ, Halperin JL, Hochman JS, Koster MA, Normand SL, Ortiz E, Peterson ED, Roach WH, Sacco RL, Smith SC, Stevenson WG, Tomaselli GF, Yancy CW, Zoghbi WA, Harold JG, He Y, Mangu PB, Qaseem A, Sayre MR, Somerfield MR. ACCF/AHA clinical practice guideline methodology summit report: a report of the American College of Cardiology Foundation/American Heart Association Task Force on Practice Guidelines. J Am Coll Cardiol. 2013 Jan 15; 61(2):213-65.
    View in: PubMed
  24. Guyatt G, Akl EA, Oxman A, Wilson K, Puhan MA, Wilt T, Gutterman D, Woodhead M, Antman EM, Schünemann HJ. Synthesis, grading, and presentation of evidence in guidelines: article 7 in Integrating and coordinating efforts in COPD guideline development. An official ATS/ERS workshop report. Proc Am Thorac Soc. 2012 Dec; 9(5):256-61.
    View in: PubMed
  25. Antman EM, Harrington RA. Transforming clinical trials in cardiovascular disease: mission critical for health and economic well-being. JAMA. 2012 Nov 7; 308(17):1743-4.
    View in: PubMed
  26. Mogabgab O, Giugliano RP, Sabatine MS, Cannon CP, Mohanavelu S, Wiviott SD, Antman EM, Braunwald E. Circadian variation in patient characteristics and outcomes in ST-segment elevation myocardial infarction. Chronobiol Int. 2012 Dec; 29(10):1390-6.
    View in: PubMed
  27. Whelton PK, Appel LJ, Sacco RL, Anderson CA, Antman EM, Campbell N, Dunbar SB, Frohlich ED, Hall JE, Jessup M, Labarthe DR, MacGregor GA, Sacks FM, Stamler J, Vafiadis DK, Van Horn LV. Sodium, blood pressure, and cardiovascular disease: further evidence supporting the American Heart Association sodium reduction recommendations. Circulation. 2012 Dec 11; 126(24):2880-9.
    View in: PubMed
  28. Leonardi S, Thomas L, Neely ML, Tricoci P, Lopes RD, White HD, Armstrong PW, Giugliano RP, Antman EM, Califf RM, Newby LK, Mahaffey KW. Comparison of the prognosis of spontaneous and percutaneous coronary intervention-related myocardial infarction. J Am Coll Cardiol. 2012 Dec 4; 60(22):2296-304.
    View in: PubMed
  29. Ito K, Shrank WH, Avorn J, Patrick AR, Brennan TA, Antman EM, Choudhry NK. Comparative cost-effectiveness of interventions to improve medication adherence after myocardial infarction. Health Serv Res. 2012 Dec; 47(6):2097-117.
    View in: PubMed
  30. Thygesen K, Alpert JS, Jaffe AS, Simoons ML, Chaitman BR, White HD, Thygesen K, Alpert JS, White HD, Jaffe AS, Katus HA, Apple FS, Lindahl B, Morrow DA, Chaitman BR, Clemmensen PM, Johanson P, Hod H, Underwood R, Bax JJ, Bonow JJ, Pinto F, Gibbons RJ, Fox KA, Atar D, Newby LK, Galvani M, Hamm CW, Uretsky BF, Steg PG, Wijns W, Bassand JP, Menasche P, Ravkilde J, Ohman EM, Antman EM, Wallentin LC, Armstrong PW, Simoons ML, Januzzi JL, Nieminen MS, Gheorghiade M, Filippatos G, Luepker RV, Fortmann SP, Rosamond WD, Levy D, Wood D, Smith SC, Hu D, Lopez-Sendon JL, Robertson RM, Weaver D, Tendera M, Bove AA, Parkhomenko AN, Vasilieva EJ, Mendis S, Bax JJ, Baumgartner H, Ceconi C, Dean V, Deaton C, Fagard R, Funck-Brentano C, Hasdai D, Hoes A, Kirchhof P, Knuuti J, Kolh P, McDonagh T, Moulin C, Popescu BA, Reiner Z, Sechtem U, Sirnes PA, Tendera M, Torbicki A, Vahanian A, Windecker S, Morais J, Aguiar C, Almahmeed W, Arnar DO, Barili F, Bloch KD, Bolger AF, Botker HE, Bozkurt B, Bugiardini R, Cannon C, de Lemos J, Eberli FR, Escobar E, Hlatky M, James S, Kern KB, Moliterno DJ, Mueller C, Neskovic AN, Pieske BM, Schulman SP, Storey RF, Taubert KA, Vranckx P, Wagner DR. Third universal definition of myocardial infarction. J Am Coll Cardiol. 2012 Oct 16; 60(16):1581-98.
    View in: PubMed
  31. Thygesen K, Alpert JS, Jaffe AS, Simoons ML, Chaitman BR, White HD, Thygesen K, Alpert JS, White HD, Jaffe AS, Katus HA, Apple FS, Lindahl B, Morrow DA, Chaitman BA, Clemmensen PM, Johanson P, Hod H, Underwood R, Bax JJ, Bonow RO, Pinto F, Gibbons RJ, Fox KA, Atar D, Newby LK, Galvani M, Hamm CW, Uretsky BF, Steg PG, Wijns W, Bassand JP, Menasché P, Ravkilde J, Ohman EM, Antman EM, Wallentin LC, Armstrong PW, Simoons ML, Januzzi JL, Nieminen MS, Gheorghiade M, Filippatos G, Luepker RV, Fortmann SP, Rosamond WD, Levy D, Wood D, Smith SC, Hu D, Lopez-Sendon JL, Robertson RM, Weaver D, Tendera M, Bove AA, Parkhomenko AN, Vasilieva EJ, Mendis S. Third universal definition of myocardial infarction. Eur Heart J. 2012 Oct; 33(20):2551-67.
    View in: PubMed
  32. Thygesen K, Alpert JS, Jaffe AS, Simoons ML, Chaitman BR, White HD, Katus HA, Lindahl B, Morrow DA, Clemmensen PM, Johanson P, Hod H, Underwood R, Bax JJ, Bonow RO, Pinto F, Gibbons RJ, Fox KA, Atar D, Newby LK, Galvani M, Hamm CW, Uretsky BF, Steg PG, Wijns W, Bassand JP, Menasché P, Ravkilde J, Ohman EM, Antman EM, Wallentin LC, Armstrong PW, Simoons ML, Januzzi JL, Nieminen MS, Gheorghiade M, Filippatos G, Luepker RV, Fortmann SP, Rosamond WD, Levy D, Wood D, Smith SC, Hu D, Lopez-Sendon JL, Robertson RM, Weaver D, Tendera M, Bove AA, Parkhomenko AN, Vasilieva EJ, Mendis S. Third universal definition of myocardial infarction. Circulation. 2012 Oct 16; 126(16):2020-35.
    View in: PubMed
  33. Kuriachan V, Tedrow U, Antman E, Epstein LM. Acute hyperkalemia detected by alert from implantable cardioverter-defibrillator. Pacing Clin Electrophysiol. 2012 Sep; 35(9):e276-9.
    View in: PubMed
  34. Antman EM, Harrington R, Tomaselli G. Usefulness of medical conferences. JAMA. 2012 Jul 4; 308(1):31-2; author reply 32-3.
    View in: PubMed
  35. Thomas MP, Mahaffey KW, Chiswell K, Cohen M, Kontos MC, Antman EM, Ferguson JJ, Califf RM, Goodman SG, Becker RC. Activated partial thromboplastin time measurement is not associated with clinical outcomes in patients with high-risk non-ST-segment elevation acute coronary syndromes treated with unfractionated heparin. J Thromb Thrombolysis. 2012 Jul; 34(1):114-9.
    View in: PubMed
  36. Antman EM. Implications of contemporary clinical trials series: the Placement of Aortic Transcatheter Valve trial (PARTNER). Circulation. 2012 Jun 26; 125(25):3054.
    View in: PubMed
  37. Jollis JG, Granger CB, Henry TD, Antman EM, Berger PB, Moyer PH, Pratt FD, Rokos IC, Acuña AR, Roettig ML, Jacobs AK. Systems of care for ST-segment-elevation myocardial infarction: a report From the American Heart Association's Mission: Lifeline. Circ Cardiovasc Qual Outcomes. 2012 Jul 1; 5(4):423-8.
    View in: PubMed
  38. Antman E, Weiss S, Loscalzo J. Systems pharmacology, pharmacogenetics, and clinical trial design in network medicine. Wiley Interdiscip Rev Syst Biol Med. 2012 Jul-Aug; 4(4):367-83.
    View in: PubMed
  39. Salazar DE, Mendell J, Kastrissios H, Green M, Carrothers TJ, Song S, Patel I, Bocanegra TS, Antman EM, Giugliano RP, Kunitada S, Dornseif B, Shi M, Tachibana M, Zhou S, Rohatagi S. Modelling and simulation of edoxaban exposure and response relationships in patients with atrial fibrillation. Thromb Haemost. 2012 May; 107(5):925-36.
    View in: PubMed
  40. Bonaca MP, Wiviott SD, Braunwald E, Murphy SA, Ruff CT, Antman EM, Morrow DA. American College of Cardiology/American Heart Association/European Society of Cardiology/World Heart Federation universal definition of myocardial infarction classification system and the risk of cardiovascular death: observations from the TRITON-TIMI 38 trial (Trial to Assess Improvement in Therapeutic Outcomes by Optimizing Platelet Inhibition With Prasugrel-Thrombolysis in Myocardial Infarction 38). Circulation. 2012 Jan 31; 125(4):577-83.
    View in: PubMed
  41. Choudhry NK, Avorn J, Glynn RJ, Antman EM, Schneeweiss S, Toscano M, Reisman L, Fernandes J, Spettell C, Lee JL, Levin R, Brennan T, Shrank WH. Full coverage for preventive medications after myocardial infarction. N Engl J Med. 2011 Dec 1; 365(22):2088-97.
    View in: PubMed
  42. Wiviott SD, Desai N, Murphy SA, Musumeci G, Ragosta M, Antman EM, Braunwald E. Efficacy and safety of intensive antiplatelet therapy with prasugrel from TRITON-TIMI 38 in a core clinical cohort defined by worldwide regulatory agencies. Am J Cardiol. 2011 Oct 1; 108(7):905-11.
    View in: PubMed
  43. Frelinger AL, Michelson AD, Wiviott SD, Trenk D, Neumann FJ, Miller DL, Jakubowski JA, Costigan TM, McCabe CH, Antman EM, Braunwald E. Intrinsic platelet reactivity before P2Y12 blockade contributes to residual platelet reactivity despite high-level P2Y12 blockade by prasugrel or high-dose clopidogrel. Results from PRINCIPLE-TIMI 44. Thromb Haemost. 2011 Aug; 106(2):219-26.
    View in: PubMed
  44. Mathews R, Peterson ED, Li S, Roe MT, Glickman SW, Wiviott SD, Saucedo JF, Antman EM, Jacobs AK, Wang TY. Use of emergency medical service transport among patients with ST-segment-elevation myocardial infarction: findings from the National Cardiovascular Data Registry Acute Coronary Treatment Intervention Outcomes Network Registry-Get With The Guidelines. Circulation. 2011 Jul 12; 124(2):154-63.
    View in: PubMed
  45. Hochholzer W, Wiviott SD, Antman EM, Contant CF, Guo J, Giugliano RP, Dalby AJ, Montalescot G, Braunwald E. Predictors of bleeding and time dependence of association of bleeding with mortality: insights from the Trial to Assess Improvement in Therapeutic Outcomes by Optimizing Platelet Inhibition With Prasugrel--Thrombolysis in Myocardial Infarction 38 (TRITON-TIMI 38). Circulation. 2011 Jun 14; 123(23):2681-9.
    View in: PubMed
  46. Wright RS, Anderson JL, Adams CD, Bridges CR, Casey DE, Ettinger SM, Fesmire FM, Ganiats TG, Jneid H, Lincoff AM, Peterson ED, Philippides GJ, Theroux P, Wenger NK, Zidar JP, Anderson JL, Adams CD, Antman EM, Bridges CR, Califf RM, Casey DE, Chavey WE, Fesmire FM, Hochman JS, Levin TN, Lincoff AM, Peterson ED, Theroux P, Wenger NK, Zidar JP. 2011 ACCF/AHA focused update incorporated into the ACC/AHA 2007 Guidelines for the Management of Patients with Unstable Angina/Non-ST-Elevation Myocardial Infarction: a report of the American College of Cardiology Foundation/American Heart Association Task Force on Practice Guidelines developed in collaboration with the American Academy of Family Physicians, Society for Cardiovascular Angiography and Interventions, and the Society of Thoracic Surgeons. J Am Coll Cardiol. 2011 May 10; 57(19):e215-367.
    View in: PubMed
  47. Wright RS, Anderson JL, Adams CD, Bridges CR, Casey DE, Ettinger SM, Fesmire FM, Ganiats TG, Jneid H, Lincoff AM, Peterson ED, Philippides GJ, Theroux P, Wenger NK, Zidar JP, Anderson JL, Adams CD, Antman EM, Bridges CR, Califf RM, Casey DE, Chavey WE, Fesmire FM, Hochman JS, Levin TN, Lincoff AM, Peterson ED, Theroux P, Wenger NK, Wright RS. 2011 ACCF/AHA focused update of the Guidelines for the Management of Patients with Unstable Angina/Non-ST-Elevation Myocardial Infarction (updating the 2007 guideline): a report of the American College of Cardiology Foundation/American Heart Association Task Force on Practice Guidelines developed in collaboration with the American College of Emergency Physicians, Society for Cardiovascular Angiography and Interventions, and Society of Thoracic Surgeons. J Am Coll Cardiol. 2011 May 10; 57(19):1920-59.
    View in: PubMed
  48. Anderson JL, Adams CD, Antman EM, Bridges CR, Califf RM, Casey DE, Chavey WE, Fesmire FM, Hochman JS, Levin TN, Lincoff AM, Peterson ED, Theroux P, Wenger NK, Wright RS, Smith SC. 2011 ACCF/AHA Focused Update Incorporated Into the ACC/AHA 2007 Guidelines for the Management of Patients With Unstable Angina/Non-ST-Elevation Myocardial Infarction: a report of the American College of Cardiology Foundation/American Heart Association Task Force on Practice Guidelines. Circulation. 2011 May 10; 123(18):e426-579.
    View in: PubMed
  49. Antman EM. Evidence and education. Circulation. 2011 Feb 15; 123(6):681-5.
    View in: PubMed
  50. Mahaffey KW, Pieper KS, Lokhnygina Y, Califf RM, Antman EM, Kleiman NS, Goodman SG, White HD, Rao SV, Hochman JS, Cohen M, Col JJ, Roe MT, Ferguson JJ. The impact of postrandomization crossover of therapy in acute coronary syndromes care. Circ Cardiovasc Qual Outcomes. 2011 Mar; 4(2):211-9.
    View in: PubMed
  51. Abraham NS, Hlatky MA, Antman EM, Bhatt DL, Bjorkman DJ, Clark CB, Furberg CD, Johnson DA, Kahi CJ, Laine L, Mahaffey KW, Quigley EM, Scheiman J, Sperling LS, Tomaselli GF. ACCF/ACG/AHA 2010 expert consensus document on the concomitant use of proton pump inhibitors and thienopyridines: a focused update of the ACCF/ACG/AHA 2008 expert consensus document on reducing the gastrointestinal risks of antiplatelet therapy and NSAID use. A Report of the American College of Cardiology Foundation Task Force on Expert Consensus Documents. J Am Coll Cardiol. 2010 Dec 7; 56(24):2051-66.
    View in: PubMed
  52. Abraham NS, Hlatky MA, Antman EM, Bhatt DL, Bjorkman DJ, Clark CB, Furberg CD, Johnson DA, Kahi CJ, Laine L, Mahaffey KW, Quigley EM, Scheiman J, Sperling LS, Tomaselli GF. ACCF/ACG/AHA 2010 expert consensus document on the concomitant use of proton pump inhibitors and thienopyridines: a focused update of the ACCF/ACG/AHA 2008 expert consensus document on reducing the gastrointestinal risks of antiplatelet therapy and NSAID use. Am J Gastroenterol. 2010 Dec; 105(12):2533-49.
    View in: PubMed
  53. Ruff CT, Giugliano RP, Antman EM, Murphy SA, Lotan C, Heuer H, Merkely B, Baracioli L, Schersten F, Seabro-Gomes R, Braunwald E, Wiviott SD. Safety and efficacy of prasugrel compared with clopidogrel in different regions of the world. Int J Cardiol. 2012 Mar 22; 155(3):424-9.
    View in: PubMed
  54. Abraham NS, Hlatky MA, Antman EM, Bhatt DL, Bjorkman DJ, Clark CB, Furberg CD, Johnson DA, Kahi CJ, Laine L, Mahaffey KW, Quigley EM, Scheiman J, Sperling LS, Tomaselli GF. ACCF/ACG/AHA 2010 Expert Consensus Document on the concomitant use of proton pump inhibitors and thienopyridines: a focused update of the ACCF/ACG/AHA 2008 expert consensus document on reducing the gastrointestinal risks of antiplatelet therapy and NSAID use: a report of the American College of Cardiology Foundation Task Force on Expert Consensus Documents. Circulation. 2010 Dec 14; 122(24):2619-33.
    View in: PubMed
  55. Mega JL, Simon T, Collet JP, Anderson JL, Antman EM, Bliden K, Cannon CP, Danchin N, Giusti B, Gurbel P, Horne BD, Hulot JS, Kastrati A, Montalescot G, Neumann FJ, Shen L, Sibbing D, Steg PG, Trenk D, Wiviott SD, Sabatine MS. Reduced-function CYP2C19 genotype and risk of adverse clinical outcomes among patients treated with clopidogrel predominantly for PCI: a meta-analysis. JAMA. 2010 Oct 27; 304(16):1821-30.
    View in: PubMed
  56. Mega JL, Close SL, Wiviott SD, Shen L, Walker JR, Simon T, Antman EM, Braunwald E, Sabatine MS. Genetic variants in ABCB1 and CYP2C19 and cardiovascular outcomes after treatment with clopidogrel and prasugrel in the TRITON-TIMI 38 trial: a pharmacogenetic analysis. Lancet. 2010 Oct 16; 376(9749):1312-9.
    View in: PubMed
  57. Ruff CT, Giugliano RP, Antman EM, Crugnale SE, Bocanegra T, Mercuri M, Hanyok J, Patel I, Shi M, Salazar D, McCabe CH, Braunwald E. Evaluation of the novel factor Xa inhibitor edoxaban compared with warfarin in patients with atrial fibrillation: design and rationale for the Effective aNticoaGulation with factor xA next GEneration in Atrial Fibrillation-Thrombolysis In Myocardial Infarction study 48 (ENGAGE AF-TIMI 48). Am Heart J. 2010 Oct; 160(4):635-41.
    View in: PubMed
  58. Pride YB, Tung P, Mohanavelu S, Zorkun C, Wiviott SD, Antman EM, Giugliano R, Braunwald E, Gibson CM. Angiographic and clinical outcomes among patients with acute coronary syndromes presenting with isolated anterior ST-segment depression: a TRITON-TIMI 38 (Trial to Assess Improvement in Therapeutic Outcomes by Optimizing Platelet Inhibition With Prasugrel-Thrombolysis In Myocardial Infarction 38) substudy. JACC Cardiovasc Interv. 2010 Aug; 3(8):806-11.
    View in: PubMed
  59. Wiviott SD, Antman EM, Braunwald E. Prasugrel. Circulation. 2010 Jul 27; 122(4):394-403.
    View in: PubMed
  60. Wiviott SD, Antman EM, Braunwald E. Mortality in the TRITON trial: update from the FDA prasugrel action package. Am J Cardiol. 2010 Jul 15; 106(2):293-4.
    View in: PubMed
  61. Antman EM. Bundle branch block in ST-elevation myocardial infarction: evidence for action. Arch Cardiol Mex. 2010 Jul-Sep; 80(3):159-62.
    View in: PubMed
  62. Antman E, Pfeffer M, Stevenson W, Loscalzo J. New section in Circulation: implications of contemporary clinical trials. Circulation. 2010 Jun 8; 121(22):2446.
    View in: PubMed
  63. Cohen M, Levine GN, Pieper KS, Lan L, Antman EM, Aylward PE, White HD, Kleiman NS, Califf RM, Mahaffey KW. Enoxaparin 0.3 mg/kg IV supplement for patients transitioning to PCI after subcutaneous enoxaparin therapy for NSTE ACS: a subgroup analysis from the SYNERGY trial. Catheter Cardiovasc Interv. 2010 May 1; 75(6):928-35.
    View in: PubMed
  64. Giugliano RP, Giraldez RR, Morrow DA, Antman EM, Gibson CM, Mohanavelu S, Murphy SA, McCabe CH, Braunwald E. Relations between bleeding and outcomes in patients with ST-elevation myocardial infarction in the ExTRACT-TIMI 25 trial. Eur Heart J. 2010 Sep; 31(17):2103-10.
    View in: PubMed
  65. Morrow DA, Antman EM, Fox KA, White HD, Giugliano R, Murphy SA, McCabe CH, Braunwald E. One-year outcomes after a strategy using enoxaparin vs. unfractionated heparin in patients undergoing fibrinolysis for ST-segment elevation myocardial infarction: 1-year results of the ExTRACT-TIMI 25 trial. Eur Heart J. 2010 Sep; 31(17):2097-102.
    View in: PubMed
  66. Gibbons RJ, Antman EM, Smith SC. Has guideline development gone astray? No. BMJ. 2010; 340:c343.
    View in: PubMed
  67. Harkness JR, Sabatine MS, Braunwald E, Morrow DA, Sloan S, Wiviott SD, Giugliano RP, Antman EM, Cannon CP, Scirica BM. Extent of ST-segment resolution after fibrinolysis adds improved risk stratification to clinical risk score for ST-segment elevation myocardial infarction. Am Heart J. 2010 Jan; 159(1):55-62.
    View in: PubMed
  68. Mahoney EM, Wang K, Arnold SV, Proskorovsky I, Wiviott S, Antman E, Braunwald E, Cohen DJ. Cost-effectiveness of prasugrel versus clopidogrel in patients with acute coronary syndromes and planned percutaneous coronary intervention: results from the trial to assess improvement in therapeutic outcomes by optimizing platelet inhibition with Prasugrel-Thrombolysis in Myocardial Infarction TRITON-TIMI 38. Circulation. 2010 Jan 5; 121(1):71-9.
    View in: PubMed
  69. Kushner FG, Hand M, Smith SC, King SB, Anderson JL, Antman EM, Bailey SR, Bates ER, Blankenship JC, Casey DE, Green LA, Jacobs AK, Hochman JS, Krumholz HM, Morrison DA, Ornato JP, Pearle DL, Peterson ED, Sloan MA, Whitlow PL, Williams DO. 2009 focused updates: ACC/AHA guidelines for the management of patients with ST-elevation myocardial infarction (updating the 2004 guideline and 2007 focused update) and ACC/AHA/SCAI guidelines on percutaneous coronary intervention (updating the 2005 guideline and 2007 focused update): a report of the American College of Cardiology Foundation/American Heart Association Task Force on Practice Guidelines. Catheter Cardiovasc Interv. 2009 Dec 1; 74(7):E25-68.
    View in: PubMed
  70. Kushner FG, Hand M, Smith SC, King SB, Anderson JL, Antman EM, Bailey SR, Bates ER, Blankenship JC, Casey DE, Green LA, Hochman JS, Jacobs AK, Krumholz HM, Morrison DA, Ornato JP, Pearle DL, Peterson ED, Sloan MA, Whitlow PL, Williams DO. 2009 focused updates: ACC/AHA guidelines for the management of patients with ST-elevation myocardial infarction (updating the 2004 guideline and 2007 focused update) and ACC/AHA/SCAI guidelines on percutaneous coronary intervention (updating the 2005 guideline and 2007 focused update) a report of the American College of Cardiology Foundation/American Heart Association Task Force on Practice Guidelines. J Am Coll Cardiol. 2009 Dec 1; 54(23):2205-41.
    View in: PubMed
  71. Kushner FG, Hand M, Smith SC, King SB, Anderson JL, Antman EM, Bailey SR, Bates ER, Blankenship JC, Casey DE, Green LA, Hochman JS, Jacobs AK, Krumholz HM, Morrison DA, Ornato JP, Pearle DL, Peterson ED, Sloan MA, Whitlow PL, Williams DO. 2009 Focused Updates: ACC/AHA Guidelines for the Management of Patients With ST-Elevation Myocardial Infarction (updating the 2004 Guideline and 2007 Focused Update) and ACC/AHA/SCAI Guidelines on Percutaneous Coronary Intervention (updating the 2005 Guideline and 2007 Focused Update): a report of the American College of Cardiology Foundation/American Heart Association Task Force on Practice Guidelines. Circulation. 2009 Dec 1; 120(22):2271-306.
    View in: PubMed
  72. Linefsky JP, Lin M, Pieper KS, Reist CJ, Berdan LG, Antman EM, Goodman SG, French JK, Guneri S, Roe MT, Newby LK, Harrington RA, Ferguson JJ, Califf RM, Mahaffey KW. Comparison of site-reported and core laboratory-reported creatine kinase-MB values in non-ST-segment elevation acute coronary syndrome (from the international trial SYNERGY). Am J Cardiol. 2009 Nov 15; 104(10):1330-5.
    View in: PubMed
  73. Pride YB, Wiviott SD, Buros JL, Zorkun C, Tariq MU, Antman EM, Braunwald E, Gibson CM. Effect of prasugrel versus clopidogrel on outcomes among patients with acute coronary syndrome undergoing percutaneous coronary intervention without stent implantation: a TRial to assess Improvement in Therapeutic Outcomes by optimizing platelet inhibitioN with prasugrel (TRITON)-Thrombolysis in Myocardial Infarction (TIMI) 38 substudy. Am Heart J. 2009 Sep; 158(3):e21-6.
    View in: PubMed
  74. O'Donoghue ML, Braunwald E, Antman EM, Murphy SA, Bates ER, Rozenman Y, Michelson AD, Hautvast RW, Ver Lee PN, Close SL, Shen L, Mega JL, Sabatine MS, Wiviott SD. Pharmacodynamic effect and clinical efficacy of clopidogrel and prasugrel with or without a proton-pump inhibitor: an analysis of two randomised trials. Lancet. 2009 Sep 19; 374(9694):989-97.
    View in: PubMed
  75. Sabatine MS, Antman EM, Widimsky P, Ebrahim IO, Kiss RG, Saaiman A, Polasek R, Contant CF, McCabe CH, Braunwald E. Otamixaban for the treatment of patients with non-ST-elevation acute coronary syndromes (SEPIA-ACS1 TIMI 42): a randomised, double-blind, active-controlled, phase 2 trial. Lancet. 2009 Sep 5; 374(9692):787-95.
    View in: PubMed
  76. O'Donoghue M, Antman EM, Braunwald E, Murphy SA, Steg PG, Finkelstein A, Penny WF, Fridrich V, McCabe CH, Sabatine MS, Wiviott SD. The efficacy and safety of prasugrel with and without a glycoprotein IIb/IIIa inhibitor in patients with acute coronary syndromes undergoing percutaneous intervention: a TRITON-TIMI 38 (Trial to Assess Improvement in Therapeutic Outcomes by Optimizing Platelet Inhibition With Prasugrel-Thrombolysis In Myocardial Infarction 38) analysis. J Am Coll Cardiol. 2009 Aug 18; 54(8):678-85.
    View in: PubMed
  77. Giraldez RR, Wiviott SD, Nicolau JC, Mohanavelu S, Morrow DA, Antman EM, Giugliano RP. Streptokinase and enoxaparin as an alternative to fibrin-specific lytic-based regimens: an ExTRACT-TIMI 25 analysis. Drugs. 2009 Jul 30; 69(11):1433-43.
    View in: PubMed
  78. Antman EM, Gibbons RJ. Clinical practice guidelines and scientific evidence. JAMA. 2009 Jul 8; 302(2):143-4; author reply 145-7.
    View in: PubMed
  79. Wrishko RE, Ernest CS, Small DS, Li YG, Weerakkody GJ, Riesmeyer JR, Macias WL, Rohatagi S, Salazar DE, Antman EM, Wiviott SD, Braunwald E, Ni L. Population pharmacokinetic analyses to evaluate the influence of intrinsic and extrinsic factors on exposure of prasugrel active metabolite in TRITON-TIMI 38. J Clin Pharmacol. 2009 Aug; 49(8):984-98.
    View in: PubMed
  80. Morrow DA, Wiviott SD, White HD, Nicolau JC, Bramucci E, Murphy SA, Bonaca MP, Ruff CT, Scirica BM, McCabe CH, Antman EM, Braunwald E. Effect of the novel thienopyridine prasugrel compared with clopidogrel on spontaneous and procedural myocardial infarction in the Trial to Assess Improvement in Therapeutic Outcomes by Optimizing Platelet Inhibition with Prasugrel-Thrombolysis in Myocardial Infarction 38: an application of the classification system from the universal definition of myocardial infarction. Circulation. 2009 Jun 2; 119(21):2758-64.
    View in: PubMed
  81. Michelson AD, Frelinger AL, Braunwald E, Downey WE, Angiolillo DJ, Xenopoulos NP, Jakubowski JA, Li Y, Murphy SA, Qin J, McCabe CH, Antman EM, Wiviott SD. Pharmacodynamic assessment of platelet inhibition by prasugrel vs. clopidogrel in the TRITON-TIMI 38 trial. Eur Heart J. 2009 Jul; 30(14):1753-63.
    View in: PubMed
  82. Spinler SA, Mahaffey KW, Gallup D, Levine GN, Ferguson JJ, Rao SV, Gallo R, Ducas J, Goodman SG, Antman E, White HD, Biasucci L, Becker RC, Col JJ, Cohen M, Harrington RA, Califf RM. Relationship between renal function and outcomes in high-risk patients with non-ST-segment elevation acute coronary syndromes: results from SYNERGY. Int J Cardiol. 2010 Sep 24; 144(1):36-41.
    View in: PubMed
  83. Mega JL, Close SL, Wiviott SD, Shen L, Hockett RD, Brandt JT, Walker JR, Antman EM, Macias WL, Braunwald E, Sabatine MS. Cytochrome P450 genetic polymorphisms and the response to prasugrel: relationship to pharmacokinetic, pharmacodynamic, and clinical outcomes. Circulation. 2009 May 19; 119(19):2553-60.
    View in: PubMed
  84. Antman EM, Peterson ED. Tools for guiding clinical practice from the american heart association and the american college of cardiology: what are they and how should clinicians use them? Circulation. 2009 Mar 10; 119(9):1180-5.
    View in: PubMed
  85. Giraldez RR, Sabatine MS, Morrow DA, Mohanavelu S, McCabe CH, Antman EM, Braunwald E. Baseline hemoglobin concentration and creatinine clearance composite laboratory index improves risk stratification in ST-elevation myocardial infarction. Am Heart J. 2009 Mar; 157(3):517-24.
    View in: PubMed
  86. Montalescot G, Wiviott SD, Braunwald E, Murphy SA, Gibson CM, McCabe CH, Antman EM. Prasugrel compared with clopidogrel in patients undergoing percutaneous coronary intervention for ST-elevation myocardial infarction (TRITON-TIMI 38): double-blind, randomised controlled trial. Lancet. 2009 Feb 28; 373(9665):723-31.
    View in: PubMed
  87. Cheng S, Morrow DA, Sloan S, Antman EM, Sabatine MS. Predictors of initial nontherapeutic anticoagulation with unfractionated heparin in ST-segment elevation myocardial infarction. Circulation. 2009 Mar 10; 119(9):1195-202.
    View in: PubMed
  88. Spinler SA, Mahaffey KW, Gallup D, Levine GN, Ferguson JJ, Rao SV, Gallo R, Ducas J, Goodman SG, ANtman E, White HD, Biasucci L, Becker RC, Col JJ, Cohen M, Harrington RA, Califf RM. Relationship between renal function and outcomes in high-risk patients with non-ST-segment elevation acute coronary syndromes: results from SYNERGY. International Journal of Cardiology. 2009.
  89. Antman, EM. Acute coronary syndromes. Libby P (ed.). Essential Atlas of Cardiovascular Disease. 2009; 21-38.
  90. Antman, EM. ST-Elevation Myocardial Infarction. Fuster V (ed). The AHA Guidelines and Scientific Statements Handbook. 2009; 46-90.
  91. O'Donoghue M, Wiviott SD, Sabatine MS, Braunwald E, Antman EM, Murphy SA, Bates ER, Rozenman Y, Michelson AD, Hautvast RW, Ver Lee P, Close SL, Shen L, Mega JL. The pharmacodynamic effect and clinical efficacy of clopidogrel and prasugrel with and without a proton pump inhibitor. Lancet, in press. 2009.
  92. Wiviott SD, Antman EM. Three generations of thienopyrdines: ticlopidine, clopidogrel, and prasugrel. Freedman JE, Loscalzo (eds.) New Therapeutic Agents in Thrombosis and Thrombolysis. 2009.
  93. O'Donoghue M, Wiviott SD, Murphy SA, Bates ER, Sabatine MS, Mega JL, Desai NR, McCabe CH, Antman EM, Braunwald E. Absence of an interaction between drugs metabolized by Cytochrome P450 enzymes and the benefit of treatment with prasugrel versus clopidogrel in patients with acute coronary syndromes undergoing percutaneous intervention: a TRITON TIMI-38 analysis. J Am Coll Cardiol. 2009; in press.
  94. Wiviott SD, Antman EM. Assessment and initial management of ST-segment elevation myocardial infarction. Mushlin SB, Greene HL (eds). Decision Making in Medicine: An Algorithmic Approach. 2009; in press.
  95. Mega JL, Close SL, Wiviott SD, Shen L, Hockett RD, Brandt JT, Walker JR, Antman EM, Macias W, Braunwald E, Sabatine MS. Cytochrome p-450 polymorphisms and response to clopidogrel. N Engl J Med. 2009 Jan 22; 360(4):354-62.
    View in: PubMed
  96. Warnes CA, Williams RG, Bashore TM, Child JS, Connolly HM, Dearani JA, del Nido P, Fasules JW, Graham TP, Hijazi ZM, Hunt SA, King ME, Landzberg MJ, Miner PD, Radford MJ, Walsh EP, Webb GD, Smith SC, Jacobs AK, Adams CD, Anderson JL, Antman EM, Buller CE, Creager MA, Ettinger SM, Halperin JL, Hunt SA, Krumholz HM, Kushner FG, Lytle BW, Nishimura RA, Page RL, Riegel B, Tarkington LG, Yancy CW. ACC/AHA 2008 guidelines for the management of adults with congenital heart disease: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines (Writing Committee to Develop Guidelines on the Management of Adults With Congenital Heart Disease). Developed in Collaboration With the American Society of Echocardiography, Heart Rhythm Society, International Society for Adult Congenital Heart Disease, Society for Cardiovascular Angiography and Interventions, and Society of Thoracic Surgeons. J Am Coll Cardiol. 2008 Dec 2; 52(23):e143-263.
    View in: PubMed
  97. Morrow DA, Antman EM. Evaluation of high-sensitivity assays for cardiac troponin. Clin Chem. 2009 Jan; 55(1):5-8.
    View in: PubMed
  98. Mahaffey KW, Tonev ST, Spinler SA, Levine GN, Gallo R, Ducas J, Goodman SG, Antman EM, Becker RC, Langer A, White HD, Aylward PE, Col JJ, Ferguson JJ, Califf RM. Obesity in patients with non-ST-segment elevation acute coronary syndromes: results from the SYNERGY trial. Int J Cardiol. 2010 Mar 4; 139(2):123-33.
    View in: PubMed
  99. Bhatt DL, Scheiman J, Abraham NS, Antman EM, Chan FK, Furberg CD, Johnson DA, Mahaffey KW, Quigley EM, Harrington RA, Bates ER, Bridges CR, Eisenberg MJ, Ferrari VA, Hlatky MA, Kaul S, Lindner JR, Moliterno DJ, Mukherjee D, Schofield RS, Rosenson RS, Stein JH, Weitz HH, Wesley DJ. ACCF/ACG/AHA 2008 expert consensus document on reducing the gastrointestinal risks of antiplatelet therapy and NSAID use: a report of the American College of Cardiology Foundation Task Force on Clinical Expert Consensus Documents. J Am Coll Cardiol. 2008 Oct 28; 52(18):1502-17.
    View in: PubMed
  100. Antman EM. Time is muscle: translation into practice. J Am Coll Cardiol. 2008 Oct 7; 52(15):1216-21.
    View in: PubMed
  101. Bhatt DL, Scheiman J, Abraham NS, Antman EM, Chan FK, Furberg CD, Johnson DA, Mahaffey KW, Quigley EM. ACCF/ACG/AHA 2008 expert consensus document on reducing the gastrointestinal risks of antiplatelet therapy and NSAID use: a report of the American College of Cardiology Foundation Task Force on Clinical Expert Consensus Documents. Circulation. 2008 Oct 28; 118(18):1894-909.
    View in: PubMed
  102. Bhatt DL, Scheiman J, Abraham NS, Antman EM, Chan FK, Furberg CD, Johnson DA, Mahaffey KW, Quigley EM, Harrington RA, Bates ER, Bridges CR, Eisenberg MJ, Ferrari VA, Hlatky MA, Kaul S, Lindner JR, Moliterno DJ, Mukherjee D, Schofield RS, Rosenson RS, Stein JH, Weitz HH, Wesley DJ. ACCF/ACG/AHA 2008 expert consensus document on reducing the gastrointestinal risks of antiplatelet therapy and NSAID use. Am J Gastroenterol. 2008 Nov; 103(11):2890-907.
    View in: PubMed
  103. Antman EM. The specialty of emergency medicine: needed now more than ever before. Ann Emerg Med. 2008 Oct; 52(4):317-9.
    View in: PubMed
  104. Wiviott SD, Braunwald E, Angiolillo DJ, Meisel S, Dalby AJ, Verheugt FW, Goodman SG, Corbalan R, Purdy DA, Murphy SA, McCabe CH, Antman EM. Greater clinical benefit of more intensive oral antiplatelet therapy with prasugrel in patients with diabetes mellitus in the trial to assess improvement in therapeutic outcomes by optimizing platelet inhibition with prasugrel-Thrombolysis in Myocardial Infarction 38. Circulation. 2008 Oct 14; 118(16):1626-36.
    View in: PubMed
  105. Gibson CM, Pride YB, Aylward PE, Col JJ, Goodman SG, Gulba D, Bergovec M, Kunadian V, Zorkun C, Buros JL, Murphy SA, Antman EM. Association of non-steroidal anti-inflammatory drugs with outcomes in patients with ST-segment elevation myocardial infarction treated with fibrinolytic therapy: an ExTRACT-TIMI 25 analysis. J Thromb Thrombolysis. 2009 Jan; 27(1):11-7.
    View in: PubMed
  106. Murphy SA, Antman EM, Wiviott SD, Weerakkody G, Morocutti G, Huber K, Lopez-Sendon J, McCabe CH, Braunwald E. Reduction in recurrent cardiovascular events with prasugrel compared with clopidogrel in patients with acute coronary syndromes from the TRITON-TIMI 38 trial. Eur Heart J. 2008 Oct; 29(20):2473-9.
    View in: PubMed
  107. Antman EM, Morrow DA. Biomarker release after percutaneous coronary intervention: a message from the heart. Circ Cardiovasc Interv. 2008 Aug; 1(1):3-6.
    View in: PubMed
  108. Choudhry NK, Brennan T, Toscano M, Spettell C, Glynn RJ, Rubino M, Schneeweiss S, Brookhart AM, Fernandes J, Mathew S, Christiansen B, Antman EM, Avorn J, Shrank WH. Rationale and design of the Post-MI FREEE trial: a randomized evaluation of first-dollar drug coverage for post-myocardial infarction secondary preventive therapies. Am Heart J. 2008 Jul; 156(1):31-6.
    View in: PubMed
  109. Pollack CV, Antman EM, Hollander JE. 2007 focused update to the ACC/AHA guidelines for the management of patients with ST-segment elevation myocardial infarction: implications for emergency department practice. Ann Emerg Med. 2008 Oct; 52(4):344-355.e1.
    View in: PubMed
  110. Antman EM, Wiviott SD, Murphy SA, Voitk J, Hasin Y, Widimsky P, Chandna H, Macias W, McCabe CH, Braunwald E. Early and late benefits of prasugrel in patients with acute coronary syndromes undergoing percutaneous coronary intervention: a TRITON-TIMI 38 (TRial to Assess Improvement in Therapeutic Outcomes by Optimizing Platelet InhibitioN with Prasugrel-Thrombolysis In Myocardial Infarction) analysis. J Am Coll Cardiol. 2008 May 27; 51(21):2028-33.
    View in: PubMed
  111. Leung S, Gallup D, Mahaffey KW, Cohen M, Antman EM, Goodman SG, Harrington RA, Langer A, Aylward P, Ferguson JJ, Califf RM. Smoking status and antithrombin therapy in patients with non-ST-segment elevation acute coronary syndrome. Am Heart J. 2008 Jul; 156(1):177-84.
    View in: PubMed
  112. Wiviott SD, Braunwald E, McCabe CH, Horvath I, Keltai M, Herrman JP, Van de Werf F, Downey WE, Scirica BM, Murphy SA, Antman EM. Intensive oral antiplatelet therapy for reduction of ischaemic events including stent thrombosis in patients with acute coronary syndromes treated with percutaneous coronary intervention and stenting in the TRITON-TIMI 38 trial: a subanalysis of a randomised trial. Lancet. 2008 Apr 19; 371(9621):1353-63.
    View in: PubMed
  113. Wiviott SD, Braunwald E, Murphy SA, Antman EM. A perspective on the efficacy and safety of intensive antiplatelet therapy in the trial to assess improvement in therapeutic outcomes by optimizing platelet inhibition with prasugrel-thrombolysis in myocardial infarction 38. Am J Cardiol. 2008 May 1; 101(9):1367-70.
    View in: PubMed
  114. Fleisher LA, Beckman JA, Brown KA, Calkins H, Chaikof E, Fleischmann KE, Freeman WK, Froehlich JB, Kasper EK, Kersten JR, Riegel B, Robb JF, Smith SC, Jacobs AK, Adams CD, Anderson JL, Antman EM, Buller CE, Creager MA, Ettinger SM, Faxon DP, Fuster V, Halperin JL, Hiratzka LF, Hunt SA, Lytle BW, Nishimura R, Ornato JP, Page RL, Riegel B, Tarkington LG, Yancy CW. ACC/AHA 2007 guidelines on perioperative cardiovascular evaluation and care for noncardiac surgery: executive summary: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines (Writing Committee to Revise the 2002 Guidelines on Perioperative Cardiovascular Evaluation for Noncardiac Surgery). Anesth Analg. 2008 Mar; 106(3):685-712.
    View in: PubMed
  115. Choudhry NK, Patrick AR, Antman EM, Avorn J, Shrank WH. Cost-effectiveness of providing full drug coverage to increase medication adherence in post-myocardial infarction Medicare beneficiaries. Circulation. 2008 Mar 11; 117(10):1261-8.
    View in: PubMed
  116. Antman EM. Is fondaparinux safer than enoxaparin for patients undergoing percutaneous coronary intervention? Nat Clin Pract Cardiovasc Med. 2008 Apr; 5(4):184-5.
    View in: PubMed
  117. Mahaffey KW, Yang Q, Pieper KS, Antman EM, White HD, Goodman SG, Cohen M, Kleiman NS, Langer A, Aylward PE, Col JJ, Reist C, Ferguson JJ, Califf RM. Prediction of one-year survival in high-risk patients with acute coronary syndromes: results from the SYNERGY trial. J Gen Intern Med. 2008 Mar; 23(3):310-6.
    View in: PubMed
  118. Antman EM, Hand M, Armstrong PW, Bates ER, Green LA, Halasyamani LK, Hochman JS, Krumholz HM, Lamas GA, Mullany CJ, Pearle DL, Sloan MA, Smith SC, Anbe DT, Kushner FG, Ornato JP, Pearle DL, Sloan MA, Jacobs AK, Adams CD, Anderson JL, Buller CE, Creager MA, Ettinger SM, Halperin JL, Hunt SA, Lytle BW, Nishimura R, Page RL, Riegel B, Tarkington LG, Yancy CW. 2007 focused update of the ACC/AHA 2004 guidelines for the management of patients with ST-elevation myocardial infarction: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines. J Am Coll Cardiol. 2008 Jan 15; 51(2):210-47.
    View in: PubMed
  119. Ahmed S, Cannon CP, Giugliano RP, Murphy SA, Morrow DA, Antman EM, Braunwald E, Gibson CM. The independent and combined risk of diabetes and non-endstage renal impairment in non-ST-segment elevation acute coronary syndromes. Int J Cardiol. 2008 Dec 17; 131(1):105-12.
    View in: PubMed
  120. Dalby AJ, Wiviott SD, Murphy SA, Dawood SY, Antman EM. The influence of the arterial access site and its management of bleeding events in acute coronary syndromes in TRITON-TIMI 38. Circulation. 2008; 118(Suppl2):S638.
  121. Antman EM. The future of reperfusion therapy. Bates ER (ed.) Reperfusion Therapy for Acute Myocardial Infarction. 2008.
  122. Salazar DE, Ernest CS, Wrishko RE, Weerakkody GJ, Small DS, Li YG, Rhohatagi S, Dornseif BE, Ni L, Antman EM, Wiviott SD, Macias WL, Reismeyer JS. Relationship between exposure to the prasugrel active metabolite with TIMI major/minor bleeding in TRITON-TIMI 38. Circulation. 2008; 118(Suppl2):S815.
  123. Frelinger AL, Michelson AD, Wiviott SD, Trenk D, Neumann FJ, Miller DL, Jakuboswki JA, Costigan TM, McCabe CH, Antman EM, Braunwald E. Intrinsic platelet variability in response to ADP before exposure to thienopyridines contributes to the variability in residual platelet reactivity to ADP after treatment with clopidogrel or prasugrel: results from PRINCIPLE-TIMI 44. Circulation. 2008; 118(Suppl2):S814.
  124. Fleisher LA, Beckman JA, Brown KA, Calkins H, Chaikoff EL, Fleischmann KE, Freeman WK, Froehlich JB, Kasper EK, Kersten JR, Riegel B, Robb JF, Smith SC Jr., Jacobs AK, Adams CD, Anderson JL, Antman EM, Buller CE, Creager MA, Ettinger SM, Faxon DP, Fuster V, Halperin JL, Hiratzka LF, Hunt SA, Lytle BW, Nishimura R, Ornato JP, Page RL, Riegel B, Tarkington LG, Yancy CW. ACC/AHA 2007 guidelines on perioperative cardiovascular evaluation and care for noncardiac surgery: executive summary. Anesth Analg. 2008; 106:685-712.
  125. Antman EM, Braunwald E. ST-Segment Elevation Myocardial Infarction. In: Fauci AS, Kasper DL, Longo DL, Braunwald E, Hauser SL, Jameson JL, Loscalzo J (eds). Harrison's Principles of Internal Medicine. 2008; 1532-1544.
  126. Antman EM, Loscalzo J. Ischemic Heart Disease. In: Fauci AS, Kasper DL, Longo DL, Braunwald E, Hauser SL, Jameson JL, Loscalzo J (eds). Harrison's Principles of Internal Medicine. 2008; 1514-1527.
  127. Antman EM. ST-Elevation Myocardial Infarction: Management. Libby P, Bonow RO, Mann DL, Zipes DP (eds.). Braunwald's Heart Disease: A Textbook of Cardiovascular Medicine. 2008; 1233-1299.
  128. Schoen MW, Antman EM, Strichartz GR, Lilly LS. Cardiovascular drugs. Pathophysiology of Heart Disease. 2008; in press:397-449.
  129. Wiviott SD, Ruff CT, Antman EM, Murphy SA, Ver Lee PN, White HD, Braunwald E. Regional safety and efficacy of prasugrel compared to clopidogrel: a TRITON-TIMI 38 analysis. Circulation. 2008; 118(Suppl2):S917.
  130. Frelinger AL, Michelson AD, Braunwald E, Trenk D, Neumann FJ, Miller DL, Jakubowski JA, Cairns R, Murphy SA, McCabe CH, Antman EM, Wiviott SD. Comparison of the effects of prasugrel and high dose clopidogrel on in vivo and in vitro platelet activation: results from PRINCIPLE-TIMI 44. Circulation. 2008; 118(Suppl2):S814.
  131. Mega JL, Shen L, Wiviott SD, Walker JR, Hockett RD, Brandt JT, Moser BA, Macias W, Antman EM, Close SL, Sabatine MS. Cytochrome P450 genetic variants predict cardiovascular outcomes following treatment with clopidogrel but not with prasugrel. Circulation. 2008; 118(Suppl2):S325.
  132. Forman DE, Giugliano RP, Cannon CP, Morrow DA, Qin J, Antman EM, Braunwald E. A simple TIMI discharge risk score post ACS predicts CV mortality at 2 years. Circulation. 2008; 218(Suppl2):S1060.
  133. Frelinger AL, Michelson AD, Braunwald E, Downey WE, Angiolillo DJ, Xenopoulos NP, Jakubowski JA, Li Y, Murphy SA, McCabe CH, Antman EM, Wiviott SD. Pharmacodynamic assessment of platelet inhibition by prasugrel versus clopidogrel in the TRITON-TIMI 38 trial. Circulation. 2008; 118(Suppl2):S814.
  134. Wiviott SD, Antman EM. Prasugrel--a third-generation thienopyridine. Angiolillo DJ, Kastrati A, Simon DI (eds). Clinical Guide to the Use of Antithrombotic Drugs in Coronary Artery Disease. 2008; 79-84.
  135. Mega JL, Wiviott SD, Mohanavelu S, Nicolau JC, McCabe CH, Antman EM, Braunwald E. Cardiovascular outcomes of woman and men with acute coronary syndromes and angiographically confirmed epicardial coronary artery disease in TRITON-TIMI 38. Circulation. 2008; 118(Suppl2):S967.
  136. Gibson CM, Pride YB, Mohanavelu S, Wiviott SD, Antman EM, Braunwald E. Angiographic and clinical outcomes among patients with acute coronary syndrome presenting with isolated anterior ST-segment depressions. Circulation. 2008; 118(Suppl2):S654.
  137. Antman EM, Hand M, Armstrong PW, Bates ER, Green LA, Halasyamani LK, Hochman JS, Krumholz HM, Lamas GA, Mullany CJ, Pearle DL, Sloan MA, Smith SC. 2007 Focused Update of the ACC/AHA 2004 Guidelines for the Management of Patients With ST-Elevation Myocardial Infarction: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines: developed in collaboration With the Canadian Cardiovascular Society endorsed by the American Academy of Family Physicians: 2007 Writing Group to Review New Evidence and Update the ACC/AHA 2004 Guidelines for the Management of Patients With ST-Elevation Myocardial Infarction, Writing on Behalf of the 2004 Writing Committee. Circulation. 2008 Jan 15; 117(2):296-329.
    View in: PubMed
  138. Wiviott SD, Trenk D, Frelinger AL, O'Donoghue M, Neumann FJ, Michelson AD, Angiolillo DJ, Hod H, Montalescot G, Miller DL, Jakubowski JA, Cairns R, Murphy SA, McCabe CH, Antman EM, Braunwald E. Prasugrel compared with high loading- and maintenance-dose clopidogrel in patients with planned percutaneous coronary intervention: the Prasugrel in Comparison to Clopidogrel for Inhibition of Platelet Activation and Aggregation-Thrombolysis in Myocardial Infarction 44 trial. Circulation. 2007 Dec 18; 116(25):2923-32.
    View in: PubMed
  139. Morrow DA, Antman EM, Murphy SA, Qin J, Ruda M, Guneri S, Jacob AJ, Budaj A, Braunwald E. Effect of enoxaparin versus unfractionated heparin in diabetic patients with ST-elevation myocardial infarction in the Enoxaparin and Thrombolysis Reperfusion for Acute Myocardial Infarction Treatment-Thrombolysis In Myocardial Infarction study 25 (ExTRACT-TIMI 25) trial. Am Heart J. 2007 Dec; 154(6):1078-84, 1084.e1.
    View in: PubMed
  140. Tricoci P, Lokhnygina Y, Berdan LG, Steinhubl SR, Gulba DC, White HD, Kleiman NS, Aylward PE, Langer A, Califf RM, Ferguson JJ, Antman EM, Newby LK, Harrington RA, Goodman SG, Mahaffey KW. Time to coronary angiography and outcomes among patients with high-risk non ST-segment elevation acute coronary syndromes: results from the SYNERGY trial. Circulation. 2007 Dec 4; 116(23):2669-77.
    View in: PubMed
  141. Wiviott SD, Braunwald E, McCabe CH, Montalescot G, Ruzyllo W, Gottlieb S, Neumann FJ, Ardissino D, De Servi S, Murphy SA, Riesmeyer J, Weerakkody G, Gibson CM, Antman EM. Prasugrel versus clopidogrel in patients with acute coronary syndromes. N Engl J Med. 2007 Nov 15; 357(20):2001-15.
    View in: PubMed
  142. Ruff CT, Wiviott SD, Morrow DA, Mohanavelu S, Murphy SA, Antman EM, Braunwald E. TIMI risk index and the benefit of enoxaparin in patients with ST-elevation myocardial infarction. Am J Med. 2007 Nov; 120(11):993-8.
    View in: PubMed
  143. Yeh RW, Wiviott SD, Giugliano RP, Morrow DA, Shui A, Qin J, Scirica B, Bradner JE, Jang IK, Gibson CM, Antman EM. Effect of thrombocytopenia on outcomes following treatment with either enoxaparin or unfractionated heparin in patients presenting with acute coronary syndromes. Am J Cardiol. 2007 Dec 15; 100(12):1734-8.
    View in: PubMed
  144. Fleisher LA, Beckman JA, Brown KA, Calkins H, Chaikof EL, Chaikof E, Fleischmann KE, Freeman WK, Froehlich JB, Kasper EK, Kersten JR, Riegel B, Robb JF, Smith SC, Jacobs AK, Adams CD, Anderson JL, Antman EM, Buller CE, Creager MA, Ettinger SM, Faxon DP, Fuster V, Halperin JL, Hiratzka LF, Hunt SA, Lytle BW, Nishimura R, Ornato JP, Page RL, Riegel B, Tarkington LG, Yancy CW. ACC/AHA 2007 Guidelines on Perioperative Cardiovascular Evaluation and Care for Noncardiac Surgery: Executive Summary: A Report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines (Writing Committee to Revise the 2002 Guidelines on Perioperative Cardiovascular Evaluation for Noncardiac Surgery) Developed in Collaboration With the American Society of Echocardiography, American Society of Nuclear Cardiology, Heart Rhythm Society, Society of Cardiovascular Anesthesiologists, Society for Cardiovascular Angiography and Interventions, Society for Vascular Medicine and Biology, and Society for Vascular Surgery. J Am Coll Cardiol. 2007 Oct 23; 50(17):1707-32.
    View in: PubMed
  145. Fleisher LA, Beckman JA, Brown KA, Calkins H, Chaikof EL, Chaikof E, Fleischmann KE, Freeman WK, Froehlich JB, Kasper EK, Kersten JR, Riegel B, Robb JF, Smith SC, Jacobs AK, Adams CD, Anderson JL, Antman EM, Buller CE, Creager MA, Ettinger SM, Faxon DP, Fuster V, Halperin JL, Hiratzka LF, Hunt SA, Lytle BW, Nishimura R, Ornato JP, Page RL, Riegel B, Tarkington LG, Yancy CW. ACC/AHA 2007 guidelines on perioperative cardiovascular evaluation and care for noncardiac surgery: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines (Writing Committee to Revise the 2002 Guidelines on Perioperative Cardiovascular Evaluation for Noncardiac Surgery) developed in collaboration with the American Society of Echocardiography, American Society of Nuclear Cardiology, Heart Rhythm Society, Society of Cardiovascular Anesthesiologists, Society for Cardiovascular Angiography and Interventions, Society for Vascular Medicine and Biology, and Society for Vascular Surgery. J Am Coll Cardiol. 2007 Oct 23; 50(17):e159-241.
    View in: PubMed
  146. Thygesen K, Alpert JS, White HD. Universal definition of myocardial infarction. Circulation. 2007 Nov 27; 116(22):2634-53.
    View in: PubMed
  147. Fleisher LA, Beckman JA, Brown KA, Calkins H, Chaikof E, Fleischmann KE, Freeman WK, Froehlich JB, Kasper EK, Kersten JR, Riegel B, Robb JF, Smith SC, Jacobs AK, Adams CD, Anderson JL, Antman EM, Buller CE, Creager MA, Ettinger SM, Faxon DP, Fuster V, Halperin JL, Hiratzka LF, Hunt SA, Lytle BW, Nishimura R, Ornato JP, Page RL, Tarkington LG, Yancy CW. ACC/AHA 2007 guidelines on perioperative cardiovascular evaluation and care for noncardiac surgery: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines (Writing Committee to Revise the 2002 Guidelines on Perioperative Cardiovascular Evaluation for Noncardiac Surgery): developed in collaboration with the American Society of Echocardiography, American Society of Nuclear Cardiology, Heart Rhythm Society, Society of Cardiovascular Anesthesiologists, Society for Cardiovascular Angiography and Interventions, Society for Vascular Medicine and Biology, and Society for Vascular Surgery. Circulation. 2007 Oct 23; 116(17):e418-99.
    View in: PubMed
  148. Fleisher LA, Beckman JA, Brown KA, Calkins H, Chaikof E, Fleischmann KE, Freeman WK, Froehlich JB, Kasper EK, Kersten JR, Riegel B, Robb JF, Smith SC, Jacobs AK, Adams CD, Anderson JL, Antman EM, Buller CE, Creager MA, Ettinger SM, Faxon DP, Fuster V, Halperin JL, Hiratzka LF, Hunt SA, Lytle BW, Nishimura R, Ornato JP, Page RL, Riegel B, Tarkington LG, Yancy CW. ACC/AHA 2007 Guidelines on Perioperative Cardiovascular Evaluation and Care for Noncardiac Surgery: Executive Summary: A Report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines (Writing Committee to Revise the 2002 Guidelines on Perioperative Cardiovascular Evaluation for Noncardiac Surgery): Developed in Collaboration With the American Society of Echocardiography, American Society of Nuclear Cardiology, Heart Rhythm Society, Society of Cardiovascular Anesthesiologists, Society for Cardiovascular Angiography and Interventions, Society for Vascular Medicine and Biology, and Society for Vascular Surgery. Circulation. 2007 Oct 23; 116(17):1971-96.
    View in: PubMed
  149. Donahoe SM, Stewart GC, McCabe CH, Mohanavelu S, Murphy SA, Cannon CP, Antman EM. Diabetes and mortality following acute coronary syndromes. JAMA. 2007 Aug 15; 298(7):765-75.
    View in: PubMed
  150. Anderson JL, Adams CD, Antman EM, Bridges CR, Califf RM, Casey DE, Chavey WE, Fesmire FM, Hochman JS, Levin TN, Lincoff AM, Peterson ED, Theroux P, Wenger NK, Wright RS, Smith SC, Jacobs AK, Adams CD, Anderson JL, Antman EM, Halperin JL, Hunt SA, Krumholz HM, Kushner FG, Lytle BW, Nishimura R, Ornato JP, Page RL, Riegel B. ACC/AHA 2007 guidelines for the management of patients with unstable angina/non-ST-Elevation myocardial infarction: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines (Writing Committee to Revise the 2002 Guidelines for the Management of Patients With Unstable Angina/Non-ST-Elevation Myocardial Infarction) developed in collaboration with the American College of Emergency Physicians, the Society for Cardiovascular Angiography and Interventions, and the Society of Thoracic Surgeons endorsed by the American Association of Cardiovascular and Pulmonary Rehabilitation and the Society for Academic Emergency Medicine. J Am Coll Cardiol. 2007 Aug 14; 50(7):e1-e157.
    View in: PubMed
  151. Anderson JL, Adams CD, Antman EM, Bridges CR, Califf RM, Casey DE, Chavey WE, Fesmire FM, Hochman JS, Levin TN, Lincoff AM, Peterson ED, Theroux P, Wenger NK, Wright RS, Smith SC, Jacobs AK, Halperin JL, Hunt SA, Krumholz HM, Kushner FG, Lytle BW, Nishimura R, Ornato JP, Page RL, Riegel B. ACC/AHA 2007 guidelines for the management of patients with unstable angina/non ST-elevation myocardial infarction: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines (Writing Committee to Revise the 2002 Guidelines for the Management of Patients With Unstable Angina/Non ST-Elevation Myocardial Infarction): developed in collaboration with the American College of Emergency Physicians, the Society for Cardiovascular Angiography and Interventions, and the Society of Thoracic Surgeons: endorsed by the American Association of Cardiovascular and Pulmonary Rehabilitation and the Society for Academic Emergency Medicine. Circulation. 2007 Aug 14; 116(7):e148-304.
    View in: PubMed
  152. Steinberg BA, Moghbeli N, Buros J, Ruda M, Parkhomenko A, Raju BS, García-Castillo A, Janion M, Nicolau JC, Fox KA, Morrow DA, Gibson CM, Antman EM. Global outcomes of ST-elevation myocardial infarction: comparisons of the Enoxaparin and Thrombolysis Reperfusion for Acute Myocardial Infarction Treatment-Thrombolysis In Myocardial Infarction study 25 (ExTRACT-TIMI 25) registry and trial. Am Heart J. 2007 Jul; 154(1):54-61.
    View in: PubMed
  153. Murphy SA, Gibson CM, Morrow DA, Van de Werf F, Menown IB, Goodman SG, Mahaffey KW, Cohen M, McCabe CH, Antman EM, Braunwald E. Efficacy and safety of the low-molecular weight heparin enoxaparin compared with unfractionated heparin across the acute coronary syndrome spectrum: a meta-analysis. Eur Heart J. 2007 Sep; 28(17):2077-86.
    View in: PubMed
  154. Scirica BM, Morrow DA, Sadowski Z, Ruda M, Nicolau JC, Giugliano RP, Wiviott SD, Sabatine MS, Shui A, Antman EM, Braunwald E. A strategy of using enoxaparin as adjunctive antithrombin therapy reduces death and recurrent myocardial infarction in patients who achieve early ST-segment resolution after fibrinolytic therapy: the ExTRACT-TIMI 25 ECG study. Eur Heart J. 2007 Sep; 28(17):2070-6.
    View in: PubMed
  155. Giraldez RR, Nicolau JC, Corbalan R, Gurfinkel EP, Juarez U, Lopez-Sendon J, Parkhomenko A, Molhoek P, Mohanavelu S, Morrow DA, Antman EM. Enoxaparin is superior to unfractionated heparin in patients with ST elevation myocardial infarction undergoing fibrinolysis regardless of the choice of lytic: an ExTRACT-TIMI 25 analysis. Eur Heart J. 2007 Jul; 28(13):1566-73.
    View in: PubMed
  156. Jacobs AK, Antman EM, Faxon DP, Gregory T, Solis P. Development of systems of care for ST-elevation myocardial infarction patients: executive summary. Circulation. 2007 Jul 10; 116(2):217-30.
    View in: PubMed
  157. Mensah GA, Hand MM, Antman EM, Ryan TJ, Schriever R, Smith SC. Development of systems of care for ST-elevation myocardial infarction patients: the patient and public perspective. Circulation. 2007 Jul 10; 116(2):e33-8.
    View in: PubMed
  158. Fox KA, Antman EM, Montalescot G, Agewall S, SomaRaju B, Verheugt FW, Lopez-Sendon J, Hod H, Murphy SA, Braunwald E. The impact of renal dysfunction on outcomes in the ExTRACT-TIMI 25 trial. J Am Coll Cardiol. 2007 Jun 12; 49(23):2249-55.
    View in: PubMed
  159. Sabatine MS, Morrow DA, Dalby A, Pfisterer M, Duris T, Lopez-Sendon J, Murphy SA, Gao R, Antman EM, Braunwald E. Efficacy and safety of enoxaparin versus unfractionated heparin in patients with ST-segment elevation myocardial infarction also treated with clopidogrel. J Am Coll Cardiol. 2007 Jun 12; 49(23):2256-63.
    View in: PubMed
  160. Gibson CM, Murphy SA, Montalescot G, Morrow DA, Ardissino D, Cohen M, Gulba DC, Kracoff OH, Lewis BS, Roguin N, Antman EM, Braunwald E. Percutaneous coronary intervention in patients receiving enoxaparin or unfractionated heparin after fibrinolytic therapy for ST-segment elevation myocardial infarction in the ExTRACT-TIMI 25 trial. J Am Coll Cardiol. 2007 Jun 12; 49(23):2238-46.
    View in: PubMed
  161. Mega JL, Morrow DA, Ostör E, Dorobantu M, Qin J, Antman EM, Braunwald E. Outcomes and optimal antithrombotic therapy in women undergoing fibrinolysis for ST-elevation myocardial infarction. Circulation. 2007 Jun 5; 115(22):2822-8.
    View in: PubMed
  162. White HD, Braunwald E, Murphy SA, Jacob AJ, Gotcheva N, Polonetsky L, Antman EM. Enoxaparin vs. unfractionated heparin with fibrinolysis for ST-elevation myocardial infarction in elderly and younger patients: results from ExTRACT-TIMI 25. Eur Heart J. 2007 May; 28(9):1066-71.
    View in: PubMed
  163. Miller CD, Banerjee A, Mahaffey KW, Kontos MC, Fermann G, Pollack CV, Antman E, Aylward P, Goodman SG, Santos R, Ferguson JJ, Califf RM, Hoekstra JW. Treatment and outcomes of patients with evolving myocardial infarction: experiences from the SYNERGY trial. Eur Heart J. 2007 May; 28(9):1079-84.
    View in: PubMed
  164. Fuster V, Rydén LE, Cannom DS, Crijns HJ, Curtis AB, Ellenbogen KA, Halperin JL, Le Heuzey JY, Kay GN, Lowe JE, Olsson SB, Prystowsky EN, Tamargo JL, Wann S, Priori SG, Blanc JJ, Budaj A, Camm AJ, Dean V, Deckers JW, Despres C, Dickstein K, Lekakis J, McGregor K, Metra M, Morais J, Osterspey A, Zamorano JL, Smith SC, Jacobs AK, Adams CD, Anderson JL, Antman EM, Hunt SA, Nishimura R, Ornato JP, Page RL, Riegel B. [ACC/AHA/ESC 2006 guidelines for the management of patients with atrial fibrillation--excutive summary]. Rev Port Cardiol. 2007 Apr; 26(4):383-446.
    View in: PubMed
  165. Antman EM, Bennett JS, Daugherty A, Furberg C, Roberts H, Taubert KA. Use of nonsteroidal antiinflammatory drugs: an update for clinicians: a scientific statement from the American Heart Association. Circulation. 2007 Mar 27; 115(12):1634-42.
    View in: PubMed
  166. Cantor WJ, Mahaffey KW, Huang Z, Das P, Gulba DC, Glezer S, Gallo R, Ducas J, Cohen M, Antman EM, Langer A, Kleiman NS, White HD, Chisholm RJ, Harrington RA, Ferguson JJ, Califf RM, Goodman SG. Bleeding complications in patients with acute coronary syndrome undergoing early invasive management can be reduced with radial access, smaller sheath sizes, and timely sheath removal. Catheter Cardiovasc Interv. 2007 Jan; 69(1):73-83.
    View in: PubMed
  167. Giraldez RR, Sabatine MS, Morrow DA, Shui A, McCabe CH, Antman EM, Braunwald E. Baseline hemoglobin and white blood cell composite CBC index improves risk stratification in STEMI patients. Journal of the American College of Cardiology. 2007; 49(Suppl1):224A.
  168. Fleisher LA, Beckman JA, Brown KA, Calkins H, Chaikoff EL, Fleischmann KE, Freeman WK, Froehlich JB, Kasper EK, Kersten JR, Riegel B, Robb JF, Smith SC Jr., Jacobs AK, Adams CD, Anderson JL, Antman EM, Buller CE, Creager MA, Ettinger SM, Faxon DP, Fuster V, Halperin JL, Hiratzka LF, Hunt SA, Lytle BW, Nishimura R, Ornato JP, Page RL, Riegel B, Tarkington LG, Yancy CW. ACC/AHA 2007 guidelines on perioperative cardiovascular evaluation and care for noncardiac surgery: executive summary. Circulation. 2007; 116:1971-1996.
  169. Fleisher LA, Beckman JA, Brown KA, Calkins H, Chaikoff EL, Fleischmann KE, Freeman WK, Froehlich JB, Kasper EK, Kersten JR, Riegel B, Robb JF, Smith SC Jr., Jacobs AK, Adams CD, Anderson JL, Antman EM, Buller CE, Creager MA, Ettinger SM, Faxon DP, Fuster V, Halperin JL, Hiratzka LF, Hunt SA, Lytle BW, Nishimura R, Ornato JP, Page RL, Riegel B, Tarkington LG, Yancy CW. ACC/AHA 2007 guidelines on perioperative cardiovascular evaluation and care for noncardiac surgery: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines (Writing Committee to Revise the 2002 Guidelines on Perioperative Cardiovascular Evaluation for Noncardiac Surgery). Journal of the American College of Cardiology. 2007; 50:e159-241.
  170. Fleisher LA, Beckman JA, Brown KA, Calkins H, Chaikoff EL, Fleischmann KE, Freeman WK, Froehlich JB, Kasper EK, Kersten JR, Riegel B, Robb JF, Smith SC Jr., Jacobs AK, Adams CD, Anderson JL, Antman EM, Buller CE, Creager MA, Ettinger SM, Faxon DP, Fuster V, Halperin JL, Hiratzka LF, Hunt SA, Lytle BW, Nishimura R, Ornato JP, Page RL, Riegel B, Tarkington LG, Yancy CW. ACC/AHA 2007 guidelines on perioperative cardiovascular evaluation and care for noncardiac surgery: executive summary. Journal of the American College of Cardiology. 2007; 50:1707-1732.
  171. Nguyen M, Murphy SA, Mega JL, Brieger D, Antman EM, Gibson CM. Triple therapy (TTx): ASA, thienopyridine and oral anticoagulation (OA) therapy following ST elevation myocardial infarction (STEMI): is it safe?. Circulation. 2007; 116:II_483.
  172. Giraldez RR, Antman EM, Giugliano RP. The challenge of treating ST-segment elevation myocardial infarction in the elderly. Thrombosis Clinic. 2007; 1:27-41.
  173. Bonaca MP, Wiviott SD, Sabatine M, Buros J, Murphy SA, Scirica BM, Rifai N, Antman EM, Morrow DA. Hemodynamic significance of peri-procedural myocardial injury assessed with N-terminal pro-B-type natriuretic peptide after percutaneous coronary intervention in patients with stable and unstable coronary artery disease (from the JUMBO-TIMI 26 trial). American Journal of Cardiology. 2007; 99:344-348.
  174. Choudhry NK, Avorn J, Antman EM, Schneeweiss S, Shrank WH. Should patients receive secondary prevention medications for free after a myocardial infarction? An economic analysis. Health Aff (Millwood). 2007 Jan-Feb; 26(1):186-94.
    View in: PubMed
  175. Fleisher LA, Beckman JA, Brown KA, Calkins H, Chaikoff EL, Fleischmann KE, Freeman WK, Froehlich JB, Kasper EK, Kersten JR, Riegel B, Robb JF, Smith SC Jr., Jacobs AK, Adams CD, Anderson JL, Antman EM, Buller CE, Creager MA, Ettinger SM, Faxon DP, Fuster V, Halperin JL, Hiratzka LF, Hunt SA, Lytle BW, Nishimura R, Ornato JP, Page RL, Riegel B, Tarkington LG, Yancy CW. ACC/AHA 2007 guidelines on perioperative cardiovascular evaluation and care for noncardiac surgery: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines (Writing Committee to Revise the 2002 Guidelines on Perioperative Cardiovascular Evaluation for Noncardiac Surgery). Circulation. 2007; 116:e418-499.
  176. Antman EM, Murphy SA, Morrow DA, McCabe CH, Braunwald E. Dynamic updating of TIMI risk score for STEMI: an ExTRACT-TIMI 25 analysis. Circulation. 2007; 116:II_675.
  177. Stone SJ, Mahaffey KW, Clare R, Pieper KS, Antman EM, Col J, Ferguson JJ, Califf RM, Hochman JS, Grines CL. Women and men have differences in outcomes and potentially response to antithrombin therapy: preliminary results from subgroup analyses in SYNERGY. Journal of the American College of Cardiology. 2007; 49(Suppl1):191A.
  178. Mega JL, Murphy S, Morrow DA, McCabe CH, Antman EM, Braunwald E, Gibson CM. A risk score to predict sudden cardiac death in patients with ST-elevation myocardial infarction. Journal of the American College of Cardiology. 2007; 49(Suppl1):212A.
  179. Goodman SG, Mahaffey KW, Chiswell K, Cohen M, Kontos MC, Antman EM, Ferguson JJ, Califf RM, Becker R. Activated partial thromboplastin time measurement is not associated with clinical outcomes in patients with high-risk non-ST-segment elevation acute coronary syndromes treated with unfractionated heparin. Journal of the American College of Cardiology. 2007; 49(Suppl1):186A.
  180. Choudhry NK, Avorn J, Antman EM, Schneeweiss S, Shrank WH. Should patients receive secondary prevention medications for free after a myocardial infarction? An economic analysis. Health Affairs. 2007; 26:186-194.
  181. Dzau VJ, Antman EM, Black HR, Hayes DL, Manson JE, Plutzky J, Popma JJ, Stevenson W. The cardiovascular disease continuum validated: clinical evidence of improved patient outcomes: part I: Pathophysiology and clinical trial evidence (risk factors through stable coronary artery disease). Circulation. 2006 Dec 19; 114(25):2850-70.
    View in: PubMed
  182. Dzau VJ, Antman EM, Black HR, Hayes DL, Manson JE, Plutzky J, Popma JJ, Stevenson W. The cardiovascular disease continuum validated: clinical evidence of improved patient outcomes: part II: Clinical trial evidence (acute coronary syndromes through renal disease) and future directions. Circulation. 2006 Dec 19; 114(25):2871-91.
    View in: PubMed
  183. Bonaca MP, Wiviott SD, Sabatine MS, Buros J, Murphy SA, Scirica BM, Rifai N, Antman EM, Morrow DA. Hemodynamic significance of periprocedural myocardial injury assessed with N-terminal pro-B-type natriuretic peptide after percutaneous coronary intervention in patients with stable and unstable coronary artery disease (from the JUMBO-TIMI 26 trial). Am J Cardiol. 2007 Feb 1; 99(3):344-8.
    View in: PubMed
  184. Marple AF, Antman EM, Hand MM. Cardiology patient pages. Modern treatment for heart attacks: opening blocked arteries quickly. Circulation. 2006 Nov 14; 114(20):e578-80.
    View in: PubMed
  185. Pinto DS, Kirtane AJ, Nallamothu BK, Murphy SA, Cohen DJ, Laham RJ, Cutlip DE, Bates ER, Frederick PD, Miller DP, Carrozza JP, Antman EM, Cannon CP, Gibson CM. Hospital delays in reperfusion for ST-elevation myocardial infarction: implications when selecting a reperfusion strategy. Circulation. 2006 Nov 7; 114(19):2019-25.
    View in: PubMed
  186. Wiviott SD, Antman EM, Gibson CM, Montalescot G, Riesmeyer J, Weerakkody G, Winters KJ, Warmke JW, McCabe CH, Braunwald E. Evaluation of prasugrel compared with clopidogrel in patients with acute coronary syndromes: design and rationale for the TRial to assess Improvement in Therapeutic Outcomes by optimizing platelet InhibitioN with prasugrel Thrombolysis In Myocardial Infarction 38 (TRITON-TIMI 38). Am Heart J. 2006 Oct; 152(4):627-35.
    View in: PubMed
  187. Cohen M, Mahaffey KW, Pieper K, Pollack CV, Antman EM, Hoekstra J, Goodman SG, Langer A, Col JJ, White HD, Califf RM, Ferguson JJ. A subgroup analysis of the impact of prerandomization antithrombin therapy on outcomes in the SYNERGY trial: enoxaparin versus unfractionated heparin in non-ST-segment elevation acute coronary syndromes. J Am Coll Cardiol. 2006 Oct 3; 48(7):1346-54.
    View in: PubMed
  188. ACC/AHA/ESC 2006 guidelines for management of patients with ventricular arrhythmias and the prevention of sudden cardiac death: a report of the American College of Cardiology/American Heart Association Task Force and the European Society of Cardiology Committee for Practice Guidelines (Writing Committee to Develop Guidelines for Management of Patients With Ventricular Arrhythmias and the Prevention of Sudden Cardiac Death). J Am Coll Cardiol. 2006 Sep 5; 48(5):e247-346.
    View in: PubMed
  189. Zipes DP, Camm AJ, Borggrefe M, Buxton AE, Chaitman B, Fromer M, Gregoratos G, Klein G, Moss AJ, Myerburg RJ, Priori SG, Quinones MA, Roden DM, Silka MJ, Tracy C, Blanc JJ, Budaj A, Dean V, Deckers JW, Despres C, Dickstein K, Lekakis J, McGregor K, Metra M, Morais J, Osterspey A, Tamargo JL, Zamorano JL, Smith SC, Jacobs AK, Adams CD, Antman EM, Anderson JL, Hunt SA, Halperin JL, Nishimura R, Ornato JP, Page RL, Riegel B. ACC/AHA/ESC 2006 guidelines for management of patients with ventricular arrhythmias and the prevention of sudden cardiac death--executive summary: A report of the American College of Cardiology/American Heart Association Task Force and the European Society of Cardiology Committee for Practice Guidelines (Writing Committee to Develop Guidelines for Management of Patients with Ventricular Arrhythmias and the Prevention of Sudden Cardiac Death) Developed in collaboration with the European Heart Rhythm Association and the Heart Rhythm Society. Eur Heart J. 2006 Sep; 27(17):2099-140.
    View in: PubMed
  190. Fuster V, Rydén LE, Cannom DS, Crijns HJ, Curtis AB, Ellenbogen KA, Halperin JL, Le Heuzey JY, Kay GN, Lowe JE, Olsson SB, Prystowsky EN, Tamargo JL, Wann S, Smith SC, Jacobs AK, Adams CD, Anderson JL, Antman EM, Halperin JL, Hunt SA, Nishimura R, Ornato JP, Page RL, Riegel B, Priori SG, Blanc JJ, Budaj A, Camm AJ, Dean V, Deckers JW, Despres C, Dickstein K, Lekakis J, McGregor K, Metra M, Morais J, Osterspey A, Tamargo JL, Zamorano JL. ACC/AHA/ESC 2006 guidelines for the management of patients with atrial fibrillation: full text: a report of the American College of Cardiology/American Heart Association Task Force on practice guidelines and the European Society of Cardiology Committee for Practice Guidelines (Writing Committee to Revise the 2001 guidelines for the management of patients with atrial fibrillation) developed in collaboration with the European Heart Rhythm Association and the Heart Rhythm Society. Europace. 2006 Sep; 8(9):651-745.
    View in: PubMed
  191. Hirsch AT, Haskal ZJ, Hertzer NR, Bakal CW, Creager MA, Halperin JL, Hiratzka LF, Murphy WR, Olin JW, Puschett JB, Rosenfield KA, Sacks D, Stanley JC, Taylor LM, White CJ, White J, White RA, Antman EM, Smith SC, Adams CD, Anderson JL, Faxon DP, Fuster V, Gibbons RJ, Hunt SA, Jacobs AK, Nishimura R, Ornato JP, Page RL, Riegel B. ACC/AHA Guidelines for the Management of Patients with Peripheral Arterial Disease (lower extremity, renal, mesenteric, and abdominal aortic): a collaborative report from the American Associations for Vascular Surgery/Society for Vascular Surgery, Society for Cardiovascular Angiography and Interventions, Society for Vascular Medicine and Biology, Society of Interventional Radiology, and the ACC/AHA Task Force on Practice Guidelines (writing committee to develop guidelines for the management of patients with peripheral arterial disease)--summary of recommendations. J Vasc Interv Radiol. 2006 Sep; 17(9):1383-97; quiz 1398.
    View in: PubMed
  192. Kereiakes DJ, Antman EM. Clinical guidelines and practice: in search of the truth. J Am Coll Cardiol. 2006 Sep 19; 48(6):1129-35; discussion 1136-8.
    View in: PubMed
  193. Zipes DP, Camm AJ, Borggrefe M, Buxton AE, Chaitman B, Fromer M, Gregoratos G, Klein G, Moss AJ, Myerburg RJ, Priori SG, Quinones MA, Roden DM, Silka MJ, Tracy C, Smith SC, Jacobs AK, Adams CD, Antman EM, Anderson JL, Hunt SA, Halperin JL, Nishimura R, Ornato JP, Page RL, Riegel B, Blanc JJ, Budaj A, Dean V, Deckers JW, Despres C, Dickstein K, Lekakis J, McGregor K, Metra M, Morais J, Osterspey A, Tamargo JL, Zamorano JL. ACC/AHA/ESC 2006 Guidelines for Management of Patients With Ventricular Arrhythmias and the Prevention of Sudden Cardiac Death: a report of the American College of Cardiology/American Heart Association Task Force and the European Society of Cardiology Committee for Practice Guidelines (writing committee to develop Guidelines for Management of Patients With Ventricular Arrhythmias and the Prevention of Sudden Cardiac Death): developed in collaboration with the European Heart Rhythm Association and the Heart Rhythm Society. Circulation. 2006 Sep 5; 114(10):e385-484.
    View in: PubMed
  194. Zipes DP, Camm AJ, Borggrefe M, Buxton AE, Chaitman B, Fromer M, Gregoratos G, Klein G, Moss AJ, Myerburg RJ, Priori SG, Quinones MA, Roden DM, Silka MJ, Tracy C, Priori SG, Blanc JJ, Budaj A, Camm AJ, Dean V, Deckers JW, Despres C, Dickstein K, Lekakis J, McGregor K, Metra M, Morais J, Osterspey A, Tamargo JL, Zamorano JL, Smith SC, Jacobs AK, Adams CD, Antman EM, Anderson JL, Hunt SA, Halperin JL, Nishimura R, Ornato JP, Page RL, Riegel B. ACC/AHA/ESC 2006 guidelines for management of patients with ventricular arrhythmias and the prevention of sudden cardiac death: a report of the American College of Cardiology/American Heart Association Task Force and the European Society of Cardiology Committee for Practice Guidelines (Writing Committee to Develop guidelines for management of patients with ventricular arrhythmias and the prevention of sudden cardiac death) developed in collaboration with the European Heart Rhythm Association and the Heart Rhythm Society. Europace. 2006 Sep; 8(9):746-837.
    View in: PubMed
  195. Fuster V, Rydén LE, Cannom DS, Crijns HJ, Curtis AB, Ellenbogen KA, Halperin JL, Le Heuzey JY, Kay GN, Lowe JE, Olsson SB, Prystowsky EN, Tamargo JL, Wann S, Smith SC, Jacobs AK, Adams CD, Anderson JL, Antman EM, Halperin JL, Hunt SA, Nishimura R, Ornato JP, Page RL, Riegel B, Priori SG, Blanc JJ, Budaj A, Camm AJ, Dean V, Deckers JW, Despres C, Dickstein K, Lekakis J, McGregor K, Metra M, Morais J, Osterspey A, Tamargo JL, Zamorano JL. ACC/AHA/ESC 2006 Guidelines for the Management of Patients with Atrial Fibrillation: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines and the European Society of Cardiology Committee for Practice Guidelines (Writing Committee to Revise the 2001 Guidelines for the Management of Patients With Atrial Fibrillation): developed in collaboration with the European Heart Rhythm Association and the Heart Rhythm Society. Circulation. 2006 Aug 15; 114(7):e257-354.
    View in: PubMed
  196. ACC/AHA/ESC 2006 guidelines for the management of patients with atrial fibrillation--executive summary: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines and the European Society of Cardiology Committee for Practice Guidelines (Writing Committee to Revise the 2001 Guidelines for the Management of Patients With Atrial Fibrillation). J Am Coll Cardiol. 2006 Aug 15; 48(4):854-906.
    View in: PubMed
  197. ACC/AHA 2006 guidelines for the management of patients with valvular heart disease: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines (writing Committee to Revise the 1998 guidelines for the management of patients with valvular heart disease) developed in collaboration with the Society of Cardiovascular Anesthesiologists endorsed by the Society for Cardiovascular Angiography and Interventions and the Society of Thoracic Surgeons. J Am Coll Cardiol. 2006 Aug 1; 48(3):e1-148.
    View in: PubMed
  198. ACC/AHA 2006 guidelines for the management of patients with valvular heart disease: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines (writing committee to revise the 1998 Guidelines for the Management of Patients With Valvular Heart Disease): developed in collaboration with the Society of Cardiovascular Anesthesiologists: endorsed by the Society for Cardiovascular Angiography and Interventions and the Society of Thoracic Surgeons. Circulation. 2006 Aug 1; 114(5):e84-231.
    View in: PubMed
  199. ACC/AHA 2006 guideline update on perioperative cardiovascular evaluation for noncardiac surgery: focused update on perioperative beta-blocker therapy: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines (Writing Committee to Update the 2002 Guidelines on Perioperative Cardiovascular Evaluation for Noncardiac Surgery) developed in collaboration with the American Society of Echocardiography, American Society of Nuclear Cardiology, Heart Rhythm Society, Society of Cardiovascular Anesthesiologists, Society for Cardiovascular Angiography and Interventions, and Society for Vascular Medicine and Biology. J Am Coll Cardiol. 2006 Jun 6; 47(11):2343-55.
    View in: PubMed
  200. Fleisher LA, Beckman JA, Brown KA, Calkins H, Chaikof E, Fleischmann KE, Freeman WK, Froehlich JB, Kasper EK, Kersten JR, Riegel B, Robb JF, Smith SC, Jacobs AK, Adams CD, Anderson JL, Antman EM, Faxon DP, Fuster V, Halperin JL, Hiratzka LF, Hunt SA, Lytle BW, Nishimura R, Page RL, Riegel B. ACC/AHA 2006 guideline update on perioperative cardiovascular evaluation for noncardiac surgery: focused update on perioperative beta-blocker therapy: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines (Writing Committee to Update the 2002 Guidelines on Perioperative Cardiovascular Evaluation for Noncardiac Surgery): developed in collaboration with the American Society of Echocardiography, American Society of Nuclear Cardiology, Heart Rhythm Society, Society of Cardiovascular Anesthesiologists, Society for Cardiovascular Angiography and Interventions, and Society for Vascular Medicine and Biology. Circulation. 2006 Jun 6; 113(22):2662-74.
    View in: PubMed
  201. Dumaine R, Gibson CM, Murphy SA, Southard M, Ly HQ, McCabe CH, Giugliano RP, Cannon CP, Antman EM, Braunwald E. Association of a history of systemic hypertension with mortality, thrombotic, and bleeding complications following non-ST-segment elevation acute coronary syndrome. J Clin Hypertens (Greenwich). 2006 May; 8(5):315-22.
    View in: PubMed
  202. Ahmed S, Antman EM, Murphy SA, Giugliano RP, Cannon CP, White H, Morrow DA, Braunwald E. Poor outcomes after fibrinolytic therapy for ST-segment elevation myocardial infarction: impact of age (a meta-analysis of a decade of trials). J Thromb Thrombolysis. 2006 Apr; 21(2):119-29.
    View in: PubMed
  203. Wiviott SD, Morrow DA, Frederick PD, Antman EM, Braunwald E. Application of the Thrombolysis in Myocardial Infarction risk index in non-ST-segment elevation myocardial infarction: evaluation of patients in the National Registry of Myocardial Infarction. J Am Coll Cardiol. 2006 Apr 18; 47(8):1553-8.
    View in: PubMed
  204. Jacobs AK, Antman EM, Ellrodt G, Faxon DP, Gregory T, Mensah GA, Moyer P, Ornato J, Peterson ED, Sadwin L, Smith SC. Recommendation to develop strategies to increase the number of ST-segment-elevation myocardial infarction patients with timely access to primary percutaneous coronary intervention. Circulation. 2006 May 2; 113(17):2152-63.
    View in: PubMed
  205. Hirsch AT, Haskal ZJ, Hertzer NR, Bakal CW, Creager MA, Halperin JL, Hiratzka LF, Murphy WR, Olin JW, Puschett JB, Rosenfield KA, Sacks D, Stanley JC, Taylor LM, White CJ, White J, White RA, Antman EM, Smith SC, Adams CD, Anderson JL, Faxon DP, Fuster V, Gibbons RJ, Hunt SA, Jacobs AK, Nishimura R, Ornato JP, Page RL, Riegel B. ACC/AHA 2005 Practice Guidelines for the management of patients with peripheral arterial disease (lower extremity, renal, mesenteric, and abdominal aortic): a collaborative report from the American Association for Vascular Surgery/Society for Vascular Surgery, Society for Cardiovascular Angiography and Interventions, Society for Vascular Medicine and Biology, Society of Interventional Radiology, and the ACC/AHA Task Force on Practice Guidelines (Writing Committee to Develop Guidelines for the Management of Patients With Peripheral Arterial Disease): endorsed by the American Association of Cardiovascular and Pulmonary Rehabilitation; National Heart, Lung, and Blood Institute; Society for Vascular Nursing; TransAtlantic Inter-Society Consensus; and Vascular Disease Foundation. Circulation. 2006 Mar 21; 113(11):e463-654.
    View in: PubMed
  206. Hirsch AT, Haskal ZJ, Hertzer NR, Bakal CW, Creager MA, Halperin JL, Hiratzka LF, Murphy WR, Olin JW, Puschett JB, Rosenfield KA, Sacks D, Stanley JC, Taylor LM, White CJ, White J, White RA, Antman EM, Smith SC, Adams CD, Anderson JL, Faxon DP, Fuster V, Gibbons RJ, Halperin JL, Hiratzka LF, Hunt SA, Jacobs AK, Nishimura R, Ornato JP, Page RL, Riegel B. ACC/AHA 2005 guidelines for the management of patients with peripheral arterial disease (lower extremity, renal, mesenteric, and abdominal aortic): executive summary a collaborative report from the American Association for Vascular Surgery/Society for Vascular Surgery, Society for Cardiovascular Angiography and Interventions, Society for Vascular Medicine and Biology, Society of Interventional Radiology, and the ACC/AHA Task Force on Practice Guidelines (Writing Committee to Develop Guidelines for the Management of Patients With Peripheral Arterial Disease) endorsed by the American Association of Cardiovascular and Pulmonary Rehabilitation; National Heart, Lung, and Blood Institute; Society for Vascular Nursing; TransAtlantic Inter-Society Consensus; and Vascular Disease Foundation. J Am Coll Cardiol. 2006 Mar 21; 47(6):1239-312.
    View in: PubMed
  207. Antman EM, Morrow DA, McCabe CH, Murphy SA, Ruda M, Sadowski Z, Budaj A, López-Sendón JL, Guneri S, Jiang F, White HD, Fox KA, Braunwald E. Enoxaparin versus unfractionated heparin with fibrinolysis for ST-elevation myocardial infarction. N Engl J Med. 2006 Apr 6; 354(14):1477-88.
    View in: PubMed
  208. Gersh BJ, Antman EM. Selection of the optimal reperfusion strategy for STEMI: does time matter? Eur Heart J. 2006 Apr; 27(7):761-3.
    View in: PubMed
  209. Smith SC, Feldman TE, Hirshfeld JW, Jacobs AK, Kern MJ, King SB, Morrison DA, O'Neil WW, Schaff HV, Whitlow PL, Williams DO, Antman EM, Adams CD, Anderson JL, Faxon DP, Fuster V, Halperin JL, Hiratzka LF, Hunt SA, Nishimura R, Ornato JP, Page RL, Riegel B. ACC/AHA/SCAI 2005 guideline update for percutaneous coronary intervention: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines (ACC/AHA/SCAI Writing Committee to Update 2001 Guidelines for Percutaneous Coronary Intervention). Circulation. 2006 Feb 21; 113(7):e166-286.
    View in: PubMed
  210. Januzzi JL, Newby LK, Murphy SA, Pieper K, Antman EM, Morrow DA, Sabatine MS, Ohman EM, Cannon CP, Braunwald E. Predicting a late positive serum troponin in initially troponin-negative patients with non-ST-elevation acute coronary syndrome: clinical predictors and validated risk score results from the TIMI IIIB and GUSTO IIA studies. Am Heart J. 2006 Feb; 151(2):360-6.
    View in: PubMed
  211. Smith SC, Feldman TE, Hirshfeld JW, Jacobs AK, Kern MJ, King SB, Morrison DA, O'Neill WW, Schaff HV, Whitlow PL, Williams DO, Antman EM, Smith SC, Adams CD, Anderson JL, Faxon DP, Fuster V, Halperin JL, Hiratzka LF, Hunt SA, Jacobs AK, Nishimura R, Ornato JP, Page RL, Riegel B. ACC/AHA/SCAI 2005 guideline update for percutaneous coronary intervention: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines (ACC/AHA/SCAI Writing Committee to Update the 2001 Guidelines for Percutaneous Coronary Intervention). J Am Coll Cardiol. 2006 Jan 3; 47(1):e1-121.
    View in: PubMed
  212. Smith SC, Feldman TE, Hirshfeld JW, Jacobs AK, Kern MJ, King SB, Morrison DA, O'Neill WW, Schaff HV, Whitlow PL, Williams DO, Antman EM, Adams CD, Anderson JL, Faxon DP, Fuster V, Halperin JL, Hiratzka LF, Hunt SA, Nishimura R, Ornato JP, Page RL, Riegel B. ACC/AHA/SCAI 2005 Guideline Update for Percutaneous Coronary Intervention--summary article: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines (ACC/AHA/SCAI Writing Committee to Update the 2001 Guidelines for Percutaneous Coronary Intervention). Circulation. 2006 Jan 3; 113(1):156-75.
    View in: PubMed
  213. Smith SC, Feldman TE, Hirshfeld JW, Jacobs AK, Kern MJ, King SB, Morrison DA, O'neill WW, Schaff HV, Whitlow PL, Williams DO, Antman EM, Smith SC, Adams CD, Anderson JL, Faxon DP, Fuster V, Halperin JL, Hiratzka LF, Hunt SA, Jacobs AK, Nishimura R, Ornato JP, Page RL, Riegel B. ACC/AHA/SCAI 2005 Guideline Update for Percutaneous Coronary Intervention-Summary Article: A Report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines (ACC/AHA/SCAI Writing Committee to Update the 2001 Guidelines for Percutaneous Coronary Intervention). J Am Coll Cardiol. 2006 Jan 3; 47(1):216-35.
    View in: PubMed
  214. Yeh RW, Wiviott WD, Giugliano RP, Morrow DA, Bradner JE, Jang IK, Gibson CM, Antman EM. Thrombocytopenia is associated with adverse outcomes following treatment with either enoxaparin or unfractionated heparin in patients presenting with acute coronary syndromes: a TIMI 11B substudy. Journal of the American College of Cardiology. 2006; 47(Suppl1):207A.
  215. Sabatine MS, Morrow DA, McCabe CH, Antman EM, Gibson CM, Cannon CP. Combination of quantitative ST deviation and troponin elevation provides independent prognostic and therapeutic information in unstable angina and non-ST-elevation myocardial infarction. Am Heart J. 2006 Jan; 151(1):25-31.
    View in: PubMed
  216. Smith SC, Feldman TE, Hirshfeld JW, Jacobs AK, Kern MJ, King SB, Morrison DA, O'Neill WW, Schaff HV, Whitlow PL, Williams DO, Antman EM, Smith SC, Adams CD, Anderson JL, Faxon DP, Fuster V, Halperin JL, Hiratzka LF, Hunt SA, Jacobs AK, Nishimura R, Ornato JP, Page RL, Riegel B. ACC/AHA/SCAI 2005 guideline update for percutaneous coronary intervention--summary article: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines (ACC/AHA/SCAI Writing Committee to update the 2001 Guidelines for Percutaneous Coronary Intervention). Catheter Cardiovasc Interv. 2006 Jan; 67(1):87-112.
    View in: PubMed
  217. Ahmed S, Cannon CP, Giugliano RP, Shui A, Murphy SA, Morrow DA, Antman EM, Braunwald E, Gibson CM. The independent and combined risks of diabetes and non-endstage renal impairment in non ST-segment elevation acute coronary syndromes. Journal of the American College of Cardiology. 2006; 47(Suppl1):207A.
  218. Linefsky JP, Mahaffey KW, Pieper KS, Lin A, Reist CJ, Antman E, Goodman SG, French JK, Roe MT, Harrington RA, Ferguson, III, JJ, Califf. Differences between site-reported and core laboratory creatinine kinase-MB values in an international clinical trial: results from the SYNERGY trial. Circulation. 2006; 114:II_417.
  219. Wijns W, Antman EM. Ischemic Heart Disease. Prior SG, Zipes DP (eds). Sudden Cardiac Death: A Handbook for Clinical Practice. 2006; 91-108.
  220. Morrow DA, Wiviott SD, Sabatine MS, Giugliano RP, McCabe CH, Antman EM, Braunwald E. Evaluation of the TIMI risk index in a multi-continental population of 19,103 patients with STEMI in the ExTRACT-TIMI 25 trial. Journal of the American College of Cardiology. 2006; 47(Suppl1):223A.
  221. Gibson CM, Murphy SA, McCabe CH, Morrow DA, Antman EM, Braunwald E. Association of treatment with non-steroidal anti-inflammatory agents (NSAIDS) on study entry with 30 day adverse outcomes among ST elevation MI (STEMI) patients treated with a fibrinolytic agent. An ExTRACT-TIMI 25 analysis. Circulation. 2006; 114:II_697-II_698.
  222. Mahaffey KW, Cohen M, Garg J, Antman E, Kleiman NS, Goodman SG, Berdan LG, Reist CJ, Langer A, White HD, Aylward PE, Col JJ, Ferguson JJ, Califf RM. High-risk patients with acute coronary syndromes treated with low-molecular-weight or unfractionated heparin: outcomes at 6 months and 1 year in the SYNERGY trial. JAMA. 2005 Nov 23; 294(20):2594-600.
    View in: PubMed
  223. Kushner FG, Antman EM. Oral anticoagulation for atrial fibrillation after ST-elevation myocardial infarction: new evidence to guide clinical practice. Circulation. 2005 Nov 22; 112(21):3212-4.
    View in: PubMed
  224. Sabatine MS, Morrow DA, Montalescot G, Dellborg M, Leiva-Pons JL, Keltai M, Murphy SA, McCabe CH, Gibson CM, Cannon CP, Antman EM, Braunwald E. Angiographic and clinical outcomes in patients receiving low-molecular-weight heparin versus unfractionated heparin in ST-elevation myocardial infarction treated with fibrinolytics in the CLARITY-TIMI 28 Trial. Circulation. 2005 Dec 20; 112(25):3846-54.
    View in: PubMed
  225. Hunt SA, Abraham WT, Chin MH, Feldman AM, Francis GS, Ganiats TG, Jessup M, Konstam MA, Mancini DM, Michl K, Oates JA, Rahko PS, Silver MA, Stevenson LW, Yancy CW, Antman EM, Smith SC, Adams CD, Anderson JL, Faxon DP, Fuster V, Halperin JL, Hiratzka LF, Jacobs AK, Nishimura R, Ornato JP, Page RL, Riegel B. ACC/AHA 2005 Guideline Update for the Diagnosis and Management of Chronic Heart Failure in the Adult: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines (Writing Committee to Update the 2001 Guidelines for the Evaluation and Management of Heart Failure): developed in collaboration with the American College of Chest Physicians and the International Society for Heart and Lung Transplantation: endorsed by the Heart Rhythm Society. Circulation. 2005 Sep 20; 112(12):e154-235.
    View in: PubMed
  226. Antman EM, DeMets D, Loscalzo J. Cyclooxygenase inhibition and cardiovascular risk. Circulation. 2005 Aug 2; 112(5):759-70.
    View in: PubMed
  227. Ohman EM, Van de Werf F, Antman EM, Califf RM, de Lemos JA, Gibson CM, Oliverio RL, Harrelson L, McCabe C, DiBattiste P, Braunwald E. Tenecteplase and tirofiban in ST-segment elevation acute myocardial infarction: results of a randomized trial. Am Heart J. 2005 Jul; 150(1):79-88.
    View in: PubMed
  228. Wiviott SD, Antman EM, Winters KJ, Weerakkody G, Murphy SA, Behounek BD, Carney RJ, Lazzam C, McKay RG, McCabe CH, Braunwald E. Randomized comparison of prasugrel (CS-747, LY640315), a novel thienopyridine P2Y12 antagonist, with clopidogrel in percutaneous coronary intervention: results of the Joint Utilization of Medications to Block Platelets Optimally (JUMBO)-TIMI 26 trial. Circulation. 2005 Jun 28; 111(25):3366-73.
    View in: PubMed
  229. Mega JL, Morrow DA, Sabatine MS, Zhao XQ, Snapinn SM, DiBattiste PM, Gibson CM, Antman EM, Braunwald E, Théroux P. Correlation between the TIMI risk score and high-risk angiographic findings in non-ST-elevation acute coronary syndromes: observations from the Platelet Receptor Inhibition in Ischemic Syndrome Management in Patients Limited by Unstable Signs and Symptoms (PRISM-PLUS) trial. Am Heart J. 2005 May; 149(5):846-50.
    View in: PubMed
  230. De Luca G, Suryapranata H, Stone GW, Antoniucci D, Tcheng JE, Neumann FJ, Van de Werf F, Antman EM, Topol EJ. Abciximab as adjunctive therapy to reperfusion in acute ST-segment elevation myocardial infarction: a meta-analysis of randomized trials. JAMA. 2005 Apr 13; 293(14):1759-65.
    View in: PubMed
  231. Leopold JA, Antman EM. Dual antiplatelet therapy for coronary stenting: a clear path for a research agenda. Circulation. 2005 Mar 8; 111(9):1097-9.
    View in: PubMed
  232. Ly HQ, Kirtane AJ, Buros J, Giugliano RP, Popma JJ, Antman EM, Harrington RA, Ohman EM, Gibson CM. Angiographic and clinical outcomes associated with direct versus conventional stenting among patients treated with fibrinolytic therapy for ST-elevation acute myocardial infarction. Am J Cardiol. 2005 Feb 1; 95(3):383-6.
    View in: PubMed
  233. Gibson CM, Kirtane AJ, Boundy K, Ly H, Karmpaliotis D, Murphy SA, Giugliano RP, Cannon CP, Antman EM, Braunwald E. Association of a negative residual stenosis following rescue/adjunctive percutaneous coronary intervention with impaired myocardial perfusion and adverse outcomes among ST-segment elevation myocardial infarction patients. J Am Coll Cardiol. 2005 Feb 1; 45(3):357-62.
    View in: PubMed
  234. Antman EM, Morrow DA, McCabe CH, Jiang F, White HD, Fox KA, Sharma D, Chew P, Braunwald E. Enoxaparin versus unfractionated heparin as antithrombin therapy in patients receiving fibrinolysis for ST-elevation myocardial infarction. Design and rationale for the Enoxaparin and Thrombolysis Reperfusion for Acute Myocardial Infarction Treatment-Thrombolysis In Myocardial Infarction study 25 (ExTRACT-TIMI 25). Am Heart J. 2005 Feb; 149(2):217-26.
    View in: PubMed
  235. Kirtane AJ, Kosmidou I, Karmpaliotis D, Murphy SA, Giugliano RP, Cannon CP, Antman EM, Braunwald E, Gibson CM. Association of culprit lesion calcium with angiographic and clinical outcomes in patients with ST-elevation myocardial infarction treated with fibrinolytic therapy. Am J Cardiol. 2005 Feb 1; 95(3):337-42.
    View in: PubMed
  236. Morrow DA, Murphy SA, McCabe CH, Mackman N, Wong HC, Antman EM. Potent inhibition of thrombin with a monoclonal antibody against tissue factor (Sunol-cH36): results of the PROXIMATE-TIMI 27 trial. Eur Heart J. 2005 Apr; 26(7):682-8.
    View in: PubMed
  237. Ray KK, Morrow DA, Gibson CM, Murphy S, Antman EM, Braunwald E. Predictors of the rise in vWF after ST elevation myocardial infarction: implications for treatment strategies and clinical outcome: An ENTIRE-TIMI 23 substudy. Eur Heart J. 2005 Mar; 26(5):440-6.
    View in: PubMed
  238. Kirtane AJ, Martinezclark P, Rahman AM, Ray KK, Karmpaliotis D, Murphy SA, Giugliano RP, Cannon CP, Antman EM, Roe MT, Harrington RA, Ohman EM, Braunwald E, Gibson CM. Association of smoking with improved myocardial perfusion and the angiographic characterization of myocardial tissue perfusion after fibrinolytic therapy for ST-segment elevation myocardial infarction. J Am Coll Cardiol. 2005 Jan 18; 45(2):321-3.
    View in: PubMed
  239. Kirtane AJ, Weisbord A, Karmpaliotis D, Murphy SA, Giugliano RP, Cannon CP, Antman EM, Ohman EM, Roe MT, Braunwald E, Gibson CM. Relation of impaired Thrombolysis In Myocardial Infarction myocardial perfusion grades to residual thrombus following the restoration of epicardial patency in ST-elevation myocardial infarction. Am J Cardiol. 2005 Jan 15; 95(2):224-7.
    View in: PubMed
  240. Kashani A, Gibson CM, Murphy SA, Sabatine MS, Morrow DA, Antman EM, Giugliano RP. Angiography and revascularization in patients with heart failure following fibrinolytic therapy for ST-elevation acute myocardial infarction. Am J Cardiol. 2005 Jan 15; 95(2):228-33.
    View in: PubMed
  241. Leopold JA, Antman EM. Dual antiplatelet therapy for coronary stenting. Circulation. 2005; 111:1097-1099.
  242. Bonaca MP, Morrow DA, Wiviott SD, Sabatine MS, Murphy SA, Scirica BM, Rifai N, Antman EM, Braunwald E. Clinical correlates and impact of aspirin on the inflammatory response to percutaneous coronary intervention: results from TIMI 26. Circulation. 2005; 112:II-322.
  243. Adams D, Filsoufi F, Antman EM. "Medical Management of the Patient Undergoing Cardiac Surgery". Braunwald's Heart Disease: A Textbook of Cardiovascular Medicine. Zipes DW, Libby P, Bonow RO, Braunwald E (eds.). 2005.
  244. Antman EM. "ST-Elevation Myocardial Infarction: Management". Braunwald's Heart Disease: A Textbook of Cardiovascular Medicine. Zipes DW, Libby P, Bonow RO, Braunwald E (eds.). 2005.
  245. Mahaffey KW, Levine G, Gallo R, Ducas J, Goodman SG, Lokhnygina Y, Traylor L, Antman E, White HD, Becker RC, Col JJ, Cohen M, Harrington RA, Fergusion JJ, Califf RM. Relationships between renal function, age, and obesity and outcomes in high-risk patients with acute coronary syndromes: results from SYNERGY. Journal of the American College of Cardiology. 2005; 45(Suppl1):214A.
  246. Cohen M, Mahaffey KW, Berdan LG, Reist CJ, Traylor L, Langer A, Goodman SG, Antman E, Dietrich F, Califf RM, Fergusion JJ. Superiority of enoxaparin low-molecular-weight heparin over unfractionated heparin in patients with no prior antithrombin therapy or maintained on consistent antithrombin therapy: results from SYNERGY. Journal of the American College of Cardiology. 2005; 45(Suppl1):202A.
  247. Rao SV, Mahaffey KW, Antman E, Kleiman NS, Ferguson JJ, Califf RM, Becker RC, Goodman SG, Aylward PE. Predictors of major bleeding and transfusion in SYNERGY: effects of pretreatment variables and treatment assignment. Journal of the American College of Cardiology. 2005; 45(Suppl):247A.
  248. Ferguson JJ, Mahaffey KW, Huang Y, Armstrong P, Levine G, Kleiman NS, Goodman SG, Cohen M, Antman E, Califf RM. Enoxaparin versus unfractionated heparin: consequences of treatment duration on efficacy and safety in SYNERGY. Journal of the American College of Cardiology. 2005; 45(Suppl1):247A.
  249. Cantor WJ, Goodman SG, Huang Z, Mahaffey KW, Das P, Gulba DC, Glezer S, Gallo R, Ducas J, Cohen M, Antman EM, Langer A, Kleiman NS, White HD, Chisholm RJ, Harrington RA, Ferguson JJ, Califf RM. Bleeding complications in patients with acute coronary syndrome undergoing early invasive management may be reduced with radial access, smaller sheath sizes and timely sheath removal. In preparation. 2005.
  250. Wiviott SD, Morrow DA, Sabatine M, Murphy SA, Winters JK, Antman EM, Braunwald E. Prasugrel suppresses the early rise of sCD40 ligand levels following PCI compared to clopidogrel: a JUMBO-TIMI 26 substudy. Circulation. 2005; 112:II-432.
  251. Antman EM, Braunwald E. "ST-Elevation Myocardial Infarction: Pathology, Pathophysiology, and Clinical Features". Braunwald's Heart Disease: A Textbook of Cardiovascular Medicine. Zipes DW, Libby P, Bonow RO, Braunwald E (eds.). 2005.
  252. Antman EM. Book review: Inside the FDA: The Business and Politics Behind the Drugs We Take and the Food We Eat. Circulation. 2005; 112:e98.
  253. Antman EM, Braunwald E. "ST Segment Elevation Myocardial Infarction". Harrison's Principles of Internal Medicine. Braunwald E, Fauci AS, Kasper DL, Hauser SL, Longo DO, Jameson JL (eds.). 2005; 1448-1459.
  254. Antman EM, Braunwald E. “Pharmacological Developments Likely to Enhance Benefits of Pharmacoinvasive Therapy”. Pharmacoinvasive Therapy in Acute Myocardial Infarction. Dauerman, H Sobel BE (eds). 2005; 149-180.
  255. Domanski M, Antman EM, McKinlay S, Varshavsky S, Platonov P, Assmann SF, Norman J. Geographic variability in patient characteristics, treatment and outcome in an International Trial of Magnesium in acute myocardial infarction. Control Clin Trials. 2004 Dec; 25(6):553-62.
    View in: PubMed
  256. Cooper HA, Domanski MJ, Rosenberg Y, Norman J, Scott JH, Assmann SF, McKinlay SM, Hochman JS, Antman EM. Acute ST-segment elevation myocardial infarction and prior stroke: an analysis from the Magnesium in Coronaries (MAGIC) trial. Am Heart J. 2004 Dec; 148(6):1012-9.
    View in: PubMed
  257. Turakhia MP, Murphy SA, Pinto TL, Antman EM, Giugliano RP, Cannon CP, Braunwald E, Gibson CM. Association of platelet count with residual thrombus in the myocardial infarct-related coronary artery among patients treated with fibrinolytic therapy for ST-segment elevation acute myocardial infarction. Am J Cardiol. 2004 Dec 1; 94(11):1406-10.
    View in: PubMed
  258. Karmpaliotis D, Turakhia MP, Kirtane AJ, Murphy SA, Kosmidou I, Morrow DA, Giugliano RP, Cannon CP, Antman EM, Braunwald E, Gibson CM. Sequential risk stratification using TIMI risk score and TIMI flow grade among patients treated with fibrinolytic therapy for ST-segment elevation acute myocardial infarction. Am J Cardiol. 2004 Nov 1; 94(9):1113-7.
    View in: PubMed
  259. Gibson CM, Dumaine RL, Gelfand EV, Murphy SA, Morrow DA, Wiviott SD, Giugliano RP, Cannon CP, Antman EM, Braunwald E. Association of glomerular filtration rate on presentation with subsequent mortality in non-ST-segment elevation acute coronary syndrome; observations in 13,307 patients in five TIMI trials. Eur Heart J. 2004 Nov; 25(22):1998-2005.
    View in: PubMed
  260. Popp RJ, Smith SC, Adams RJ, Antman EM, Kavey RE, DeMaria AN, Ohman EM, Pitt B, Willerson JT, Bellande BJ, Fonarow GC, Nishimura RA, Shah PM, Hirshfeld JW, Messer JV, Peterson ED, Prystowsky EN, Anderson JL, Cheitlin MD, Goldstein LB, Grant AO, Beller GA, Hines EF, Livingston DW, McEntree CW. ACCF/AHA consensus conference report on professionalism and ethics. Circulation. 2004 Oct 19; 110(16):2506-49.
    View in: PubMed
  261. Alpert JS, Shine KI, Adams RJ, Antman EM, Kavey RE, Friedman L, Frye RL, Harrington RA, Korn D, Merz JF, Ofili E. Task force 1: The ACCF and AHA codes of conduct in human subjects research. J Am Coll Cardiol. 2004 Oct 19; 44(8):1724-8.
    View in: PubMed
  262. Kashani A, Giugliano RP, Antman EM, Morrow DA, Gibson CM, Murphy SA, Braunwald E. Severity of heart failure, treatments, and outcomes after fibrinolysis in patients with ST-elevation myocardial infarction. Eur Heart J. 2004 Oct; 25(19):1702-10.
    View in: PubMed
  263. Morrow DA, Sabatine MS, Antman EM, Cannon CP, Braunwald E, Theroux P. Usefulness of tirofiban among patients treated without percutaneous coronary intervention (TIMI high risk patients in PRISM-PLUS). Am J Cardiol. 2004 Sep 15; 94(6):774-6.
    View in: PubMed
  264. Nallamothu BK, Antman EM, Bates ER. Primary percutaneous coronary intervention versus fibrinolytic therapy in acute myocardial infarction: does the choice of fibrinolytic agent impact on the importance of time-to-treatment? Am J Cardiol. 2004 Sep 15; 94(6):772-4.
    View in: PubMed
  265. Gibson CM, Murphy SA, Kirtane AJ, Giugliano RP, Cannon CP, Antman EM, Braunwald E. Association of duration of symptoms at presentation with angiographic and clinical outcomes after fibrinolytic therapy in patients with ST-segment elevation myocardial infarction. J Am Coll Cardiol. 2004 Sep 1; 44(5):980-7.
    View in: PubMed
  266. Eagle KA, Guyton RA, Davidoff R, Edwards FH, Ewy GA, Gardner TJ, Hart JC, Herrmann HC, Hillis LD, Hutter AM, Lytle BW, Marlow RA, Nugent WC, Orszulak TA, Antman EM, Smith SC, Alpert JS, Anderson JL, Faxon DP, Fuster V, Gibbons RJ, Gregoratos G, Halperin JL, Hiratzka LF, Hunt SA, Jacobs AK, Ornato JP. ACC/AHA 2004 guideline update for coronary artery bypass graft surgery: summary article. A report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines (Committee to Update the 1999 Guidelines for Coronary Artery Bypass Graft Surgery). J Am Coll Cardiol. 2004 Sep 1; 44(5):e213-310.
    View in: PubMed
  267. Eagle KA, Guyton RA, Davidoff R, Edwards FH, Ewy GA, Gardner TJ, Hart JC, Herrmann HC, Hillis LD, Hutter AM, Lytle BW, Marlow RA, Nugent WC, Orszulak TA, Antman EM, Smith SC, Alpert JS, Anderson JL, Faxon DP, Fuster V, Gibbons RJ, Gregoratos G, Halperin JL, Hiratzka LF, Hunt SA, Jacobs AK, Ornato JP. ACC/AHA 2004 guideline update for coronary artery bypass graft surgery: summary article: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines (Committee to Update the 1999 Guidelines for Coronary Artery Bypass Graft Surgery). Circulation. 2004 Aug 31; 110(9):1168-76.
    View in: PubMed
  268. Antman EM, Anbe DT, Armstrong PW, Bates ER, Green LA, Hand M, Hochman JS, Krumholz HM, Kushner FG, Lamas GA, Mullany CJ, Ornato JP, Pearle DL, Sloan MA, Smith SC, Alpert JS, Anderson JL, Faxon DP, Fuster V, Gibbons RJ, Gregoratos G, Halperin JL, Hiratzka LF, Hunt SA, Jacobs AK. ACC/AHA guidelines for the management of patients with ST-elevation myocardial infarction: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines (Committee to Revise the 1999 Guidelines for the Management of Patients with Acute Myocardial Infarction). Circulation. 2004 Aug 31; 110(9):e82-292.
    View in: PubMed
  269. Wiviott SD, Morrow DA, Frederick PD, Giugliano RP, Gibson CM, McCabe CH, Cannon CP, Antman EM, Braunwald E. Performance of the thrombolysis in myocardial infarction risk index in the National Registry of Myocardial Infarction-3 and -4: a simple index that predicts mortality in ST-segment elevation myocardial infarction. J Am Coll Cardiol. 2004 Aug 18; 44(4):783-9.
    View in: PubMed
  270. Antman EM, Anbe DT, Armstrong PW, Bates ER, Green LA, Hand M, Hochman JS, Krumholz HM, Kushner FG, Lamas GA, Mullany CJ, Ornato JP, Pearle DL, Sloan MA, Smith SC. ACC/AHA guidelines for the management of patients with ST-elevation myocardial infarction--executive summary. A report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines (Writing Committee to revise the 1999 guidelines for the management of patients with acute myocardial infarction). J Am Coll Cardiol. 2004 Aug 4; 44(3):671-719.
    View in: PubMed
  271. Antman EM, Anbe DT, Armstrong PW, Bates ER, Green LA, Hand M, Hochman JS, Krumholz HM, Kushner FG, Lamas GA, Mullany CJ, Ornato JP, Pearle DL, Sloan MA, Smith SC, Alpert JS, Anderson JL, Faxon DP, Fuster V, Gibbons RJ, Gregoratos G, Halperin JL, Hiratzka LF, Hunt SA, Jacobs AK. ACC/AHA guidelines for the management of patients with ST-elevation myocardial infarction--executive summary: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines (Writing Committee to Revise the 1999 Guidelines for the Management of Patients With Acute Myocardial Infarction). Circulation. 2004 Aug 3; 110(5):588-636.
    View in: PubMed
  272. Gibson CM, Murphy SA, Morrow DA, Aroesty JM, Gibbons RJ, Gourlay SG, Barron HV, Giugliano RP, Antman EM, Braunwald E. Angiographic perfusion score: an angiographic variable that integrates both epicardial and tissue level perfusion before and after facilitated percutaneous coronary intervention in acute myocardial infarction. Am Heart J. 2004 Aug; 148(2):336-40.
    View in: PubMed
  273. Antman EM, Anbe DT, Armstrong PW, Bates ER, Green LA, Hand M, Hochman JS, Krumholz HM, Kushner FG, Lamas GA, Mullany CJ, Ornato JP, Pearle DL, Sloan MA, Smith SC. ACC/AHA guidelines for the management of patients with ST-elevation myocardial infarction--executive summary: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines (Writing Committee to Revise the 1999 Guidelines for the Management of Patients With Acute Myocardial Infarction). Can J Cardiol. 2004 Aug; 20(10):977-1025.
    View in: PubMed
  274. Mega JL, Morrow DA, De Lemos JA, Sabatine MS, Murphy SA, Rifai N, Gibson CM, Antman EM, Braunwald E. B-type natriuretic peptide at presentation and prognosis in patients with ST-segment elevation myocardial infarction: an ENTIRE-TIMI-23 substudy. J Am Coll Cardiol. 2004 Jul 21; 44(2):335-9.
    View in: PubMed
  275. Gardner GS, Frisch DR, Murphy SA, Kirtane AJ, Giugliano RP, Antman EM, Braunwald E, Gibson CM. Effect of rescue or adjunctive percutaneous coronary intervention of the culprit artery after fibrinolytic administration on epicardial flow in nonculprit arteries. Am J Cardiol. 2004 Jul 15; 94(2):178-81.
    View in: PubMed
  276. Ferguson JJ, Califf RM, Antman EM, Cohen M, Grines CL, Goodman S, Kereiakes DJ, Langer A, Mahaffey KW, Nessel CC, Armstrong PW, Avezum A, Aylward P, Becker RC, Biasucci L, Borzak S, Col J, Frey MJ, Fry E, Gulba DC, Guneri S, Gurfinkel E, Harrington R, Hochman JS, Kleiman NS, Leon MB, Lopez-Sendon JL, Pepine CJ, Ruzyllo W, Steinhubl SR, Teirstein PS, Toro-Figueroa L, White H. Enoxaparin vs unfractionated heparin in high-risk patients with non-ST-segment elevation acute coronary syndromes managed with an intended early invasive strategy: primary results of the SYNERGY randomized trial. JAMA. 2004 Jul 7; 292(1):45-54.
    View in: PubMed
  277. Petersen JL, Mahaffey KW, Hasselblad V, Antman EM, Cohen M, Goodman SG, Langer A, Blazing MA, Le-Moigne-Amrani A, de Lemos JA, Nessel CC, Harrington RA, Ferguson JJ, Braunwald E, Califf RM. Efficacy and bleeding complications among patients randomized to enoxaparin or unfractionated heparin for antithrombin therapy in non-ST-Segment elevation acute coronary syndromes: a systematic overview. JAMA. 2004 Jul 7; 292(1):89-96.
    View in: PubMed
  278. Wylie JV, Murphy SA, Morrow DA, de Lemos JA, Antman EM, Cannon CP. Validated risk score predicts the development of congestive heart failure after presentation with unstable angina or non-ST-elevation myocardial infarction: results from OPUS-TIMI 16 and TACTICS-TIMI 18. Am Heart J. 2004 Jul; 148(1):173-80.
    View in: PubMed
  279. Gibson CM, Bigelow B, James D, Tepper MR, Murphy SA, Kirtane AJ, Giugliano RP, Cannon CP, Antman EM. Association of lesion complexity following fibrinolytic administration with mortality in ST-elevation myocardial infarction. Am J Cardiol. 2004 Jul 1; 94(1):108-11.
    View in: PubMed
  280. Morrow DA, Antman EM, Murphy SA, Assmann SF, Giugliano RP, Cannon CP, Michael Gibson C, McCabe CH, Barron HV, Van De Werf F, Braunwald E. The Risk Score Profile: a novel approach to characterising the risk of populations enrolled in clinical studies. Eur Heart J. 2004 Jul; 25(13):1139-45.
    View in: PubMed
  281. Wiviott SD, Antman EM. Clopidogrel resistance: a new chapter in a fast-moving story. Circulation. 2004 Jun 29; 109(25):3064-7.
    View in: PubMed
  282. Antman EM, Van de Werf F. Pharmacoinvasive therapy: the future of treatment for ST-elevation myocardial infarction. Circulation. 2004 Jun 1; 109(21):2480-6.
    View in: PubMed
  283. Gibson CM, de Lemos JA, Antman EM. Time is muscle in primary PCI: the strength of the evidence grows. Eur Heart J. 2004 Jun; 25(12):1001-2.
    View in: PubMed
  284. Kirtane AJ, Bui A, Murphy SA, Karmpaliotis D, Kosmidou I, Boundy K, Rahman A, Pinto DS, Aroesty JM, Giugliano RP, Cannon CP, Antman EM, Gibson CM. Association of epicardial and tissue-level reperfusion with left ventricular end-diastolic pressures in ST-elevation myocardial infarction. J Thromb Thrombolysis. 2004 Jun; 17(3):177-84.
    View in: PubMed
  285. Giugliano RP, Sabatine MS, Gibson CM, Roe MT, Harrington RA, Murphy SA, Morrow DA, Antman EM, Braunwald E. Combined assessment of thrombolysis in myocardial infarction flow grade, myocardial perfusion grade, and ST-segment resolution to evaluate epicardial and myocardial reperfusion. Am J Cardiol. 2004 Jun 1; 93(11):1362-7, A5-6.
    View in: PubMed
  286. Shimpo M, Morrow DA, Weinberg EO, Sabatine MS, Murphy SA, Antman EM, Lee RT. Serum levels of the interleukin-1 receptor family member ST2 predict mortality and clinical outcome in acute myocardial infarction. Circulation. 2004 May 11; 109(18):2186-90.
    View in: PubMed
  287. Gibson CM, Karha J, Murphy SA, de Lemos JA, Morrow DA, Giugliano RP, Roe MT, Harrington RA, Cannon CP, Antman EM, Califf RM, Braunwald E. Association of a pulsatile blood flow pattern on coronary arteriography and short-term clinical outcomes in acute myocardial infarction. J Am Coll Cardiol. 2004 Apr 7; 43(7):1170-6.
    View in: PubMed
  288. Bavry AA, Kumbhani DJ, Quiroz R, Ramchandani SR, Kenchaiah S, Antman EM. Invasive therapy along with glycoprotein IIb/IIIa inhibitors and intracoronary stents improves survival in non-ST-segment elevation acute coronary syndromes: a meta-analysis and review of the literature. Am J Cardiol. 2004 Apr 1; 93(7):830-5.
    View in: PubMed
  289. De Luca G, Suryapranata H, Ottervanger JP, Antman EM. Time delay to treatment and mortality in primary angioplasty for acute myocardial infarction: every minute of delay counts. Circulation. 2004 Mar 16; 109(10):1223-5.
    View in: PubMed
  290. Wiviott SD, Cannon CP, Morrow DA, Murphy SA, Gibson CM, McCabe CH, Sabatine MS, Rifai N, Giugliano RP, DiBattiste PM, Demopoulos LA, Antman EM, Braunwald E. Differential expression of cardiac biomarkers by gender in patients with unstable angina/non-ST-elevation myocardial infarction: a TACTICS-TIMI 18 (Treat Angina with Aggrastat and determine Cost of Therapy with an Invasive or Conservative Strategy-Thrombolysis In Myocardial Infarction 18) substudy. Circulation. 2004 Feb 10; 109(5):580-6.
    View in: PubMed
  291. Sabatine MS, Morrow DA, Giugliano RP, Murphy SA, Demopoulos LA, DiBattiste PM, Weintraub WS, McCabe CH, Antman EM, Cannon CP, Braunwald E. Implications of upstream glycoprotein IIb/IIIa inhibition and coronary artery stenting in the invasive management of unstable angina/non-ST-elevation myocardial infarction: a comparison of the Thrombolysis In Myocardial Infarction (TIMI) IIIB trial and the Treat angina with Aggrastat and determine Cost of Therapy with Invasive or Conservative Strategy (TACTICS)-TIMI 18 trial. Circulation. 2004 Feb 24; 109(7):874-80.
    View in: PubMed
  292. Kessler KM, Gibbons RJ, Smith SC, Antman E. All opinions are not equal. Circulation. 2004 Jan 27; 109(3):E21.
    View in: PubMed
  293. Nallamothu BK, Antman EM, Bates ER. Percutaneous coronary intervention versus fibrinolytic therapy in acute myocardial infarction: does the choice of fibrinolytic agent impact on the importance of time-to-treatment?. American Journal of Cardiology. 2004; 94:772-774.
  294. Kirtane AJ, Karmpaliotis D, Weisbrod A, Bui A, Murphy SA, Budiu D, Kosmidou I, Aroesty JM, Giugliano RP, Cannon CP, Antman EM, Braunwald E, Gibson CM. Angiographically apparent thrombus after fibrinolytic administration is associated with impaired epicardial flow and myocardial perfusion in ST elevation myocardial infarction patients with open arteries. Journal of the American College of Cardiology. 2004; 43(Suppl. A):262A.
  295. Morrow DA, Sabatine MS, Antman EM, Cannon CP, Braunwald E, Theroux P. Usefulness of tirofiban in patients treated without percutaneous coronary intervention (TIMI high risk patients in PRISM-PLUS). American College of Cardiology. 2004; 94:774-776.
  296. Antman EM. Coronary care medicine: it's not your father's CCU anymore. Trans Am Clin Climatol Assoc. 2004; 115:123-34; discussion 134-5.
    View in: PubMed
  297. Bittl JA, White HD, Antman EM. "Direct Thrombin Inhibitors". Manson, JE, Burling JE, Ridker PM, Gaziano JM (eds.) Clinical Trials in Cardiovascular Disease: A Companion to Braunwald's Heart Disease. 2004; 83-06.
  298. Antman EM. The re-emergence of anticoagulation in coronary disease. European Heart Journal. 2004; 25 (Suppl.6SB):B2-B8.
  299. Antman EM, Anbe DT, Armstrong PW, Bates ER, Green LA, Hand M, Hochman JS, Krumholtz HM, Kushner FG, Lamas GA, Mullany CJ, Ornato JP, Pearle DL, Sloan MA, Smith SC Jr. ACC/AHA guidelines for the management of patients with ST-elevation myocardial infarction: executive summary: a report of the ACC/AHA Task Force on Practice Guidelines (Committee to Revise the 1999 Guidelines on the Management of Patients with Acute Myocardial Infarction). Canadian Journal of Cardiology. 2004; 20:977-1025.
  300. Karmpaliotis D, Turakhia MP, Kirtane AJ, Murphy SA, Kosmidou I, Morrow DA, Giugliano RP, Cannon CP, Antman EM, Braunwald E, Gibson CM. Sequential risk stratification using the TIMI risk score and TIMI flow grade among patients treated with fibrinolytic therapy for acute ST- segment elevation acute myocardial infarction. American Journal of Cardiology. 2004; 94:1113-1117.
  301. Sabatine MS, Morrow DA, Giugliano RP, Murphy SA, McCabe CH, Gibson CM, Cannon CP, Antman EM, Braunwald E. Low hemoglobin predicts worse clinical outcomes in acute coronary syndromes. Journal of the American College of Cardiology. 2004; 43(Suppl. A):278A.
  302. Mahaffey KW, Cohen M, Garg J, Traylor L, Chen M, Antman E, Kleiman NS, GOodman SG, Berdan LG, Reist C, Langer A, White HD, Aylward PE, Col JJ, Ferguson JJ, Califf RM. Long-term outcomes in high-risk acute coronary syndrome patients managed with an early invasive strategy: six-month SYNERGY results. Am J Cardiol. 2004; 94(Suppl 6A):85E.
  303. Wright S, Gersh BJ, Assmann SF, Domanski M, Cooper HA, Hochman J, McKinlay S, Antman EM. Predictors of life-threatening ventricular arrhythmias in high-risk patients with ST elevation acute myocardial infarction. Journal of the American College of Cardiology. 2004; 43(Suppl. A):261A.
  304. Turakhia M, Murphy SA, Pinto T, Antman EM, Giugliano RP, Cannon CP, Braunwald E, Gibson CM. Association of higher platelet count with residual thrombus in the myocardial infarct-related coronary artery among patients treated with fibrinolytic therapy for ST-segment elevation acute myocardial infarction. American Journal of Cardiology. 2004; 94:1406-1410.
  305. Gibson CM, Bigelow B, James D, Tepper MR, Murphy SA, Giugliano RP, Cannon CP, Antman EM, Braunwald E, for the TIMI Study Group. Classification of lesion complexity following fibrinolytic administration with mortality in ST elevation myocardial infarction. American Journal of Cardiology. 2004; 94:108-111.
  306. Gelfand EV, Morrow DA, Sabatine MS, Rifai N, Murphy SA, McCabe CH, Antman EM. Risk stratification in ST-elevation myocardial infarction with multiple biomarkers. Journal of the American College of Cardiology. 2004; 43(Suppl. A):259A.
  307. Armstrong PW, Antman EM. Coronary angioplasty versus fibrinolytic therapy in acute myocardial infarction. N Engl J Med. 2003 Nov 27; 349(22):2167-9; author reply 2167-9.
    View in: PubMed
  308. Antman EM, Ferguson JJ. Should evidence-based proof of efficacy as defined for a specific therapeutic agent be extrapolated to encompass a therapeutic class of agents? Circulation. 2003 Nov 25; 108(21):2604-7.
    View in: PubMed
  309. Gibson CM, Pinto DS, Murphy SA, Morrow DA, Hobbach HP, Wiviott SD, Giugliano RP, Cannon CP, Antman EM, Braunwald E. Association of creatinine and creatinine clearance on presentation in acute myocardial infarction with subsequent mortality. J Am Coll Cardiol. 2003 Nov 5; 42(9):1535-43.
    View in: PubMed
  310. Finn AV, Antman EM. Images in clinical medicine. Isolated right ventricular infarction. N Engl J Med. 2003 Oct 23; 349(17):1636.
    View in: PubMed
  311. Karha J, Murphy SA, Kirtane AJ, de Lemos JA, Aroesty JM, Cannon CP, Antman EM, Braunwald E, Gibson CM. Evaluation of the association of proximal coronary culprit artery lesion location with clinical outcomes in acute myocardial infarction. Am J Cardiol. 2003 Oct 15; 92(8):913-8.
    View in: PubMed
  312. Blomström-Lundqvist C, Scheinman MM, Aliot EM, Alpert JS, Calkins H, Camm AJ, Campbell WB, Haines DE, Kuck KH, Lerman BB, Miller DD, Shaeffer CW, Stevenson WG, Tomaselli GF, Antman EM, Smith SC, Alpert JS, Faxon DP, Fuster V, Gibbons RJ, Gregoratos G, Hiratzka LF, Hunt SA, Jacobs AK, Russell RO, Priori SG, Blanc JJ, Budaj A, Burgos EF, Cowie M, Deckers JW, Garcia MA, Klein WW, Lekakis J, Lindahl B, Mazzotta G, Morais JC, Oto A, Smiseth O, Trappe HJ. ACC/AHA/ESC guidelines for the management of patients with supraventricular arrhythmias--executive summary. a report of the American college of cardiology/American heart association task force on practice guidelines and the European society of cardiology committee for practice guidelines (writing committee to develop guidelines for the management of patients with supraventricular arrhythmias) developed in collaboration with NASPE-Heart Rhythm Society. J Am Coll Cardiol. 2003 Oct 15; 42(8):1493-531.
    View in: PubMed
  313. Blomström-Lundqvist C, Scheinman MM, Aliot EM, Alpert JS, Calkins H, Camm AJ, Campbell WB, Haines DE, Kuck KH, Lerman BB, Miller DD, Shaeffer CW, Stevenson WG, Tomaselli GF, Antman EM, Smith SC, Alpert JS, Faxon DP, Fuster V, Gibbons RJ, Gregoratos G, Hiratzka LF, Hunt SA, Jacobs AK, Russell RO, Priori SG, Blanc JJ, Budaj A, Burgos EF, Cowie M, Deckers JW, Garcia MA, Klein WW, Lekakis J, Lindahl B, Mazzotta G, Morais JC, Oto A, Smiseth O, Trappe HJ. ACC/AHA/ESC guidelines for the management of patients with supraventricular arrhythmias--executive summary: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines and the European Society of Cardiology Committee for Practice Guidelines (Writing Committee to Develop Guidelines for the Management of Patients With Supraventricular Arrhythmias). Circulation. 2003 Oct 14; 108(15):1871-909.
    View in: PubMed
  314. Antman EM. Glycoprotein IIb/IIIa inhibitors in patients with unstable angina/non-ST-segment elevation myocardial infarction: appropriate interpretation of the guidelines. Am Heart J. 2003 Oct; 146(4 Suppl):S18-22.
    View in: PubMed
  315. Cheitlin MD, Armstrong WF, Aurigemma GP, Beller GA, Bierman FZ, Davis JL, Douglas PS, Faxon DP, Gillam LD, Kimball TR, Kussmaul WG, Pearlman AS, Philbrick JT, Rakowski H, Thys DM, Antman EM, Smith SC, Alpert JS, Gregoratos G, Anderson JL, Hiratzka LF, Faxon DP, Hunt SA, Fuster V, Jacobs AK, Gibbons RJ, Russell RO. ACC/AHA/ASE 2003 Guideline Update for the Clinical Application of Echocardiography: summary article. A report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines (ACC/AHA/ASE Committee to Update the 1997 Guidelines for the Clinical Application of Echocardiography). J Am Soc Echocardiogr. 2003 Oct; 16(10):1091-110.
    View in: PubMed
  316. Ferguson JJ, Antman EM, Bates ER, Cohen M, Every NR, Harrington RA, Pepine CJ, Theroux P. Combining enoxaparin and glycoprotein IIb/IIIa antagonists for the treatment of acute coronary syndromes: final results of the National Investigators Collaborating on Enoxaparin-3 (NICE-3) study. Am Heart J. 2003 Oct; 146(4):628-34.
    View in: PubMed
  317. Klocke FJ, Baird MG, Lorell BH, Bateman TM, Messer JV, Berman DS, O'Gara PT, Carabello BA, Russell RO, Cerqueira MD, St John Sutton MG, DeMaria AN, Udelson JE, Kennedy JW, Verani MS, Williams KA, Antman EM, Smith SC, Alpert JS, Gregoratos G, Anderson JL, Hiratzka LF, Faxon DP, Hunt SA, Fuster V, Jacobs AK, Gibbons RJ, Russell RO. ACC/AHA/ASNC guidelines for the clinical use of cardiac radionuclide imaging--executive summary: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines (ACC/AHA/ASNC Committee to Revise the 1995 Guidelines for the Clinical Use of Cardiac Radionuclide Imaging). J Am Coll Cardiol. 2003 Oct 1; 42(7):1318-33.
    View in: PubMed
  318. Bruno R, Baille P, Retout S, Vivier N, Veyrat-Follet C, Sanderink GJ, Becker R, Antman EM. Population pharmacokinetics and pharmacodynamics of enoxaparin in unstable angina and non-ST-segment elevation myocardial infarction. Br J Clin Pharmacol. 2003 Oct; 56(4):407-14.
    View in: PubMed
  319. Klocke FJ, Baird MG, Lorell BH, Bateman TM, Messer JV, Berman DS, O'Gara PT, Carabello BA, Russell RO, Cerqueira MD, St John Sutton MG, DeMaria AN, Udelson JE, Kennedy JW, Verani MS, Williams KA, Antman EM, Smith SC, Alpert JS, Gregoratos G, Anderson JL, Hiratzka LF, Faxon DP, Hunt SA, Fuster V, Jacobs AK, Gibbons RJ, Russell RO. ACC/AHA/ASNC guidelines for the clinical use of cardiac radionuclide imaging--executive summary: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines (ACC/AHA/ASNC Committee to Revise the 1995 Guidelines for the Clinical Use of Cardiac Radionuclide Imaging). Circulation. 2003 Sep 16; 108(11):1404-18.
    View in: PubMed
  320. Cheitlin MD, Armstrong WF, Aurigemma GP, Beller GA, Bierman FZ, Davis JL, Douglas PS, Faxon DP, Gillam LD, Kimball TR, Kussmaul WG, Pearlman AS, Philbrick JT, Rakowski H, Thys DM, Antman EM, Smith SC, Alpert JS, Gregoratos G, Anderson JL, Hiratzka LF, Hunt SA, Fuster V, Jacobs AK, Gibbons RJ, Russell RO. ACC/AHA/ASE 2003 guideline update for the clinical application of echocardiography: summary article: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines (ACC/AHA/ASE Committee to Update the 1997 Guidelines for the Clinical Application of Echocardiography). Circulation. 2003 Sep 2; 108(9):1146-62.
    View in: PubMed
  321. Gibson CM, Gibson WJ, Murphy SA, Marble SJ, McCabe CH, Turakhia MP, Kirtane AJ, Karha J, Aroesty JM, Giugliano RP, Antman EM. Association of the Fibonacci Cascade with the distribution of coronary artery lesions responsible for ST-segment elevation myocardial infarction. Am J Cardiol. 2003 Sep 1; 92(5):595-7.
    View in: PubMed
  322. Antman EM. Low molecular weight heparins for acute coronary syndrome: tackling the issues head-on. Am Heart J. 2003 Aug; 146(2):191-3.
    View in: PubMed
  323. Gibson CM, Karha J, Murphy SA, James D, Morrow DA, Cannon CP, Giugliano RP, Antman EM, Braunwald E. Early and long-term clinical outcomes associated with reinfarction following fibrinolytic administration in the Thrombolysis in Myocardial Infarction trials. J Am Coll Cardiol. 2003 Jul 2; 42(1):7-16.
    View in: PubMed
  324. Murphy SA, Dauterman K, de Lemos JA, Kermgard S, Antman EM, Braunwald E, Gibson CM. Angiographic and clinical characteristics associated with the development of Q-wave and non-Q-wave myocardial infarction in the thrombolysis in myocardial infarction (TIMI) 14 trial. Am Heart J. 2003 Jul; 146(1):42-7.
    View in: PubMed
  325. Spinler SA, Inverso SM, Cohen M, Goodman SG, Stringer KA, Antman EM. Safety and efficacy of unfractionated heparin versus enoxaparin in patients who are obese and patients with severe renal impairment: analysis from the ESSENCE and TIMI 11B studies. Am Heart J. 2003 Jul; 146(1):33-41.
    View in: PubMed
  326. Gibbons RJ, Smith SC, Antman E. American College of Cardiology/American Heart Association clinical practice guidelines: Part II: evolutionary changes in a continuous quality improvement project. Circulation. 2003 Jun 24; 107(24):3101-7.
    View in: PubMed
  327. Gibbons RJ, Smith S, Antman E. American College of Cardiology/American Heart Association clinical practice guidelines: Part I: where do they come from? Circulation. 2003 Jun 17; 107(23):2979-86.
    View in: PubMed
  328. Gibson CM, Kirtane AJ, Murphy SA, Karha J, Cannon CP, Giugliano RP, Roe MT, Harrington RA, Ohman EM, Antman EM. Distance from the coronary ostium to the culprit lesion in acute ST-elevation myocardial infarction and its implications regarding the potential prevention of proximal plaque rupture. J Thromb Thrombolysis. 2003 Jun; 15(3):189-96.
    View in: PubMed
  329. Armstrong PW, Collen D, Antman E. Fibrinolysis for acute myocardial infarction: the future is here and now. Circulation. 2003 May 27; 107(20):2533-7.
    View in: PubMed
  330. Morrow DA, de Lemos JA, Sabatine MS, Antman EM. The search for a biomarker of cardiac ischemia. Clin Chem. 2003 Apr; 49(4):537-9.
    View in: PubMed
  331. Antman EM. Should bivalirudin replace heparin during percutaneous coronary interventions? JAMA. 2003 Feb 19; 289(7):903-5.
    View in: PubMed
  332. Sabatine MS, Antman EM. The thrombolysis in myocardial infarction risk score in unstable angina/non-ST-segment elevation myocardial infarction. J Am Coll Cardiol. 2003 Feb 19; 41(4 Suppl S):89S-95S.
    View in: PubMed
  333. de Lemos JA, Morrow DA, Sabatine MS, Murphy SA, Gibson CM, Antman EM, McCabe CH, Cannon CP, Braunwald E. Association between plasma levels of monocyte chemoattractant protein-1 and long-term clinical outcomes in patients with acute coronary syndromes. Circulation. 2003 Feb 11; 107(5):690-5.
    View in: PubMed
  334. Antman EM. [Present and future of antithrombotic therapy in acute coronary syndromes]. Rev Esp Cardiol. 2003 Feb; 56(2):115-20.
    View in: PubMed
  335. Wong GC, Giugliano RP, Antman EM. Use of low-molecular-weight heparins in the management of acute coronary artery syndromes and percutaneous coronary intervention. JAMA. 2003 Jan 15; 289(3):331-42.
    View in: PubMed
  336. Gibbons RJ, Abrams J, Chatterjee K, Daley J, Deedwania PC, Douglas JS, Ferguson TB, Fihn SD, Fraker TD, Gardin JM, O'Rourke RA, Pasternak RC, Williams SV, Gibbons RJ, Alpert JS, Antman EM, Hiratzka LF, Fuster V, Faxon DP, Gregoratos G, Jacobs AK, Smith SC. ACC/AHA 2002 guideline update for the management of patients with chronic stable angina--summary article: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines (Committee on the Management of Patients With Chronic Stable Angina). Circulation. 2003 Jan 7; 107(1):149-58.
    View in: PubMed
  337. Ndumele CE, Friedberg M, Antman EM, Strichartz GR, Lilly LS. Cardiovascular drugs. Pathophysiology of Heart Disease: A Collaborative Project of Medical Students and Faculty. Lilly LS, ed. 2003; 371-421.
  338. Kirtane AJ, Murphy SA, Karha J, Wong GC, Giugliano RP, Antman EM, Gibson CM. A mathematical model of preventing plaque rupture with drug-eluting stents based upon distance from the ostium to the culprit lesion in ST elevation myocardial infarction. JACC. 2003; 41 (Suppl. A):20A.
  339. Bahit MC, Cannon CP, Antman EM, Murphy SA, Gibson CM, McCabe CH, Braunwald E. Direct comparison of characteristics, treatment, and outcomes of patients enrolled versus patients not enrolled in a clinical trial at centers participating in the TIMI 9 Trial and TIMI 9 Registry. Am Heart J. 2003 Jan; 145(1):109-17.
    View in: PubMed
  340. Finn AV, Antman EM. Isolated right ventricular infarction. Images in Clinical Medicine. New England Journal of Medicine. 2003; 349:17.
  341. Gibson CM, Wong GC, Antman EM, Marble SJ, Kalapanda R, Kraimer N, Markovic R, Cannon CP. Higher platelet counts are associated with greater thrombus burden in patent arteries following thrombolytic administration: a TIMI angiographic substudy. JACC. 2003; 41(Suppl. A):322A.
  342. Antman EM. Present and future of antithrombotic therapy in acute coronary syndromes. In press, Revista Espanola de Cardiologia. 2003.
  343. Kashani A, Murphy SA, Antman EM, Giugliano RP. Heart failure following ST elevation myocardial infarction: are we aggressive enough?. JACC. 2003; 41 (Suppl. A):195A.
  344. Albert M, Antman EM. "Preoperative Evaluation for Cardiac Surgery". Cardiac Surgery in the Adult. Cohn LH, Edmunds Jr LH, eds. 2003; 235-48.
  345. Sinnaeve PR, Antman EM, Ross AM, Hasselblad V, Van de Werf FJ, Granger CB. Enoxaparin is superior to unfractionated heparin after fibrinolysis in acute myocardial infarction: meta-analysis of ASSENT-3, HART-II, and ENTIRE-TIMI-23 trials. JACC. 2003; 41(Suppl. A):334A.
  346. Sabatine M, Morrow DA, Antman EM. "Risk Stratification in Non-ST-Segment Elevation Acute Coronary Syndromes". Acute Coronary Syndromes: A Companion to Braunwald's Heart Disease. Theroux P, ed. 2003; 308-321.
  347. Morrow DA, Antman EM. Low-molecular-weight heparin in non-ST elevation acute coronary syndromes. Harrison's Advances in Cardiology. Braunwald E, ed. 2003; 155-67.
  348. Gibson CM, de Lemos JA, Murphy SA, Marble SJ, Dauterman KW, Michaels A, Barron HV, Antman EM. Methodologic and clinical validation of the TIMI myocardial perfusion grade in acute myocardial infarction. J Thromb Thrombolysis. 2002 Dec; 14(3):233-7.
    View in: PubMed
  349. Gregoratos G, Abrams J, Epstein AE, Freedman RA, Hayes DL, Hlatky MA, Kerber RE, Naccarelli GV, Schoenfeld MH, Silka MJ, Winters SL, Gibbons RI, Antman EM, Alpert JS, Hiratzka LF, Faxon DP, Jacobs AK, Fuster V, Smith SC. ACC/AHA/NASPE 2002 guideline update for implantation of cardiac pacemakers and antiarrhythmia devices: summary article. A report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines (ACC/AHA/NASPE Committee to Update the 1998 Pacemaker Guidelines). J Cardiovasc Electrophysiol. 2002 Nov; 13(11):1183-99.
    View in: PubMed
  350. Cooper HA, de Lemos JA, Morrow DA, Sabatine MS, Murphy SA, McCabe CH, Gibson CM, Antman EM, Braunwald E. Minimal ST-segment deviation: a simple, noninvasive method for identifying patients with a patent infarction-related artery after fibrinolytic administration. Am Heart J. 2002 Nov; 144(5):790-5.
    View in: PubMed
  351. Cohen M, Antman EM. Enoxaparin and unfractionated heparin in acute coronary syndromes without ST-segment elevation. Thromb Haemost. 2002 Nov; 88(5):884-6; 886-7.
    View in: PubMed
  352. Gibbons RJ, Balady GJ, Bricker JT, Chaitman BR, Fletcher GF, Froelicher VF, Mark DB, McCallister BD, Mooss AN, O'Reilly MG, Winters WL, Gibbons RJ, Antman EM, Alpert JS, Faxon DP, Fuster V, Gregoratos G, Hiratzka LF, Jacobs AK, Russell RO, Smith SC. ACC/AHA 2002 guideline update for exercise testing: summary article. A report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines (Committee to Update the 1997 Exercise Testing Guidelines). J Am Coll Cardiol. 2002 Oct 16; 40(8):1531-40.
    View in: PubMed
  353. Gregoratos G, Abrams J, Epstein AE, Freedman RA, Hayes DL, Hlatky MA, Kerber RE, Naccarelli GV, Schoenfeld MH, Silka MJ, Winters SL, Gibbons RJ, Antman EM, Alpert JS, Gregoratos G, Hiratzka LF, Faxon DP, Jacobs AK, Fuster V, Smith SC. ACC/AHA/NASPE 2002 guideline update for implantation of cardiac pacemakers and antiarrhythmia devices: summary article: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines (ACC/AHA/NASPE Committee to Update the 1998 Pacemaker Guidelines). Circulation. 2002 Oct 15; 106(16):2145-61.
    View in: PubMed
  354. Braunwald E, Antman EM, Beasley JW, Califf RM, Cheitlin MD, Hochman JS, Jones RH, Kereiakes D, Kupersmith J, Levin TN, Pepine CJ, Schaeffer JW, Smith EE, Steward DE, Theroux P, Gibbons RJ, Alpert JS, Faxon DP, Fuster V, Gregoratos G, Hiratzka LF, Jacobs AK, Smith SC. ACC/AHA 2002 guideline update for the management of patients with unstable angina and non-ST-segment elevation myocardial infarction--summary article: a report of the American College of Cardiology/American Heart Association task force on practice guidelines (Committee on the Management of Patients With Unstable Angina). J Am Coll Cardiol. 2002 Oct 2; 40(7):1366-74.
    View in: PubMed
  355. Kereiakes DJ, Montalescot G, Antman EM, Cohen M, Darius H, Ferguson JJ, Grines C, Karsch KR, Kleiman NS, Moliterno DJ, Steg PG, Teirstein P, Van de Werf F, Wallentin L. Low-molecular-weight heparin therapy for non-ST-elevation acute coronary syndromes and during percutaneous coronary intervention: an expert consensus. Am Heart J. 2002 Oct; 144(4):615-24.
    View in: PubMed
  356. Murphy SA, Chen C, Cannon CP, Antman EM, Gibson CM. Impact of gender on angiographic and clinical outcomes after fibrinolytic therapy in acute myocardial infarction. Am J Cardiol. 2002 Oct 1; 90(7):766-70.
    View in: PubMed
  357. Angeja BG, de Lemos J, Murphy SA, Marble SJ, Antman EM, Cannon CP, Braunwald E, Gibson CM. Impact of diabetes mellitus on epicardial and microvascular flow after fibrinolytic therapy. Am Heart J. 2002 Oct; 144(4):649-56.
    View in: PubMed
  358. Braunwald E, Antman EM, Beasley JW, Califf RM, Cheitlin MD, Hochman JS, Jones RH, Kereiakes D, Kupersmith J, Levin TN, Pepine CJ, Schaeffer JW, Smith EE, Steward DE, Theroux P, Gibbons RJ, Alpert JS, Faxon DP, Fuster V, Gregoratos G, Hiratzka LF, Jacobs AK, Smith SC. ACC/AHA guideline update for the management of patients with unstable angina and non-ST-segment elevation myocardial infarction--2002: summary article: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines (Committee on the Management of Patients With Unstable Angina). Circulation. 2002 Oct 1; 106(14):1893-900.
    View in: PubMed
  359. Gibbons RJ, Balady GJ, Bricker JT, Chaitman BR, Fletcher GF, Froelicher VF, Mark DB, McCallister BD, Mooss AN, O'Reilly MG, Winters WL, Gibbons RJ, Antman EM, Alpert JS, Faxon DP, Fuster V, Gregoratos G, Hiratzka LF, Jacobs AK, Russell RO, Smith SC. ACC/AHA 2002 guideline update for exercise testing: summary article: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines (Committee to Update the 1997 Exercise Testing Guidelines). Circulation. 2002 Oct 1; 106(14):1883-92.
    View in: PubMed
  360. Fox KA, Antman EM, Cohen M, Bigonzi F. Comparison of enoxaparin versus unfractionated heparin in patients with unstable angina pectoris/non-ST-segment elevation acute myocardial infarction having subsequent percutaneous coronary intervention. Am J Cardiol. 2002 Sep 1; 90(5):477-82.
    View in: PubMed
  361. Antman EM. 'I can see clearly now': a new view on the use of IV GP IIb/IIIa inhibitors in acute coronary syndromes. Eur Heart J. 2002 Sep; 23(18):1408-11.
    View in: PubMed
  362. Scirica BM, Cannon CP, Antman EM, Murphy SA, Morrow DA, Sabatine MS, McCabe CH, Gibson CM, Braunwald E. Validation of the thrombolysis in myocardial infarction (TIMI) risk score for unstable angina pectoris and non-ST-elevation myocardial infarction in the TIMI III registry. Am J Cardiol. 2002 Aug 1; 90(3):303-5.
    View in: PubMed
  363. de Lemos JA, Morrow DA, Gibson CM, Murphy SA, Sabatine MS, Rifai N, McCabe CH, Antman EM, Cannon CP, Braunwald E. The prognostic value of serum myoglobin in patients with non-ST-segment elevation acute coronary syndromes. Results from the TIMI 11B and TACTICS-TIMI 18 studies. J Am Coll Cardiol. 2002 Jul 17; 40(2):238-44.
    View in: PubMed
  364. Morrow DA, Antman EM, Sayah A, Schuhwerk KC, Giugliano RP, deLemos JA, Waller M, Cohen SA, Rosenberg DG, Cutler SS, McCabe CH, Walls RM, Braunwald E. Evaluation of the time saved by prehospital initiation of reteplase for ST-elevation myocardial infarction: results of The Early Retavase-Thrombolysis in Myocardial Infarction (ER-TIMI) 19 trial. J Am Coll Cardiol. 2002 Jul 3; 40(1):71-7.
    View in: PubMed
  365. Antman EM. Decision making with cardiac troponin tests. N Engl J Med. 2002 Jun 27; 346(26):2079-82.
    View in: PubMed
  366. Angeja BG, Kermgard S, Chen MS, McKay M, Murphy SA, Antman EM, Cannon CP, Braunwald E, Gibson CM. The smoker's paradox: insights from the angiographic substudies of the TIMI trials. J Thromb Thrombolysis. 2002 Jun; 13(3):133-9.
    View in: PubMed
  367. Antman EM, Cooper HA, Gibson CM, de Lemos JA, McCabe CH, Giugliano RP, Coussement P, Murphy S, Scherer J, Anderson K, Van de Werf F, Braunwald E. Determinants of improvement in epicardial flow and myocardial perfusion for ST elevation myocardial infarction; insights from TIMI 14 and InTIME-II. Eur Heart J. 2002 Jun; 23(12):928-33.
    View in: PubMed
  368. Sabatine MS, McCabe CH, Morrow DA, Giugliano RP, de Lemos JA, Cohen M, Antman EM, Braunwald E. Identification of patients at high risk for death and cardiac ischemic events after hospital discharge. Am Heart J. 2002 Jun; 143(6):966-70.
    View in: PubMed
  369. Eagle KA, Berger PB, Calkins H, Chaitman BR, Ewy GA, Fleischmann KE, Fleisher LA, Froehlich JB, Gusberg RJ, Leppo JA, Ryan T, Schlant RC, Winters WL, Gibbons RJ, Antman EM, Alpert JS, Faxon DP, Fuster V, Gregoratos G, Jacobs AK, Hiratzka LF, Russell RO, Smith SC. ACC/AHA Guideline Update for Perioperative Cardiovascular Evaluation for Noncardiac Surgery--Executive Summary. A report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines (Committee to Update the 1996 Guidelines on Perioperative Cardiovascular Evaluation for Noncardiac Surgery). Anesth Analg. 2002 May; 94(5):1052-64.
    View in: PubMed
  370. Becker RC, Spencer FA, Gibson M, Rush JE, Sanderink G, Murphy SA, Ball SP, Antman EM. Influence of patient characteristics and renal function on factor Xa inhibition pharmacokinetics and pharmacodynamics after enoxaparin administration in non-ST-segment elevation acute coronary syndromes. Am Heart J. 2002 May; 143(5):753-9.
    View in: PubMed
  371. Sabatine MS, Morrow DA, de Lemos JA, Gibson CM, Murphy SA, Rifai N, McCabe C, Antman EM, Cannon CP, Braunwald E. Multimarker approach to risk stratification in non-ST elevation acute coronary syndromes: simultaneous assessment of troponin I, C-reactive protein, and B-type natriuretic peptide. Circulation. 2002 Apr 16; 105(15):1760-3.
    View in: PubMed
  372. Antman EM, Louwerenburg HW, Baars HF, Wesdorp JC, Hamer B, Bassand JP, Bigonzi F, Pisapia G, Gibson CM, Heidbuchel H, Braunwald E, Van de Werf F. Enoxaparin as adjunctive antithrombin therapy for ST-elevation myocardial infarction: results of the ENTIRE-Thrombolysis in Myocardial Infarction (TIMI) 23 Trial. Circulation. 2002 Apr 9; 105(14):1642-9.
    View in: PubMed
  373. Cohen M, Antman EM. Superiority of enoxaparin over unfractionated heparin for the treatment of acute coronary syndromes. Pharmacotherapy. 2002 Apr; 22(4):542-6; author reply 546-50.
    View in: PubMed
  374. Eagle KA, Berger PB, Calkins H, Chaitman BR, Ewy GA, Fleischmann KE, Fleisher LA, Froehlich JB, Gusberg RJ, Leppo JA, Ryan T, Schlant RC, Winters WL, Gibbons RJ, Antman EM, Alpert JS, Faxon DP, Fuster V, Gregoratos G, Jacobs AK, Hiratzka LF, Russell RO, Smith SC. ACC/AHA guideline update for perioperative cardiovascular evaluation for noncardiac surgery---executive summary a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines (Committee to Update the 1996 Guidelines on Perioperative Cardiovascular Evaluation for Noncardiac Surgery). Circulation. 2002 Mar 12; 105(10):1257-67.
    View in: PubMed
  375. Cannon CP, Bahit MC, Haugland JM, Henry TD, Schweiger MJ, McKendall GR, Shah PK, Murphy S, Gibson CM, McCabe CH, Antman EM, Braunwald E. Underutilization of evidence-based medications in acute ST elevation myocardial infarction: results of the Thrombolysis in Myocardial Infarction (TIMI) 9 Registry. Crit Pathw Cardiol. 2002 Mar; 1(1):44-52.
    View in: PubMed
  376. Omland T, de Lemos JA, Morrow DA, Antman EM, Cannon CP, Hall C, Braunwald E. Prognostic value of N-terminal pro-atrial and pro-brain natriuretic peptide in patients with acute coronary syndromes. Am J Cardiol. 2002 Feb 15; 89(4):463-5.
    View in: PubMed
  377. Eagle KA, Berger PB, Calkins H, Chaitman BR, Ewy GA, Fleischmann KE, Fleisher LA, Froehlich JB, Gusberg RJ, Leppo JA, Ryan T, Schlant RC, Winters WL, Gibbons RJ, Antman EM, Alpert JS, Faxon DP, Fuster V, Gregoratos G, Jacobs AK, Hiratzka LF, Russell RO, Smith SC. ACC/AHA guideline update for perioperative cardiovascular evaluation for noncardiac surgery--executive summary: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines (Committee to Update the 1996 Guidelines on Perioperative Cardiovascular Evaluation for Noncardiac Surgery). J Am Coll Cardiol. 2002 Feb 6; 39(3):542-53.
    View in: PubMed
  378. Morrow DA, Antman EM, Snapinn SM, McCabe CH, Theroux P, Braunwald E. An integrated clinical approach to predicting the benefit of tirofiban in non-ST elevation acute coronary syndromes. Application of the TIMI Risk Score for UA/NSTEMI in PRISM-PLUS. Eur Heart J. 2002 Feb; 23(3):223-9.
    View in: PubMed
  379. Antman EM, Cohen M, McCabe C, Goodman SG, Murphy SA, Braunwald E. Enoxaparin is superior to unfractionated heparin for preventing clinical events at 1-year follow-up of TIMI 11B and ESSENCE. Eur Heart J. 2002 Feb; 23(4):308-14.
    View in: PubMed
  380. Antman EM, McCabe CH, Braunwald E. Bivalirudin as a replacement for unfractionated heparin in unstable angina/non-ST-elevation myocardial infarction: observations from the TIMI 8 trial. The Thrombolysis in Myocardial Infarction. Am Heart J. 2002 Feb; 143(2):229-34.
    View in: PubMed
  381. Hunt SA, Baker DW, Chin MH, Cinquegrani MP, Feldman AM, Francis GS, Ganiats TG, Goldstein S, Gregoratos G, Jessup ML, Noble RJ, Packer M, Silver MA, Stevenson LW, Gibbons RJ, Antman EM, Alpert JS, Faxon DP, Fuster V, Gregoratos G, Jacobs AK, Hiratzka LF, Russell RO, Smith SC. ACC/AHA guidelines for the evaluation and management of chronic heart failure in the adult: executive summary. J Heart Lung Transplant. 2002 Feb; 21(2):189-203.
    View in: PubMed
  382. Antman EM, Califf RM, Kupersmith J. "Tools for Assesment for Cardiovascular Tests and Therapies". Cardiovascular Therapeutics: A Companion to Braunwald's Heart Disease. 2002; 1-33.
  383. The Atrial Fibrillation Follow-up of Investigation of Rhythm Management (AFFIRM) Investigators. E. Antman, member of Steering Committee. A comparison of rate control and rhythm control in patients with atrial fibrillation. N Engl J Med. 2002; 347:1825-33.
  384. James D, Murphy SA, Wong GC, Morrow DA, Antman EM, McCabe CH, Marble SJ, Markovic R, Gibson CM. Increased AHA lesion complexity following thrombolytic administration is associated with mortality in ST elevation myocardial infarction. Circulation. 2002; 106 (Suppl. II):II-660.
  385. Cardiovascular Therapeutics: A Companion to Braunwald's Heart Disease (EM Antman, Editor-in-Chief). 2002.
  386. Cohen M, Antman EM, Murphy SA, Radley D. Mode and timing of treatment failure (recurrent ischemic events) after hospital admission for non-ST segment elevation acute coronary syndromes. Am Heart J. 2002 Jan; 143(1):63-9.
    View in: PubMed
  387. Sabatine MS, Morrow DA, Heidbuchel H, de Lemos JA, Cooper HA, Schuhwerk KC, Murphy SA, McCabe CH, Giugliano RP, Antman EM, Gibson M, Braunwald E, Van de Werf F. Correlation between ST resolution and angiographic findings in ST elevation myocardial infarction. Journal of the American College of Cardiology. 2002; 39(Suppl. A):301A.
  388. Giri S, Gibson M, Eisenhauer AC, Kuntz RE, Rogers C, Murphy S, Michel J, Antman EM, Simon DI. Aging of intracoronary thrombus due to delayed time-to-perfusion increases ischemic and angiographic complications in acute myocardial infarction. Journal of the American College of Cardiology. 2002; 39(Suppl. A):281A.
  389. Gibson M, Murphy SA, James D, Wong G, Cannon CP, Giugliano RP, Antman EM, Braunwald E. Is recurrent myocardial infarction following thrombolytic administration associated with long-term mortality?. Journal of the American College of Cardiology. 2002; 39 (Suppl. A):280A.
  390. Direct Thrombin Inhibitor Trialists' Collaborative Group. Direct Thrombin Inhibitor Trialist: TIMI 9B: Elliott M. Antman, M.D. Direct thrombin inhibitors in acute coronary syndromes: principal results of a meta-analysis based on individual patients' data. Lancet. 2002; 359:294-302.
  391. The SYNERGY trial: study design and rationale. American Heart Journal. 2002; 143:952-60.
  392. "Unstable Angina/Non ST Elevation MI/ST Elevation MI". Acute Coronary Syndromes Monograph Series (EM Antman, ed.). 2002.
  393. Gibson CM, Murphy SA, James D, Marble SJ, Wong GC, Kalapanda R, Kraimer N, Antman EM. Facilitated angioplasty is associated with an improvement in the number of frames required for dye to fill the myocardium (TIMI Myocardial Frame Count) in ST segment elevation myocardial infarction (STEMI). Circulation. 2002; 106 (Suppl. II):II-598.
  394. The Magnesium in Coronaries (MAGIC) Trial Investigators. E. Antman, Chair, Steering Committee. Early administration of intravenous magnesium to high-risk patients with acute myocardial infarction in the Magnesium in Coronaries (MAGIC) Trial: a randomised controlled trial. Lancet. 2002; 360:1189-96.
  395. Morrow DA, Antman EM. "Low-Molecular-Weight Heparins in the Acute Coronary Syndromes". Therapeutic Agents in Thrombosis and Thrombolysis. Sasahara A, Loscalzo J, eds. 2002; 75-90.
  396. Murphy SA, Giugliano RP, Wong G, Cannon CP, Antman EM, Gibson M. Comparison of the frequency and outcomes of investigator assessed recurrent MI versus clinical event committee (CEC) adjudicated recurrent MI in acute MI trials: a TIMI 14 and TIMI 9 substudy. Journal of the American College of Cardiology. 2002; 39(Suppl. A):279A.
  397. Van de Werf FJ, Antman EM, Simoons ML. Managing ST-elevation myocardial infarction. European Heart Journal. 2002; 4 (Suppl E):E15-E23.
  398. Hunt SA, Baker DW, Chin MH, Cinquegrani MP, Feldman AM, Francis GS, Ganiats TG, Goldstein S, Gregoratos G, Jessup ML, Noble RJ, Packer M, Silver MA, Stevenson LW, Gibbons RJ, Antman EM, Alpert JS, Faxon DP, Fuster V, Gregoratos G, Jacobs AK, Hiratzka LF, Russell RO, Smith SC. ACC/AHA Guidelines for the Evaluation and Management of Chronic Heart Failure in the Adult: Executive Summary A Report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines (Committee to Revise the 1995 Guidelines for the Evaluation and Management of Heart Failure): Developed in Collaboration With the International Society for Heart and Lung Transplantation; Endorsed by the Heart Failure Society of America. Circulation. 2001 Dec 11; 104(24):2996-3007.
    View in: PubMed
  399. Giugliano RP, Antman EM. Caeteris paribus - all things being equal. Eur Heart J. 2001 Dec; 22(24):2221-3.
    View in: PubMed
  400. Cohen M, Antman EM, Gurfinkel EP, Radley D. Enoxaparin in unstable angina/non-ST-segment elevation myocardial infarction: treatment benefits in prespecified subgroups. J Thromb Thrombolysis. 2001 Dec; 12(3):199-206.
    View in: PubMed
  401. Hunt SA, Baker DW, Chin MH, Cinquegrani MP, Feldman AM, Francis GS, Ganiats TG, Goldstein S, Gregoratos G, Jessup ML, Noble RJ, Packer M, Silver MA, Stevenson LW, Gibbons RJ, Antman EM, Alpert JS, Faxon DP, Fuster V, Jacobs AK, Hiratzka LF, Russell RO, Smith SC. ACC/AHA guidelines for the evaluation and management of chronic heart failure in the adult: executive summary. A report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines (Committee to revise the 1995 Guidelines for the Evaluation and Management of Heart Failure). J Am Coll Cardiol. 2001 Dec; 38(7):2101-13.
    View in: PubMed
  402. Antman EM, Braunwald E. A second look at bivalirudin. Am Heart J. 2001 Dec; 142(6):929-31.
    View in: PubMed
  403. Morrow DA, Antman EM, Giugliano RP, Cairns R, Charlesworth A, Murphy SA, de Lemos JA, McCabe CH, Braunwald E. A simple risk index for rapid initial triage of patients with ST-elevation myocardial infarction: an InTIME II substudy. Lancet. 2001 Nov 10; 358(9293):1571-5.
    View in: PubMed
  404. Llevadot J, Giugliano RP, Antman EM, Wilcox RG, Gurfinkel EP, Henry T, McCabe CH, Charlesworth A, Thompson S, Nicolau JC, Tebbe U, Sadowski Z, Braunwald E. Availability of on-site catheterization and clinical outcomes in patients receiving fibrinolysis for ST-elevation myocardial infarction. Eur Heart J. 2001 Nov; 22(22):2104-15.
    View in: PubMed
  405. Fuster V, Rydén LE, Asinger RW, Cannom DS, Crijns HJ, Frye RL, Halperin JL, Kay GN, Klein WW, Lévy S, McNamara RL, Prystowsky EN, Wann LS, Wyse DG, Gibbons RJ, Antman EM, Alpert JS, Faxon DP, Fuster V, Gregoratos G, Hiratzka LF, Jacobs AK, Russell RO, Smith SC, Klein WW, Alonso-Garcia A, Blomström-Lundqvist C, de Backer G, Flather M, Hradec J, Oto A, Parkhomenko A, Silber S, Torbicki A. ACC/AHA/ESC Guidelines for the Management of Patients With Atrial Fibrillation: Executive Summary A Report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines and the European Society of Cardiology Committee for Practice Guidelines and Policy Conferences (Committee to Develop Guidelines for the Management of Patients With Atrial Fibrillation) Developed in Collaboration With the North American Society of Pacing and Electrophysiology. Circulation. 2001 Oct 23; 104(17):2118-50.
    View in: PubMed
  406. Schweiger MJ, Cannon CP, Murphy SA, Gibson CM, Cook JR, Giugliano RP, Changezi HU, Antman EM, Braunwald E. Early coronary intervention following pharmacologic therapy for acute myocardial infarction (the combined TIMI 10B-TIMI 14 experience). Am J Cardiol. 2001 Oct 15; 88(8):831-6.
    View in: PubMed
  407. Henry TD, Satran D, Knox LL, Iacarella CL, Laxson DD, Antman EM. Are activated clotting times helpful in the management of anticoagulation with subcutaneous low-molecular-weight heparin? Am Heart J. 2001 Oct; 142(4):590-3.
    View in: PubMed
  408. Fuster V, Rydén LE, Asinger RW, Cannom DS, Crijns HJ, Frye RL, Halperin JL, Kay GN, Klein WW, Lévy S, McNamara RL, Prystowsky EN, Wann LS, Wyse DG, Gibbons RJ, Antman EM, Alpert JS, Faxon DP, Fuster V, Gregoratos G, Hiratzka LF, Jacobs AK, Russell RO, Smith SC, Klein WW, Alonso-Garcia A, Blomström-Lundqvist C, De Backer G, Flather M, Hradec J, Oto A, Parkhomenko A, Silber S, Torbicki A. ACC/AHA/ESC guidelines for the management of patients with atrial fibrillation: executive summary. A Report of the American College of Cardiology/ American Heart Association Task Force on Practice Guidelines and the European Society of Cardiology Committee for Practice Guidelines and Policy Conferences (Committee to Develop Guidelines for the Management of Patients With Atrial Fibrillation): developed in Collaboration With the North American Society of Pacing and Electrophysiology. J Am Coll Cardiol. 2001 Oct; 38(4):1231-66.
    View in: PubMed
  409. Antman EM. Troponin measurements in ischemic heart disease: more than just a black and white picture. J Am Coll Cardiol. 2001 Oct; 38(4):987-90.
    View in: PubMed
  410. Juárez U, Antman EM. [Magnesium in the treatment of acute myocardial infarction. Review and controversies]. Arch Cardiol Mex. 2001 Oct-Dec; 71(4):335-44.
    View in: PubMed
  411. Morrow DA, Antman EM, Parsons L, de Lemos JA, Cannon CP, Giugliano RP, McCabe CH, Barron HV, Braunwald E. Application of the TIMI risk score for ST-elevation MI in the National Registry of Myocardial Infarction 3. JAMA. 2001 Sep 19; 286(11):1356-9.
    View in: PubMed
  412. Giugliano RP, Llevadot J, Wilcox RG, Gurfinkel EP, McCabe CH, Charlesworth A, Thompson SL, Antman EM, Braunwald E. Geographic variation in patient and hospital characteristics, management, and clinical outcomes in ST-elevation myocardial infarction treated with fibrinolysis. Results from InTIME-II. Eur Heart J. 2001 Sep; 22(18):1702-15.
    View in: PubMed
  413. de Lemos JA, Morrow DA, Gibson CM, Murphy SA, Rifai N, Tanasijevic M, Giugliano RP, Schuhwerk KC, McCabe CH, Cannon CP, Antman EM, Braunwald E. Early noninvasive detection of failed epicardial reperfusion after fibrinolytic therapy. Am J Cardiol. 2001 Aug 15; 88(4):353-8.
    View in: PubMed
  414. Llevadot J, Giugliano RP, Antman EM. Bolus fibrinolytic therapy in acute myocardial infarction. JAMA. 2001 Jul 25; 286(4):442-9.
    View in: PubMed
  415. Srinivas VS, Cannon CP, Gibson CM, Antman EM, Greenberg MA, Tanasijevic MJ, Murphy S, de Lemos JA, Sokol S, Braunwald E, Mueller HS. Myoglobin levels at 12 hours identify patients at low risk for 30-day mortality after thrombolysis in acute myocardial infarction: a Thrombolysis in Myocardial Infarction 10B substudy. Am Heart J. 2001 Jul; 142(1):29-36.
    View in: PubMed
  416. Turpie AG, Antman EM. Low-molecular-weight heparins in the treatment of acute coronary syndromes. Arch Intern Med. 2001 Jun 25; 161(12):1484-90.
    View in: PubMed
  417. Menon V, Berkowitz SD, Antman EM, Fuchs RM, Hochman JS. New heparin dosing recommendations for patients with acute coronary syndromes. Am J Med. 2001 Jun 1; 110(8):641-50.
    View in: PubMed
  418. Antman EM. Clinical trials in cardiovascular medicine. Circulation. 2001 May 29; 103(21):E101-4.
    View in: PubMed
  419. Gibson CM, de Lemos JA, Murphy SA, Marble SJ, McCabe CH, Cannon CP, Antman EM, Braunwald E. Combination therapy with abciximab reduces angiographically evident thrombus in acute myocardial infarction: a TIMI 14 substudy. Circulation. 2001 May 29; 103(21):2550-4.
    View in: PubMed
  420. Antman EM. The search for replacements for unfractionated heparin. Circulation. 2001 May 8; 103(18):2310-4.
    View in: PubMed
  421. Giugliano RP, McCabe CH, Antman EM, Cannon CP, Van de Werf F, Wilcox RG, Braunwald E. Lower-dose heparin with fibrinolysis is associated with lower rates of intracranial hemorrhage. Am Heart J. 2001 May; 141(5):742-50.
    View in: PubMed
  422. Gibson CM, Kirtane AJ, Murphy SA, Marble SJ, de Lemos JA, Antman EM, Braunwald E. Impact of contrast agent type (ionic versus nonionic) used for coronary angiography on angiographic, electrocardiographic, and clinical outcomes following thrombolytic administration in acute myocardial infarction. Catheter Cardiovasc Interv. 2001 May; 53(1):6-11.
    View in: PubMed
  423. Holper EM, Antman EM, McCabe CH, Premmereur J, Gurfinkel E, Bernink PJ, Turpie AG, Bayes de Luna A, Lablanche JM, Fox KM, Salein D, Radley DR, Braunwald E. A simple, readily available method for risk stratification of patients with unstable angina and non-ST elevation myocardial infarction. Am J Cardiol. 2001 Apr 15; 87(8):1008-10; A5.
    View in: PubMed
  424. Santopinto J, Gurfinkel EP, Torres V, Marcos E, Bozovich GE, Mautner B, McCabe CH, Antman EM. Prior aspirin users with acute non-ST-elevation coronary syndromes are at increased risk of cardiac events and benefit from enoxaparin. Am Heart J. 2001 Apr; 141(4):566-72.
    View in: PubMed
  425. de Lemos JA, Gibson CM, Antman EM, Murphy SA, Morrow DA, Schuhwerk KC, Schweiger M, Coussement P, Van de Werf F, Braunwald E. Abciximab and early adjunctive percutaneous coronary intervention are associated with improved ST-segment resolution after thrombolysis: Observations from the TIMI 14 Trial. Am Heart J. 2001 Apr; 141(4):592-8.
    View in: PubMed
  426. Lev D, Watemberg N, Aviram A, Fishoff J, Antman E, Lerman-Sagie T. Febrile convulsions, ataxia, developmental delay, and obesity: a new syndrome? J Child Neurol. 2001 Mar; 16(3):174-6.
    View in: PubMed
  427. Gibson CM, Murphy SA, Marble SJ, McCabe CH, Antman EM, Cannon CP, Braunwald E. Can we replace the 90-minute thrombolysis in myocardial infarction (TIMI) flow grades with those at 60 minutes as a primary end point in thrombolytic trials? TIMI Study Group. Am J Cardiol. 2001 Feb 15; 87(4):450-3, A6.
    View in: PubMed
  428. Becker RC, Spencer FA, Bruno R, Ball SP, Antman EM. Excess body weight does not adversely influence either bioavailability or anticoagulant activity of enoxaparin administered subcutaneously in acute coronary syndromes. Circulation. 2001; 102:II-427.
  429. Antman EM. Clinical trials in cardiovascular medicine (Clinical Cardiology: Physician Update). Circulation. 2001; 103:e101-e104.
  430. Cannon CP, McCabe CH, Antman EM, Bentley J, Rifai N, Braunwald E. Are there high-risk patients who are troponin negative? Further risk stratification with the TIMI risk score in patients with acute coronary syndromes: results from OPUS-TIMI 16. Journal of the American College of Cardiology. 2001; 37(Suppl. A):326A.
  431. de Lemos JA, Antman EM, Murphy SA, McCabe CH, Morrow DA, Marble SJ, Giugliano RP, Braunwald E. Early adjunctive stenting is associated with less ST resolution than early adjunctive PTCA. Circulation. 2001; 102:II-754.
  432. Ganz LI, Antman EM. "Cardiac Arrhythmias During Myocardial Infarction". Contemporary Cardiology: Management of Cardiac Arrhythmias. Ganz LI, ed. 2001; 419-60.
  433. Antman EM, Corbalan R, Huber K, Jaffe AS. Issues in early risk stratification for UA/NSTEMI. European Heart Journal Supplements. 2001; 3 (Suppl J):J6-J14.
  434. Giugliano R, Antman EM. Caeteris paribus--all things being equal. (Editorial). European Heart Journal. 2001; 22 (doi: 10.1053/euhj.2001.268:2221-23.
  435. Sabatine MS, McCabe CH, Morrow DA, Giugliano RP, de Lemos JA, Antman EM. Predicting risk of post-discharge events in unstable angina. Circulation. 2001; 102:II-589.
  436. Antman EM. Cybersessions: Incorporating the TIMI Risk Score into ACS Critical Pathways. www.TIMI.tv. 2001.
  437. Antman EM, Braunwald E. "Acute Myocardial Infarction". Heart Disease: A Textbook of Cardiovascular Medicine. Braunwald E, Zipes DW, Libby P, eds. 2001; 1114-1219.
  438. Ziegelstein RC, Hilbe JM, French WJ, Antman EM, Chandra-Strobos N. Magnesium use in the treatment of acute myocardial infarction in the United States (observations from the Second National Registry of Myocardial Infarction). Am J Cardiol. 2001 Jan 1; 87(1):7-10.
    View in: PubMed
  439. Antman EM, Braunwald E. "Acute Myocardial Infarction". Harrison's Principles of Internal Medicine. Fauci AS, Braunwald E, Isselbacher KJ, Wilson JD, Martin JB, Kasper DL, Hauser SL, Longo DO, eds. 2001; 1386-1399.
  440. Antman EM. "Advances in pharmacologic reperfusion for myocardial infarction--Thrombolysis, IIb/IIIa Receptor Antagonists, and antithrombins." (CD-ROM). 2001.
  441. Direct Thrombin Inhibitor Trialists' Collaborative Group. Direct Thrombin Inhibitor Trialist: TIMI 9A and 9B: Elliott M. Antman, M.D. Direct thrombin inhibitors in acute coronary syndromes and during percutaneous coronary intervention: design of a meta-analysis based on individual patient data. American Heart Journal. 2001; 141:E2.
  442. Sloan MA, Giugliano RP, Thompson, SL, Antman EM, McCabe CH, Braunwald E. Prediction of intracranical hemorrhage in the InTIME-II trial. Journal of the American College of Cardiology. 2001; 37(Suppl. A):372A.
  443. Moliterno DJ, Antman EM, Ohman EM, Miller J, Marble SJ, Murphy SA, Ivanc TB, Schuhwerk K, Gibson CM. Concordance between core labs in trial results using TIMI flow grades & frame counts. Circulation. 2001; 102:II-590.
  444. Braunwald E, Antman EM. Epicardial flow and myocardial reperfusion following abciximab and low-dose thrombolytic therapy for acute myocardial infarction. European Heart Journal Supplement. 2001; Suppl. A:A8-A13.
  445. Giugliano RP, Antman EM, Thompson SL, McCabe CH, Braunwald E. Lipid lowering drug therapy initiated during hospitalization for acute MI is associated with lower postdischarge 1-year mortality. Journal of the American College of Cardiology. 2001; 37(Suppl. A):316A.
  446. Antman EM. Cybersessions (Conceptis): ENTIRE-TIMI 23. 2001.
  447. Adams D, Antman EM. "Medical Management of the Patient Undergoing Cardiac Surgery". Heart Disease: A Textbook of Cardiovascular Medicine. Braunwald E, Zipes DW, Libby P, eds. 2001; 2059-83.
  448. Gibson CM, Anshelevich M, Murphy S, Luu L, Hynes C, Kliris J, Kermgard S, Otten MH, Antman EM, Cannon CP, Braunwald E. Impact of injections during diagnostic coronary arteriography on coronary patency in the setting of acute myocardial infarction from the TIMI trials. Thrombolysis In Myocardial Infarction. Am J Cardiol. 2000 Dec 15; 86(12):1378-9, A5.
    View in: PubMed
  449. Antman EM, Gibson CM, de Lemos JA, Giugliano RP, McCabe CH, Coussement P, Menown I, Nienaber CA, Rehders TC, Frey MJ, Van der Wieken R, Andresen D, Scherer J, Anderson K, Van de Werf F, Braunwald E. Combination reperfusion therapy with abciximab and reduced dose reteplase: results from TIMI 14. The Thrombolysis in Myocardial Infarction (TIMI) 14 Investigators. Eur Heart J. 2000 Dec; 21(23):1944-53.
    View in: PubMed
  450. Antman EM, Kereiakes DJ. Antithrombotic therapy in unstable angina/non-ST elevation myocardial infarction: the evolving role of low-molecular-weight heparin. J Invasive Cardiol. 2000 Dec; 12 Suppl E:E1-4;discussion E25-8.
    View in: PubMed
  451. de Lemos JA, Antman EM, Giugliano RP, Morrow DA, McCabe CH, Cutler SS, Charlesworth A, Schröder R, Braunwald E. Comparison of a 60- versus 90-minute determination of ST-segment resolution after thrombolytic therapy for acute myocardial infarction. In TIME-II Investigators. Intravenous nPA for Treatment of Infarcting Myocardium Early-II. Am J Cardiol. 2000 Dec 1; 86(11):1235-7, A5.
    View in: PubMed
  452. Morrow DA, Antman EM, Tanasijevic M, Rifai N, de Lemos JA, McCabe CH, Cannon CP, Braunwald E. Cardiac troponin I for stratification of early outcomes and the efficacy of enoxaparin in unstable angina: a TIMI-11B substudy. J Am Coll Cardiol. 2000 Nov 15; 36(6):1812-7.
    View in: PubMed
  453. Morrow DA, Antman EM, Charlesworth A, Cairns R, Murphy SA, de Lemos JA, Giugliano RP, McCabe CH, Braunwald E. TIMI risk score for ST-elevation myocardial infarction: A convenient, bedside, clinical score for risk assessment at presentation: An intravenous nPA for treatment of infarcting myocardium early II trial substudy. Circulation. 2000 Oct 24; 102(17):2031-7.
    View in: PubMed
  454. Bozovich GE, Gurfinkel EP, Antman EM, McCabe CH, Mautner B. Superiority of enoxaparin versus unfractionated heparin for unstable angina/non-Q-wave myocardial infarction regardless of activated partial thromboplastin time. Am Heart J. 2000 Oct; 140(4):637-42.
    View in: PubMed
  455. Marsh JD, Antman EM. T-type calcium channel blockade in the management of chronic ischemic heart disease. Cardiovasc Drugs Ther. 2000 Oct; 14(5):459-61.
    View in: PubMed
  456. Braunwald E, Antman EM, Beasley JW, Califf RM, Cheitlin MD, Hochman JS, Jones RH, Kereiakes D, Kupersmith J, Levin TN, Pepine CJ, Schaeffer JW, Smith EE, Steward DE, Theroux P, Gibbons RJ, Alpert JS, Eagle KA, Faxon DP, Fuster V, Gardner TJ, Gregoratos G, Russell RO, Smith SC. ACC/AHA guidelines for the management of patients with unstable angina and non-ST-segment elevation myocardial infarction: executive summary and recommendations. A report of the American College of Cardiology/American Heart Association task force on practice guidelines (committee on the management of patients with unstable angina). Circulation. 2000 Sep 5; 102(10):1193-209.
    View in: PubMed
  457. De Lemos JA, Antman EM, Giugliano RP, Morrow DA, McCabe CH, Charlesworth A, Schröder R, Braunwald E. Very early risk stratification after thrombolytic therapy with a bedside myoglobin assay and the 12-lead electrocardiogram. Am Heart J. 2000 Sep; 140(3):373-8.
    View in: PubMed
  458. Cohen M, Antman EM, Gurfinkel E, Turpie AG, Furst J, Bigonzi F, Radley D. Impact of enoxaparin low molecular weight heparin in patients with Q-wave myocardial infarction. Am J Cardiol. 2000 Sep 1; 86(5):553-6, A9.
    View in: PubMed
  459. Braunwald E, Antman EM, Beasley JW, Califf RM, Cheitlin MD, Hochman JS, Jones RH, Kereiakes D, Kupersmith J, Levin TN, Pepine CJ, Schaeffer JW, Smith EE, Steward DE, Theroux P, Alpert JS, Eagle KA, Faxon DP, Fuster V, Gardner TJ, Gregoratos G, Russell RO, Smith SC. ACC/AHA guidelines for the management of patients with unstable angina and non-ST-segment elevation myocardial infarction. A report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines (Committee on the Management of Patients With Unstable Angina). J Am Coll Cardiol. 2000 Sep; 36(3):970-1062.
    View in: PubMed
  460. Alpert JS, Thygesen K, Antman E, Bassand JP. Myocardial infarction redefined--a consensus document of The Joint European Society of Cardiology/American College of Cardiology Committee for the redefinition of myocardial infarction. J Am Coll Cardiol. 2000 Sep; 36(3):959-69.
    View in: PubMed
  461. Antman EM, Cohen M, Bernink PJ, McCabe CH, Horacek T, Papuchis G, Mautner B, Corbalan R, Radley D, Braunwald E. The TIMI risk score for unstable angina/non-ST elevation MI: A method for prognostication and therapeutic decision making. JAMA. 2000 Aug 16; 284(7):835-42.
    View in: PubMed
  462. de Lemos JA, Antman EM, Morrow DA, Llevadot J, Giugliano RP, Coulter SA, Schuhwerk KC, Arslanian S, McCabe CH, Gibson CM, Rifai N. Heart-type fatty acid binding protein as a marker of reperfusion after thrombolytic therapy. Clin Chim Acta. 2000 Aug; 298(1-2):85-97.
    View in: PubMed
  463. Llevadot J, Giugliano RP, McCabe CH, Cannon CP, Antman EM, Murphy S, Gibson CM. Degree of residual stenosis in the culprit coronary artery after thrombolytic administration (Thrombolysis In Myocardial Infarction [TIMI] trials). Am J Cardiol. 2000 Jun 15; 85(12):1409-13.
    View in: PubMed
  464. Coulter SA, Cannon CP, Ault KA, Antman EM, Van de Werf F, Adgey AA, Gibson CM, Giugliano RP, Mascelli MA, Scherer J, Barnathan ES, Braunwald E, Kleiman NS. High levels of platelet inhibition with abciximab despite heightened platelet activation and aggregation during thrombolysis for acute myocardial infarction: results from TIMI (thrombolysis in myocardial infarction) 14. Circulation. 2000 Jun 13; 101(23):2690-5.
    View in: PubMed
  465. Morrow DA, Rifai N, Tanasijevic MJ, Wybenga DR, de Lemos JA, Antman EM. Clinical efficacy of three assays for cardiac troponin I for risk stratification in acute coronary syndromes: a Thrombolysis In Myocardial Infarction (TIMI) 11B Substudy. Clin Chem. 2000 Apr; 46(4):453-60.
    View in: PubMed
  466. Antman EM, Kuntz KM. The length of the hospital stay after myocardial infarction. N Engl J Med. 2000 Mar 16; 342(11):808-10.
    View in: PubMed
  467. Antman EM, Fox KM. Guidelines for the diagnosis and management of unstable angina and non-Q-wave myocardial infarction: proposed revisions. International Cardiology Forum. Am Heart J. 2000 Mar; 139(3):461-75.
    View in: PubMed
  468. de Lemos JA, Antman EM, Giugliano RP, McCabe CH, Murphy SA, Van de Werf F, Gibson CM, Braunwald E. ST-segment resolution and infarct-related artery patency and flow after thrombolytic therapy. Thrombolysis in Myocardial Infarction (TIMI) 14 investigators. Am J Cardiol. 2000 Feb 1; 85(3):299-304.
    View in: PubMed
  469. Morrow DA, Antman EM. Cardiac marker elevation after cardioversion: sorting out chicken and egg. Eur Heart J. 2000 Feb; 21(3):171-3.
    View in: PubMed
  470. Morrow DA, Rifai N, Antman EM, Weiner DL, McCabe CH, Cannon CP, Braunwald E. Serum amyloid A predicts early mortality in acute coronary syndromes: A TIMI 11A substudy. J Am Coll Cardiol. 2000 Feb; 35(2):358-62.
    View in: PubMed
  471. de Lemos JA, Antman EM, Gibson CM, McCabe CH, Giugliano RP, Murphy SA, Coulter SA, Anderson K, Scherer J, Frey MJ, Van Der Wieken R, Van De Werf F, Braunwald E. Abciximab improves both epicardial flow and myocardial reperfusion in ST-elevation myocardial infarction. Observations from the TIMI 14 trial. Circulation. 2000 Jan 25; 101(3):239-43.
    View in: PubMed
  472. Antman EM. Enoxaparin: a new standard of care. European Heart Journal Supplements. 2000; 2 (Suppl F):F7-F11.
  473. Piana RN, Giugliano RP, Coulter S, de Lemos J, McCabe CH, Antman EM, Skene AM, Neuhaus K, Braunwald E. Clinical outcome remains poor in diabetics with myocardial infarction despite early fibrinolytic therapy: findings from InTIME II. Journal of the American College of Cardiology. 2000; 35(Suppl. A):407A.
  474. Gibson CM, Mesley R, Saunders T, Hynes C, Murphy S, Zemble R, Marble SJ, McCabe CH, Antman EM, Braunwald E. Quantitative angiographic measurement of absolute coronary blood flow & its relation to mortality in acute myocardial infarction. Journal of the American College of Cardiology. 2000; 35(Suppl. A):396A.
  475. Warnica W, Antman EM, Wilcox R, McCabe C, Neuhaus K, Braunwald E. Recurrent ischemia and clinical outcome after thrombolysis for myocardial infarction: observations from InTIME II. Journal of the American College of Cardiology. 2000; 35(Suppl.A):386A.
  476. Marsh JD, Antman EM. T-type calcium channel blockade in the management of chronic ischemic heart disease. (Editorial). Cardiovascular Drugs and Therapy. 2000; 14:459-61.
  477. Morrow DA, Antman EM. Low molecular weight heparin in non-ST elevation acute coronary syndromes. 2000.
  478. Wilcox R, Charlesworth A, Antman E, Braunwald E, Neuhaus K. Prior MI or angina and the risk from acute myocardial infarction: observations from InTIME II. Journal of the American College of Cardiology. 2000; 35(Suppl. A):390A.
  479. The InTIME-II Investigators. Antman EM, Operations and Writing Committees. Intravenous NPA for the Treatment of Infarcting Myocardial Early: InTIME-II, a double blind comparison of single bolus lanoteplase vs. accelerated alteplase for the treatment of patients with acute myocardial infarction. European Heart Journal. 2000; 21:2005-13.
  480. Syllabus material on meta-analysis. 2000.
  481. The MAGIC Steering Committee. Antman EM; Chair, Steering Committee. Rationale and design of the Magnesium in Coronaries (MAGIC) study: A clinical trial to reevaluate the efficacy of early administration of magnesium in acute myocardial infarction. American Heart Journal. 2000; 139:10-14.
  482. The Joint European Society of Cardiology/American College of Cardiology Committee. Antman EM: Member of Consensus Panel [ACC Representative] and Member of Writing Committee. Myocardial infarction redefined--a consensus document of the Joint European Society of Cardiology/American College of Cardiology Committee for the Redefinition of Myocardial Infarction. European Heart Journal. 2000; 21:1502-13.
  483. Antman EM, Kuntz KM. The length of the hospital stay after myocardial infarction. (Editorial). New England Journal of Medicine. 2000; 342:808-10.
  484. Holper EM, Giugliano RP, Antman EM. Glycoprotein IIb/IIIa inhibitors in acute ST segment elevation myocardial infarction. Coron Artery Dis. 1999 Dec; 10(8):567-73.
    View in: PubMed
  485. Antman EM, Cohen M. Newer antithrombin agents in acute coronary syndromes. Am Heart J. 1999 Dec; 138(6 Pt 2):S563-9.
    View in: PubMed
  486. Gibson CM, Murphy S, Menown IB, Sequeira RF, Greene R, Van de Werf F, Schweiger MJ, Ghali M, Frey MJ, Ryan KA, Marble SJ, Giugliano RP, Antman EM, Cannon CP, Braunwald E. Determinants of coronary blood flow after thrombolytic administration. TIMI Study Group. Thrombolysis in Myocardial Infarction. J Am Coll Cardiol. 1999 Nov 1; 34(5):1403-12.
    View in: PubMed
  487. Antman EM, Cohen M, Radley D, McCabe C, Rush J, Premmereur J, Braunwald E. Assessment of the treatment effect of enoxaparin for unstable angina/non-Q-wave myocardial infarction. TIMI 11B-ESSENCE meta-analysis. Circulation. 1999 Oct 12; 100(15):1602-8.
    View in: PubMed
  488. Antman EM, McCabe CH, Gurfinkel EP, Turpie AG, Bernink PJ, Salein D, Bayes De Luna A, Fox K, Lablanche JM, Radley D, Premmereur J, Braunwald E. Enoxaparin prevents death and cardiac ischemic events in unstable angina/non-Q-wave myocardial infarction. Results of the thrombolysis in myocardial infarction (TIMI) 11B trial. Circulation. 1999 Oct 12; 100(15):1593-601.
    View in: PubMed
  489. Ridker PM, Antman EM. Pathogenesis and pathology of coronary heart disease syndromes. J Thromb Thrombolysis. 1999 Oct; 8(3):167-89.
    View in: PubMed
  490. Gibson CM, Ryan KA, Murphy SA, Mesley R, Marble SJ, Giugliano RP, Cannon CP, Antman EM, Braunwald E. Impaired coronary blood flow in nonculprit arteries in the setting of acute myocardial infarction. The TIMI Study Group. Thrombolysis in myocardial infarction. J Am Coll Cardiol. 1999 Oct; 34(4):974-82.
    View in: PubMed
  491. Tanasijevic MJ, Cannon CP, Antman EM, Wybenga DR, Fischer GA, Grudzien C, Gibson CM, Winkelman JW, Braunwald E. Myoglobin, creatine-kinase-MB and cardiac troponin-I 60-minute ratios predict infarct-related artery patency after thrombolysis for acute myocardial infarction: results from the Thrombolysis in Myocardial Infarction study (TIMI) 10B. J Am Coll Cardiol. 1999 Sep; 34(3):739-47.
    View in: PubMed
  492. Ryan TJ, Antman EM, Brooks NH, Califf RM, Hillis LD, Hiratzka LF, Rapaport E, Riegel B, Russell RO, Smith EE, Weaver WD, Gibbons RJ, Alpert JS, Eagle KA, Gardner TJ, Garson A, Gregoratos G, Ryan TJ, Smith SC. 1999 update: ACC/AHA guidelines for the management of patients with acute myocardial infarction. A report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines (Committee on Management of Acute Myocardial Infarction). J Am Coll Cardiol. 1999 Sep; 34(3):890-911.
    View in: PubMed
  493. Ryan TJ, Antman EM, Brooks NH, Califf RM, Hillis LD, Hiratzka LF, Rapaport E, Riegel B, Russell RO, Smith EE, Weaver WD, Gibbons RJ, Alpert JS, Eagle KA, Gardner TJ, Garson A, Gregoratos G, Smith SC. 1999 update: ACC/AHA Guidelines for the Management of Patients With Acute Myocardial Infarction: Executive Summary and Recommendations: A report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines (Committee on Management of Acute Myocardial Infarction). Circulation. 1999 Aug 31; 100(9):1016-30.
    View in: PubMed
  494. Gibson CM, Ryan KA, Kelley M, Rizzo MJ, Mesley R, Murphy S, Swanson J, Marble SJ, Dodge JT, Giugliano RP, Cannon CP, Antman EM. Methodologic drift in the assessment of TIMI grade 3 flow and its implications with respect to the reporting of angiographic trial results. The TIMI Study Group. Am Heart J. 1999 Jun; 137(6):1179-84.
    View in: PubMed
  495. Antman EM, Giugliano RP, Gibson CM, McCabe CH, Coussement P, Kleiman NS, Vahanian A, Adgey AA, Menown I, Rupprecht HJ, Van der Wieken R, Ducas J, Scherer J, Anderson K, Van de Werf F, Braunwald E. Abciximab facilitates the rate and extent of thrombolysis: results of the thrombolysis in myocardial infarction (TIMI) 14 trial. The TIMI 14 Investigators. Circulation. 1999 Jun 1; 99(21):2720-32.
    View in: PubMed
  496. Ross A, Van de Werf F, Weaver D, Antman EM. "Combining Antithrombotics with Thrombolytics" at interactive videoconference (satellite and Internet) on The Pursuit of Optimal Infarct Therapy: Changing Options in the Management of Acute MI. 1999.
  497. Tanasijevic MJ, Antman EM. Diagnostic performance of cardiac troponin I in suspected acute myocardial infarction: implications for clinicians. Am Heart J. 1999 Feb; 137(2):203-6.
    View in: PubMed
  498. Becker RC, Hochman JS, Cannon CP, Spencer FA, Ball SP, Rizzo MJ, Antman EM. Fatal cardiac rupture among patients treated with thrombolytic agents and adjunctive thrombin antagonists: observations from the Thrombolysis and Thrombin Inhibition in Myocardial Infarction 9 Study. J Am Coll Cardiol. 1999 Feb; 33(2):479-87.
    View in: PubMed
  499. Cannon CP, Rizzo MJ, Antman EM, McCabe CH, Gibson CM, Braunwald E. Validation of a multivariate model for risk stratification in acute ST elevation myocardial infarction: results from TIMI 9B. Journal of the American College of Cardiology. 1999; 33(suppl.A):396A.
  500. Ryan TG, Antman EM, Brooks NH, Califf RM, Hillis LD, Hiratzka LF, Rapoport E, Riegel B, Russell RO, Smith EE III, Weaver WD. ACC/AHA guidelines for the management of patients with acute myocardial infarction. 1999.
  501. Antman EM, Bittl JA. "Direct Thrombin Inhibitors". Clinical Trials in Cardiovascular Disease. Hennekens C, ed. 1999; 145-65.
  502. Kizer JR, Cannon CP, McCabe CH, Mueller HS, Schweiger MJ, Davis VG, Perritt R, Antman EM. Trends in the use of pharmacotherapies for acute myocardial infarction among physicians who design and/or implement randomized trials versus physicians in routine clinical practice: the MILIS-TIMI experience. Multicenter Investigation on Limitation of Infarct Size. Thrombolysis in Myocardial Infarction. Am Heart J. 1999 Jan; 137(1):79-92.
    View in: PubMed
  503. Morrow DA, Antman EM. Optimal use of new cardiac makers in patients with chest pain syndromes: selecting the best tools for reaching an accurate diagnosis and determining the patient's prognosis. 1999.
  504. Antman EM. Editor. CD-ROM series on Acute Coronary Syndromes. 1999.
  505. Guzman LA, Henquin R, Gurfinkel E, Bozovich G, Radley A, Antman EM. Role of enoxaparin in patients undergoing percutaneous revascularization in the setting of unstable angina. A TIMI 11B substudy. European Heart Journal. 1999; 20(Suppl):260.
  506. Tanasijevic MJ, Cannon CP, Antman EM. The role of cardiac troponin-I (cTnI) in risk stratification of patients with unstable coronary artery disease. Clin Cardiol. 1999 Jan; 22(1):13-6.
    View in: PubMed
  507. Giugliano RP, Antman EM, McCabe CH, Menown I, Kleiman NS, Ghali M, Coussement P, Braunwald E. Factors associated with major hemorrhage during reperfusion therapy in acute myocardial infarction: a TIMI 14 substudy. Journal of the American College of Cardiology. 1999; 33(suppl.A):398A.
  508. Antman EM, Smith TW. "Digitalis Toxicity". Oxford Textbook of Critical Care. Webb AR, Shapiro MJ, singer M, Suter PM, eds. 1999; 64-42.
  509. Antman EM. Antiplatelet therapy in daily practice. Cardiology Review. 1999; 15:55.
  510. Reimold SC, Maisel WH, Antman EM. Propafenone for the treatment of supraventricular tachycardia and atrial fibrillation: a meta-analysis. Am J Cardiol. 1998 Oct 16; 82(8A):66N-71N.
    View in: PubMed
  511. Gurfinkel E, Fareed J, Antman E, Cohen M, Mautner B. Rationale for the management of coronary syndromes with low-molecular-weight heparins. Am J Cardiol. 1998 Sep 10; 82(5B):15L-18L.
    View in: PubMed
  512. Fox KA, Antman EM. Treatment options in unstable angina: a clinical update. Eur Heart J. 1998 Sep; 19 Suppl K:K8-10.
    View in: PubMed
  513. Antman EM, Handin R. Low-molecular-weight heparins: an intriguing new twist with profound implications. Circulation. 1998 Jul 28; 98(4):287-9.
    View in: PubMed
  514. Morrow DA, Rifai N, Antman EM, Weiner DL, McCabe CH, Cannon CP, Braunwald E. C-reactive protein is a potent predictor of mortality independently of and in combination with troponin T in acute coronary syndromes: a TIMI 11A substudy. Thrombolysis in Myocardial Infarction. J Am Coll Cardiol. 1998 Jun; 31(7):1460-5.
    View in: PubMed
  515. Antman EM. TIMI 11B. Enoxaparin versus unfractionated heparin for unstable angina or non-Q-wave myocardial infarction: a double-blind, placebo-controlled, parallel-group, multicenter trial. Rationale, study design, and methods. Thrombolysis in Myocardial Infarction (TIMI) 11B Trial Investigators. Am Heart J. 1998 Jun; 135(6 Pt 3 Su):S353-60.
    View in: PubMed
  516. Seelig MS, Elin RJ, Antman EM. Magnesium in acute myocardial infarction: still an open question. Can J Cardiol. 1998 May; 14(5):745-9.
    View in: PubMed
  517. Kloner RA, Shook T, Antman EM, Cannon CP, Przyklenk K, Yoo K, McCabe CH, Braunwald E. Prospective temporal analysis of the onset of preinfarction angina versus outcome: an ancillary study in TIMI-9B. Circulation. 1998 Mar 24; 97(11):1042-5.
    View in: PubMed
  518. Borzak S, Cannon CP, Kraft PL, Douthat L, Becker RC, Palmeri ST, Henry T, Hochman JS, Fuchs J, Antman EM, McCabe C, Braunwald E. Effects of prior aspirin and anti-ischemic therapy on outcome of patients with unstable angina. TIMI 7 Investigators. Thrombin Inhibition in Myocardial Ischemia. Am J Cardiol. 1998 Mar 15; 81(6):678-81.
    View in: PubMed
  519. Antman EM, Sacks DB, Rifai N, McCabe CH, Cannon CP, Braunwald E. Time to positivity of a rapid bedside assay for cardiac-specific troponin T predicts prognosis in acute coronary syndromes: a Thrombolysis in Myocardial Infarction (TIMI) 11A substudy. J Am Coll Cardiol. 1998 Feb; 31(2):326-30.
    View in: PubMed
  520. Antman EM. ACCEL (ACC audio journal). Interviews at AHA, ACC, ESC annual meetings on clinical trial reports (TIMI 9, TIMI 11B, TIMI 14, TIMI 23, MAGIC), cardiac troponins, initial evaluation and management of patients with UA/NSTEMI/STEMI. 1998.
  521. Reimold SC, Antman EM. Noninvasive cardiac imaging in chest pain syndromes. Journal of Thrombosis and Thrombolysis. 1998; 6:239-52.
  522. Antman EM. The thrombin hypothesis: dead or alive?. Journal of Thrombosis and Thrombolysis. 1998; 5:S131-S135.
  523. Giugliano RP, Antman EM, McCabe CH, Anderson KM, Adgey AAJ, Kleiman NS, Ghali M, Van de Werf F, Braunwald E. Abciximab + tPA improves coronary flow in a wide range of subgroups: results from TIMI 14. Circulation. 1998; 98:I-560.
  524. Kelly RA, Antman EM. Pharmacological therapy of cardiac arrhythmias. Journal of Thrombosis and Thrombolysis. 1998; 6:211-38.
  525. Fung AY, Gawad Y, Thompson CR, Jackowski G, Leitman R, Antman EM, Tanasijevic MJ, Canner J, Thompson B, Braunwald E. The prognostic value of cardiac myosin light chains in acute ischemic syndromes--results from TIMI 9B. Journal of the American College of Cardiology. 1998; 31:380A.
  526. "Unstable Angina; Non-Q-wave Myocardial Infarction". Acute Coronary Syndromes Monograph Series (EM Antman, ed.). 1998.
  527. de Lemos JA, Antman EM, Giugliano RP, Coulter SA, McCabe CH, Lambrew C, Ghali M, Gibson M. Non-culprit blood flow is an independent correlate of ECG injury patterns after thrombolytic therapy: a TIMI 14 substudy. Circulation. 1998; 98:I-826.
  528. Cannon CP, McCabe CH, Borzak S, Henry TK, Tischler MD, Mueller HS, Feldman R, Palmeri ST, Ault K, Hamilton SA, Rothman JM, Novotny WF, Braunwald E, for the TIMI 12 Investigators. Antman EM, Coinvestigator. Randomized trial of an oral platelet glycoprotein IIb/IIIa antagonist, sibrafiban, in patients after an acute coronary syndrome: results of the TIMI 12 trial. Circulation. 1998; 97:340-9.
  529. Gibson CM, Dodge JT, Goel M, Al-Mousa EN, Rizzo M, McLean C, Ryan K, Sparano A, Marble SJ, Daley WL, Cannon CP, Antman EM. Angioplasty guidewire velocity: a new simple method to calculate absolute coronary blood velocity and flow. Am J Cardiol. 1997 Dec 15; 80(12):1536-9.
    View in: PubMed
  530. Nichol G, Walls R, Goldman L, Pearson S, Hartley LH, Antman E, Stockman M, Teich JM, Cannon CP, Johnson PA, Kuntz KM, Lee TH. A critical pathway for management of patients with acute chest pain who are at low risk for myocardial ischemia: recommendations and potential impact. Ann Intern Med. 1997 Dec 1; 127(11):996-1005.
    View in: PubMed
  531. Ware JH, Antman EM. Equivalence trials. N Engl J Med. 1997 Oct 16; 337(16):1159-61.
    View in: PubMed
  532. Ganz LI, Antman EM. Antiarrhythmic drug therapy in the management of atrial fibrillation. J Cardiovasc Electrophysiol. 1997 Oct; 8(10):1175-89.
    View in: PubMed
  533. Tanasijevic MJ, Cannon CP, Wybenga DR, Fischer GA, Grudzien C, Gibson CM, Winkelman JW, Antman EM, Braunwald E. Myoglobin, creatine kinase MB, and cardiac troponin-I to assess reperfusion after thrombolysis for acute myocardial infarction: results from TIMI 10A. Am Heart J. 1997 Oct; 134(4):622-30.
    View in: PubMed
  534. Antman EM. Another chapter of the antithrombin story has been written... Eur Heart J. 1997 Sep; 18(9):1365-7.
    View in: PubMed
  535. Maisel WH, Kuntz KM, Reimold SC, Lee TH, Antman EM, Friedman PL, Stevenson WG. Risk of initiating antiarrhythmic drug therapy for atrial fibrillation in patients admitted to a university hospital. Ann Intern Med. 1997 Aug 15; 127(4):281-4.
    View in: PubMed
  536. Antman EM, Grudzien C, Mitchell RN, Sacks DB. Detection of unsuspected myocardial necrosis by rapid bedside assay for cardiac troponin T. Am Heart J. 1997 May; 133(5):596-8.
    View in: PubMed
  537. Braunwald E, Antman EM. Evidence-based coronary care. Ann Intern Med. 1997 Apr 1; 126(7):551-3.
    View in: PubMed
  538. Anderson JL, Antman EM, Breall JA, Cannon CP, Gersh BJ, Grines CL, Hillis LD, Hochman HS, Solomon AJ, Weaver WD, Welsh JC. "Acute Myocardial Infarction--The First 72 Hours" (Videocassette), teleconference. 1997.
  539. Cannon CP, Antman EM. Heparin and low-molecular-weight heparin in acute coronary syndromes and angioplasty. Cardiology Clinics: Annual Drug Therapy. Crawford MH, ed. 1997; 1(1):105-119.
  540. Cannon CP, McCabe CH, Gibson CM, Ghali M, Sequeira RF, McKendall GR, Breed J, Modi NB, Fox NL, Tracy R, Love TW, Braunwald E, and the TIMI 10A Investigators. Antman EM, Co-Investigator. TNK-tissue plasminogen activator in acute myocardial infarction: Results of the Thrombolysis in Myocardial Infarction (TIMI) 10A dose-ranging trial. 1997; 95:351-56.
  541. Selker HP, Zalenski RJ, Antman EM, Aufderheide TP, Bernard SA, Bonow RO, Gibler WB, Hagen MD, Johnson P, Lau J, McNutt RA, Ornato J, Schwartz JS, Scott JD, Tunick PA, Weaver WD. An evaluation of technologies for identifying acute cardiac ischemia in the emergency department: executive summary of a National Heart Attack Alert Program Working Group Report. Ann Emerg Med. 1997 Jan; 29(1):1-12.
    View in: PubMed
  542. Ganz LI, Antman EM. Long-term pharmacologic management of atrial fibrillation for control of rate and rhythm. Cardiac Electrophysiology Review. 1997; 1:40-43.
  543. Antman EM, Braunwald E. "Acute Myocardial Infarction". Harrison's Principles of Internal Medicine. Fauci AS, Braunwald E, Isselbacher KJ, Wislon JD, Martin JB, Kasper DL, Hauser SL, Longo DO, eds. 1997; 1352-65.
  544. Paul S, McCabe CH, Antman EM. Risk stratification for acute myocardial infarction in the emergency department: results of TIMI 9B. Circulation. 1997; 96:I-182.
  545. Antman EM, Smith TW. Digitalis Toxicity. Current Therapy in Adult Medicine. Kassirer JP, Greene HL, eds. 1997; 414-18.
  546. Sabatine MS, Antman EM, Ganz LI, Lilly LS. Diagnosis of Cardiac Arrhythmias. Pathophysiology of Heart Disease: a Collaborative Project of Medical Students and Faculty. Lilly LS, ed. 1997; 249-66.
  547. Paul SD, Antman EM, McCabe CH, Braunwald E. Insights from TIMI 9B on sex differences in prognosis after acute myocardial infarction: development and validation of a clinical index to predict outcome. Circulation. 1997; 96:I-259.
  548. The Thrombolysis in Myocardial Infarction (TIMI) 11A Investigators. Antman EM, Principal Investigator. Dose-ranging trial of enoxaparin for unstable angina: Results of TIMI 11A. Journal of the American College of Cardiology. 1997; 29:1474-82.
  549. The Planning and Steering Committees of the AFFIRM Study for the NHLBI AFFIRM Investigators. (E. Antman, MD, member, Steering Committee). Atrial fibrillation follow-up investigation of rhythm management - the AFFIRM Study design. American Journal of Cardiology. 1997; 79:1198-1202.
  550. Giugliano RP, Antman EM, Braunwald E. Reexamination of the thrombin hypothesis: what we have learned from TIMI 9B and GUSTO IIb. (Editorial). Journal of Thrombosis and Thrombolysis. 1997; 4:321-23.
  551. Ware JH, Antman EM. Equivalence trials. (Editorial). New England Journal of Medicine. 1997; 337:1159-61.
  552. Selker HP, Zalenski RJ, Antman EM, Aufderheide TP, Bernard SA, Bonow RO, Gibler WB, Hagen MD, Johnson P, Lau J, McNutt RA, Ornato J, Schwartz JS, Scott JD, Tunick PA, Weaver WD. An evaluation of technologies for identifying acute cardiac ischemia in the emergency department: a report from a National Heart Attack Alert Program Working Group. Ann Emerg Med. 1997 Jan; 29(1):13-87.
    View in: PubMed
  553. Sabatine MS, Antman EM, Ganz LI, Strichartz GR, Lilly LS. Mechanisms of cardiac arrhythmias. Pathophysiology of Heart Disease: a Collaborative Project of Medical Students and Faculty. Lilly LS, ed. 1997; 233-48.
  554. Rabbani LE, Antman EM. The role of magnesium therapy in acute myocardial infarction. Clin Cardiol. 1996 Nov; 19(11):841-4.
    View in: PubMed
  555. Ryan TJ, Anderson JL, Antman EM, Braniff BA, Brooks NH, Califf RM, Hillis LD, Hiratzka LF, Rapaport E, Riegel BJ, Russell RO, Smith EE, Weaver WD. ACC/AHA guidelines for the management of patients with acute myocardial infarction: executive summary. A report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines (Committee on Management of Acute Myocardial Infarction). Circulation. 1996 Nov 1; 94(9):2341-50.
    View in: PubMed
  556. Ryan TJ, Anderson JL, Antman EM, Braniff BA, Brooks NH, Califf RM, Hillis LD, Hiratzka LF, Rapaport E, Riegel BJ, Russell RO, Smith EE, Weaver WD. ACC/AHA guidelines for the management of patients with acute myocardial infarction. A report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines (Committee on Management of Acute Myocardial Infarction). J Am Coll Cardiol. 1996 Nov 1; 28(5):1328-428.
    View in: PubMed
  557. Antman EM, Tanasijevic MJ, Thompson B, Schactman M, McCabe CH, Cannon CP, Fischer GA, Fung AY, Thompson C, Wybenga D, Braunwald E. Cardiac-specific troponin I levels to predict the risk of mortality in patients with acute coronary syndromes. N Engl J Med. 1996 Oct 31; 335(18):1342-9.
    View in: PubMed
  558. Berkey CS, Mosteller F, Lau J, Antman EM. Uncertainty of the time of first significance in random effects cumulative meta-analysis. Control Clin Trials. 1996 Oct; 17(5):357-71.
    View in: PubMed
  559. Greaves SC, Rutherford JD, Aranki SF, Cohn LH, Couper GS, Adams DH, Rizzo RJ, Collins JJ, Antman EM. Current incidence and determinants of perioperative myocardial infarction in coronary artery surgery. Am Heart J. 1996 Sep; 132(3):572-8.
    View in: PubMed
  560. Antman EM. Hirudin in acute myocardial infarction. Thrombolysis and Thrombin Inhibition in Myocardial Infarction (TIMI) 9B trial. Circulation. 1996 Sep 1; 94(5):911-21.
    View in: PubMed
  561. Antman EM. Maintaining sinus rhythm with antifibrillatory drugs in atrial fibrillation. Am J Cardiol. 1996 Aug 29; 78(4A):67-72.
    View in: PubMed
  562. Antman EM. Magnesium in acute myocardial infarction: overview of available evidence. Am Heart J. 1996 Aug; 132(2 Pt 2 Su):487-95; discussion 496-502.
    View in: PubMed
  563. Antman EM, Seelig MS, Fleischmann K, Lau J, Kuntz K, Berkey CS, McIntosh MW. Magnesium in acute myocardial infarction: scientific, statistical, and economic rationale for its use. Cardiovasc Drugs Ther. 1996 Jul; 10(3):297-301.
    View in: PubMed
  564. Antman EM, Braunwald E. Trials and tribulations of thrombin inhibition. Eur Heart J. 1996 Jul; 17(7):971-3.
    View in: PubMed
  565. Barsky AJ, Delamater BA, Clancy SA, Antman EM, Ahern DK. Somatized psychiatric disorder presenting as palpitations. Arch Intern Med. 1996 May 27; 156(10):1102-8.
    View in: PubMed
  566. McLaughlin TJ, Soumerai SB, Willison DJ, Gurwitz JH, Borbas C, Guadagnoli E, McLaughlin B, Morris N, Cheng SC, Hauptman PJ, Antman E, Casey L, Asinger R, Gobel F. Adherence to national guidelines for drug treatment of suspected acute myocardial infarction: evidence for undertreatment in women and the elderly. Arch Intern Med. 1996 Apr 8; 156(7):799-805.
    View in: PubMed
  567. Antman EM. "Acute Myocardial Infarction". Heart Disease: A Textbook of Cardiovascular Medicine. Braunwald E, ed. 1996; 1184-1288.
  568. Antman EM. Magnesium in acute myocardial infarction: Overview of available evidence. (5th European Magnesium Congress, Vienna, 1995). American Heart Journal. 1996; 132:487-95.
  569. Antman EM, Yang P, Smetana R. Magnesium in acute myocardial infarction: clinical benefits of intravenous magnesium therapy. Magnesium -Bulletin. 1996; 18(3):74-76.
  570. Antman EM. Maintaining sinus rhythm by antifibrillatory drugs in atrial fibrillation. American Journal of Cardiology. 1996; 78 (suppl.4):67-72.
  571. Antman EM. "Medical Management of the Patient Undergoing Cardiac Surgery". Heart Disease: A Textbook of Cardiovascular Medicine. Braunwald E, ed. 1996; 1715-40.
  572. Antman EM, Califf RM. "Clinical Trials and Meta-analysis". Cardiovascular Therapeutics. Smith TW, ed. 1996; 678-95.
  573. Antman EM, Section Editor. "Ischemic Heart Disease." Cardiovascular Therapeutics. In Smith TE (ed.), Antman EM, Bittl JA, Colucci WS, Gotto AM, Loscalzo J, Williams GH, Zipes DP (Section eds.). 1996.
  574. Antman EM. "Overview of Medical Therapy". Acute Myocardial Infarction and other Acute Ischemic Syndromes. Califf RM, vol. ed., Atlas of Heart Diseases. Braunwald E, ed. 1996; 8:10.1-10.25.
  575. Antman EM, Seelig MS, Fleischmann K, Lau J, Kuntz K, Berkey C, McIntosh M. Magnesium in acute myocardial infarction: scientific, statistical and economic rationale for its use. (Editorial). Cardiovascular Drugs and Therapy. 1996; 10:297-301.
  576. Antman EM. Magnesium in acute MI. Timing is critical. Circulation. 1995 Nov 1; 92(9):2367-72.
    View in: PubMed
  577. Antman EM. Atrial fibrillation and flutter: maintaining stability of sinus rhythm versus ventricular rate control. J Cardiovasc Electrophysiol. 1995 Oct; 6(10 Pt 2):962-71.
    View in: PubMed
  578. Reimold SC, Lamas GA, Cantillon CO, Antman EM. Risk factors for the development of recurrent atrial fibrillation: role of pacing and clinical variables. Am Heart J. 1995 Jun; 129(6):1127-32.
    View in: PubMed
  579. Antman EM, Grudzien C, Sacks DB. Evaluation of a rapid bedside assay for detection of serum cardiac troponin T. JAMA. 1995 Apr 26; 273(16):1279-82.
    View in: PubMed
  580. Cannon CP, Braunwald E, McCabe CH, Antman EM. The Thrombolysis in Myocardial Infarction (TIMI) trials: the first decade. J Interv Cardiol. 1995 Apr; 8(2):117-35.
    View in: PubMed
  581. Antman EM. Randomized trials of magnesium in acute myocardial infarction: big numbers do not tell the whole story. Am J Cardiol. 1995 Feb 15; 75(5):391-3.
    View in: PubMed
  582. Antman EM. Randomized trials of magnesium in acute myocardial infarction: Big numbers do not tell the whole story. (Editorial). American Journal of Cardiology. 1995; 75:391-93.
  583. Kelly RA, Antman EM, Smith TW. "Monitoring of Cardiovascular and Pulmonary Drugs". Principals of Pharmacology: Basic Concepts and Clinical Applications. Munson P, Mueller RA, Bresse G, eds. 1995; 569-83.
  584. Henry TD, Haugland JM, Berger C, Gleason R, Antman EM, Sharkey SW, for the TIMI 9 Registry Investigators. Is "door to needle" time, unadjusted for severity of illness, a suitable measure of mortality risk in patients with acute myocardial infarction?. Circulation. 1995; 92:I-775.
  585. Fuchs J, Cannon CP, and the TIMI 7 investigators. Antman, EM, Co-Investigator, TIMI Study Chairman's Office; Principal Investigator, Brigham and Women's Hospital. Hirulog in the treatment of unstable angina: Results of the Thrombin inhibition in Myocardial Ischemia (TIMI 7) trial. Circulation. 1995; 92:727-33.
  586. Antman EM, Smith TW. "Digitalis Toxicity. An Overview of Mechanisms, Manifestations, and Management". Cardiac Arrhythmias, Mandel W, ed. 1995; 1051-73.
  587. Lee VL, for the TIMI 6 Investigators. Antman EM, Senior Investigator, TIMI Study Chairman's Office. Initial experience with hirudin and streptokinase in acute myocardial infarction: results of the Thrombolysis in Myocardial Infarction (TIMI) 6 trial. American Journal of Cardiology. 1995; 75:7-13.
  588. Scheiman MM, Levine JH, Cannom DS, et al for the Intravenous Amiodarone Multicenter Investigators Group. Antman EM, Principal Investigator, Brigham and Women's Hospital. Dose-ranging study of intravenous amiodarone in patients with life-threatening ventricular tachyarrhythmias. Circulation. 1995; 92:3264-72.
  589. Ayanian JZ, Hauptman PJ, Guadagnoli E, Antman EM, Pashos CL, McNeil BJ. Knowledge and practices of generalist and specialist physicians regarding drug therapy for acute myocardial infarction. N Engl J Med. 1994 Oct 27; 331(17):1136-42.
    View in: PubMed
  590. Antman EM. Hirudin in acute myocardial infarction. Safety report from the Thrombolysis and Thrombin Inhibition in Myocardial Infarction (TIMI) 9A Trial. Circulation. 1994 Oct; 90(4):1624-30.
    View in: PubMed
  591. Cubanski D, Cyganski D, Antman EM, Feldman CL. A neural network system for detection of atrial fibrillation in ambulatory electrocardiograms. J Cardiovasc Electrophysiol. 1994 Jul; 5(7):602-8.
    View in: PubMed
  592. Berlin JA, Antman EM. Advantages and limitations of metaanalytic regressions of clinical trials data. Online J Curr Clin Trials. 1994 Jun 4; Doc No 134:[8425 words; 84 paragraphs].
    View in: PubMed
  593. Antman EM. Current diagnosis and prescription for Marfan syndrome: when to operate. J Card Surg. 1994 Mar; 9(2 Suppl):174-6.
    View in: PubMed
  594. Solomon SD, Antman E. Prehospital thrombolytic therapy for myocardial infarction. N Engl J Med. 1994 Jan 27; 330(4):291.
    View in: PubMed
  595. Antman EM, Smith TW. "Digitalis Toxicity". Current Therapy in Cardiovascular Disease. Hurst JW, ed. 1994; 89-93.
  596. Antman EM. "The General Hospital Management of Acute Myocardial Infarction". Contemporary Management of Acute Myocardial Infarction. Julian D & Braunwald E, eds. 1994; 29-70.
  597. Cannon CP, Antman EM, Walls R, Braunwald E. Time as an Adjunctive Agent to Thrombolytic Therapy (editorial). Journal of Thrombosis and Thrombolysis. 1994; 1:27-34.
  598. Lau J, Antman EM. "Lessons from Meta-Analyses of Acute Myocardial Infarction Trials". Choices in Cardiology. 1994; 8:386-89.
  599. Solomon SD, Ridker PM, Antman EM. Ventricular arrhythmias in trials of thrombolytic therapy for acute myocardial infarction. A meta-analysis. Circulation. 1993 Dec; 88(6):2575-81.
    View in: PubMed
  600. Reimold SC, Cantillon CO, Friedman PL, Antman EM. Propafenone versus sotalol for suppression of recurrent symptomatic atrial fibrillation. Am J Cardiol. 1993 Mar 1; 71(7):558-63.
    View in: PubMed
  601. Strickberger SA, Fish RD, Lamas GA, Cantillon C, Bhatia S, McGowan N, Antman EM, Friedman PL. Comparison of effects of propranolol versus pindolol on sinus rate and pacing frequency in sick sinus syndrome. Am J Cardiol. 1993 Jan 1; 71(1):53-6.
    View in: PubMed
  602. Tischler MD, Antman EM. "Cardiac Glycosides in the Treatment of Heart Failure". Congestive Cardiac Failure: Pathophysiology and Treatment. Barnett, Pouleur and Francis, eds. 1993; 119-43.
  603. Reimold SC, Lamas GA, Cantillon CO, Antman EM. Dual-chamber pacing reduces the risk of recurrent atrial fibrillation. Journal of the American College of Cardiology. 1993; 21:202A.
  604. Rabbani LE, Antman EM. "Acute Myocardial Infarction". Conn's Current Therapy. Rakel RE, ed. 1993; 296-313.
  605. The NHLBI Working Group on Atrial Fibrillation. Antman EM, DiMarco J, Domanski MJ, Knatterud GL, Scheinman M, Singer D, Walso A, Wolf PA, Wyse DG. "Atrial Fibrillation: Current Understandings and Research Imperatives". Journal of the American College of Cardiology. 1993; 22:1830-34.
  606. Reimold SC, Chalmers TC, Berlin JA, Antman EM. Assessment of the efficacy and safety of antiarrhythmic therapy for chronic atrial fibrillation: observations on the role of trial design and implications of drug-related mortality. Am Heart J. 1992 Oct; 124(4):924-32.
    View in: PubMed
  607. Antman EM, Berlin JA. Declining incidence of ventricular fibrillation in myocardial infarction. Implications for the prophylactic use of lidocaine. Circulation. 1992 Sep; 86(3):764-73.
    View in: PubMed
  608. Lau J, Antman EM, Jimenez-Silva J, Kupelnick B, Mosteller F, Chalmers TC. Cumulative meta-analysis of therapeutic trials for myocardial infarction. N Engl J Med. 1992 Jul 23; 327(4):248-54.
    View in: PubMed
  609. Antman EM, Lau J, Kupelnick B, Mosteller F, Chalmers TC. A comparison of results of meta-analyses of randomized control trials and recommendations of clinical experts. Treatments for myocardial infarction. JAMA. 1992 Jul 8; 268(2):240-8.
    View in: PubMed
  610. Friedman PL, Antman EM. "Management of Ventricular Arrhythmias Following Myocardial Infarction". Heart Disease: Clinical Update. Brauwald E, ed. 1992; 41-53.
  611. Antman, EM, Kirshenbaum, J, Stone P. "Acute Myocardial Infarction" (Videocassette). 1992.
  612. Andrews TC, Reimold SC, Berlin JA, Antman EM. Prevention of supraventricular arrhythmias after coronary artery bypass surgery. A meta-analysis of randomized control trials. Circulation. 1991 Nov; 84(5 Suppl):III236-44.
    View in: PubMed
  613. Antman EM, Marsh JD. "Class IV Antiarrhythmic Drugs". Basic and Clinical Electrophysiology and Pharmacology of the Heart. Dangman KH, Miura DS, eds. 1991; 697-722.
  614. Landzberg MJ, Antman EM. Nitrates, beta adrenoceptor blockers, and calcium antagonists". Unstable Angina. Rutherford JD, ed. 1991; 159-190.
  615. Antman EM. "Medical management of the patient undergoing cardiac surgery". Heart Disease: A Textbook of Cardiovascular Medicine. Braunwald E, ed. 1991; 1670-93.
  616. Coplen SE, Antman EM, Berlin JA, Hewitt P, Chalmers TC. Efficacy and safety of quinidine therapy for maintenance of sinus rhythm after cardioversion. A meta-analysis of randomized control trials. Circulation. 1990 Oct; 82(4):1106-16.
    View in: PubMed
  617. Antman EM, Braunwald E. Acute MI management in the 1990s. Hosp Pract (Off Ed). 1990 Jul 15; 25(7):65-75, 79-82.
    View in: PubMed
  618. Tofler GH, Stone PH, Maclure M, Edelman E, Davis VG, Robertson T, Antman EM, Muller JE. Analysis of possible triggers of acute myocardial infarction (the MILIS study). Am J Cardiol. 1990 Jul 1; 66(1):22-7.
    View in: PubMed
  619. Antman EM, Wenger TL, Butler VP, Haber E, Smith TW. Treatment of 150 cases of life-threatening digitalis intoxication with digoxin-specific Fab antibody fragments. Final report of a multicenter study. Circulation. 1990 Jun; 81(6):1744-52.
    View in: PubMed
  620. Cole PL, Beamer AD, McGowan N, Cantillon CO, Benfell K, Kelly RA, Hartley LH, Smith TW, Antman EM. Efficacy and safety of perhexiline maleate in refractory angina. A double-blind placebo-controlled clinical trial of a novel antianginal agent. Circulation. 1990 Apr; 81(4):1260-70.
    View in: PubMed
  621. Antman EM, Beamer AD, Cantillon C, McGowan N, Friedman PL. Therapy of refractory symptomatic atrial fibrillation and atrial flutter: a staged care approach with new antiarrhythmic drugs. J Am Coll Cardiol. 1990 Mar 1; 15(3):698-707.
    View in: PubMed
  622. Vekshtein, VI, Yeung AC, Vita JA, Fish D, Antman EM, Selwyn AP, Ganz P. N-acetylcysteine potentiates coronary artery dilation by nitroglycerin. Journal of the American College of Cardiology. 1990; 15:159A.
  623. Rabbani LE, Antman EM. "Exercise Testing and Ambulatory Electrocardiographic Monitoring". The Guide to Cardiology, Kloner RA, ed. 1990; 55-72.
  624. Antman EM, Smith TW. "Digitalis Toxicity". Current Therapy in Cardiovascular Disease. Hurst JW, ed. 1990; 89-94.
  625. Vita JA, Friedman PL, Cantillon C, Antman EM. Efficacy of intravenous propafenone for the acute management of atrial fibrillation. Am J Cardiol. 1989 May 15; 63(17):1275-8.
    View in: PubMed
  626. Antman EM, Dupont WD, Bonalsky J, Califf RM, Corwin S, Fink L, Hansen DE, Kawanishi DT, Kronenberg MW, McKay CR, et al. Early treatment with intravenous metoprolol for suspected acute myocardial infarction: a phase IV United States trial. Phase IV Metoprolol in Myocardial Infarction Study Group. Int J Cardiol. 1989 May; 23(2):185-97.
    View in: PubMed
  627. Pohjola-Sintonen S, Muller JE, Stone PH, Willich SN, Antman EM, Davis VG, Parker CB, Braunwald E. Ventricular septal and free wall rupture complicating acute myocardial infarction: experience in the Multicenter Investigation of Limitation of Infarct Size. Am Heart J. 1989 Apr; 117(4):809-18.
    View in: PubMed
  628. Antman EM, Smith TW. Current concepts in the use of digitalis. Adv Intern Med. 1989; 34:425-54.
    View in: PubMed
  629. Rabbani LE, Antman EM. Exercise Testing. Cardiovascular Reviews and Reports. 1989; 10:46-53.
  630. Rabbani LE, Antman EM. Ambulatory Monitoring. Cardiovascular Reviews and Reports. 1989; 10:59-64.
  631. Goldberger AL, Rigney DR, Mietus J, Antman EM, Greenwald S. Nonlinear dynamics in sudden cardiac death syndrome: heartrate oscillations and bifurcations. Experientia. 1988 Dec 1; 44(11-12):983-7.
    View in: PubMed
  632. Held AC, Cole PL, Lipton B, Gore JM, Antman EM, Hockman JS, Corrao J, Goldberg RJ, Alpert JS. Rupture of the interventricular septum complicating acute myocardial infarction: a multicenter analysis of clinical findings and outcome. Am Heart J. 1988 Nov; 116(5 Pt 1):1330-6.
    View in: PubMed
  633. Antman EM, Beamer AD, Cantillon C, McGowan N, Goldman L, Friedman PL. Long-term oral propafenone therapy for suppression of refractory symptomatic atrial fibrillation and atrial flutter. J Am Coll Cardiol. 1988 Oct; 12(4):1005-11.
    View in: PubMed
  634. Kirshenbaum JM, Kloner RF, McGowan N, Antman EM. Use of an ultrashort-acting beta-receptor blocker (esmolol) in patients with acute myocardial ischemia and relative contraindications to beta-blockade therapy. J Am Coll Cardiol. 1988 Sep; 12(3):773-80.
    View in: PubMed
  635. Lamas GA, Dawley D, Splaine K, Folland ED, Friedman PL, Antman EM. Documented symptomatic bradycardia and symptom relief in patients receiving permanent pacemakers: an evaluation of the joint ACC/AHA pacing guidelines. Pacing Clin Electrophysiol. 1988 Jul; 11(7):1098-104.
    View in: PubMed
  636. Horowitz JD, Henry CA, Syrjanen ML, Louis WJ, Fish RD, Smith TW, Antman EM. Combined use of nitroglycerin and N-acetylcysteine in the management of unstable angina pectoris. Circulation. 1988 Apr; 77(4):787-94.
    View in: PubMed
  637. Liang BT, Antman EM, Taus R, Collins JJ, Schoen FJ. Atherosclerotic aneurysms of aortocoronary vein grafts. Am J Cardiol. 1988 Jan 1; 61(1):185-8.
    View in: PubMed
  638. Antman EM, Rutherford JD. "The role of early beta blockade in the thrombolytic era". Acute Coronary Care in the Thrombolytic Era. Califf RM, Wagner G, Mark D, eds. 1988; 239-59.
  639. Antman EM, Friedman PL. Propafenone hydrochloride: A unique new antiarrhythmic agent. Primary Cardiology. 1988; 14:24-34.
  640. Horowitz JD, Henry CA, Syrjanen ML, Louis WJ, Fish RD, Antman EM, Smith TW. Nitroglycerine/N-acetylcysteine in the management of unstable angina pectoris. Eur Heart J. 1988 Jan; 9 Suppl A:95-100.
    View in: PubMed
  641. Platia EV, Fitzpatrick P, Wallis D, Antman EM, Michelson EL, Hua TA. Esmolol vs verapamil for the treatment of recent-onset atrial fibrillation/flutter: A multicenter study. Journal of the American College of Cardiology. 1988; 11:170A.
  642. Friedman PL, Antman EM. Propafenone: A new class IC antiarrhythmic drug for the management of ventricular arrhythmias. Hospital Formulary. 1988; 23:531-42.
  643. Nesto RW, White HD, Wynne J, Holman BL, Antman EM. Comparison of nifedipine and isosorbide dinitrate when added to maximal propranolol therapy in stable angina pectoris. Am J Cardiol. 1987 Aug 1; 60(4):256-61.
    View in: PubMed
  644. Antman EM, Arnold JM, Friedman PL, Smith TW. Pharmacokinetic drug interactions between digoxin and antiarrhythmic agents and calcium channel blocking agents: an appraisal of study methodology. Cardiovasc Drugs Ther. 1987 Aug; 1(2):183-9.
    View in: PubMed
  645. Ludmer PL, McGowan NE, Antman EM, Friedman PL. Efficacy of propafenone in Wolff-Parkinson-White syndrome: electrophysiologic findings and long-term follow-up. J Am Coll Cardiol. 1987 Jun; 9(6):1357-63.
    View in: PubMed
  646. Ludmer PL, Baim DS, Antman EM, Gauthier DF, Rocco MB, Friedman PL, Colucci WS. Effects of milrinone on complex ventricular arrhythmias in congestive heart failure secondary to ischemic or idiopathic dilated cardiomyopathy. Am J Cardiol. 1987 Jun 1; 59(15):1351-5.
    View in: PubMed
  647. Arnold JM, Antman EM, Przyklenk K, Braunwald E, Sandor T, Vivaldi MT, Schoen FJ, Kloner RA. Differential effects of reperfusion on incidence of ventricular arrhythmias and recovery of ventricular function at 4 days following coronary occlusion. Am Heart J. 1987 May; 113(5):1055-65.
    View in: PubMed
  648. Antman EM, Arnold M, Friedman PL, White H, Bosak M, Smith TW. Drug interactions with cardiac glycosides: evaluation of a possible digoxin-ethmozine pharmacokinetic interaction. J Cardiovasc Pharmacol. 1987 May; 9(5):622-7.
    View in: PubMed
  649. Shemin RJ, Tam S, Hein R, Hill S, Sun SC, Laurence R, Cohn LH, Antman EM. Esmolol, a new intravenous titratable B-blocker to control experimental acute aortic dissection in hypertensive greyhounds. Circulation. 1987; 76:IV-22.
  650. Antman EM, Smith TW. "Management of digitalis toxicity". Cardiac Impulse. 1987; 8:1-11.
  651. Antman EM. Tachyarrhythmia Management. Journal of Intensive Care Medicine. 1987; 2:61-3.
  652. Antman EM, Friedman PL. "Digitalis Toxicity: Mechanisms, Manifestations, and Management". Recent Advances in Cardiology. Rowlands DJ, ed. 1987; 117-45.
  653. Antman EM, Ludmer PL, McGowan N, Bosak M, Friedman PL. Transtelephonic electrocardiographic transmission for management of cardiac arrhythmias. Am J Cardiol. 1986 Nov 1; 58(10):1021-4.
    View in: PubMed
  654. Rabinowe SL, Larsen PR, Antman EM, George KL, Friedman PL, Jackson RA, Eisenbarth GS. Amiodarone therapy and autoimmune thyroid disease. Increase in a new monoclonal antibody-defined T cell subset. Am J Med. 1986 Jul; 81(1):53-7.
    View in: PubMed
  655. Lee TH, Salomon DR, Rayment CM, Antman EM. Hypotension and sinus arrest with exercise-induced hyperkalemia and combined verapamil/propranolol therapy. Am J Med. 1986 Jun; 80(6):1203-4.
    View in: PubMed
  656. Lamas GA, Antman EM, Gold JP, Braunwald NS, Collins JJ. Pacemaker backup-mode reversion and injury during cardiac surgery. Ann Thorac Surg. 1986 Feb; 41(2):155-7.
    View in: PubMed
  657. Antman EM, Smith TW. Digitalis Toxicity. Mod Conc Cardiovasc Dis. 1986; 55:26-30.
  658. Antman EM, Friedman PL. "Use of Digitalis Glycosides in the Management of Cardiac Arrhythmias". Digitalis Glycosides. Smith TW, ed. 1986; 127-52.
  659. Friedman PL, Antman EM, Smith TW. "Clinical Management of Digitalis Toxicity". Digitalis Glycosides. Smith TW, ed. 1986; 295-310.
  660. Antman EM, Smith TW. "Pharmacokinetics of Digitalis Glycosides". Digitalis Glycosides. Smith TW, ed. 1986; 45-60.
  661. Lamas GA, Antman EM, Gold J, Braunwald N, Collins, JJ. Pacemaker back-up mode reversion and injury during cardiac surgery. Annals of Thoracic Surgery. 1986; 41:155-57.
  662. Antman EM, Smith TW. "Drug Interactions with Digitalis Glycosides". Digitalis Glycosides. Smith TW, ed. 1986; 65-82.
  663. Lee TH, Solomon DR, Rayment C, Antman EM. Hypotension and sinus arrest with exercise-induced hyperkalemia and combined verapamil-therapy. American Journal of Medicine. 1986; 80:1203-04.
  664. Campbell S, Holman BL, Kirshenbaum JM, Antman EM, Lister-James J, Davison A, Kozlowski J, English RJ, Jones AG. The scintigraphic evaluation of myocardial infarction and regional ventricular performance using technetium-99m hexakis (t-butylisonitrile) technetium (I) (TBI): a new myocardial imaging agent. Eur J Nucl Med. 1986; 12(5-6):219-25.
    View in: PubMed
  665. Loscalzo J, Antman EM. "Artificial Cardiac Pacemakers: Current Concepts". Journal of Critical Care. 1986; 3.
  666. Friedman PL, Antman EM, Berkovits B. Prevention of accessory pathway mediated tachycardia with a new antitachycardia pacemaker. Journal of the American College of Cardiology. 1986; 7:183A.
  667. Friedman PL, Antman EM. "Electrocardiographic Manifestations of Digitalis Toxicity". Digitalis Glycosides. Smith TW, ed. 1986; 241-76.
  668. Antman EM, Ludmer PL, Friedman PL. Clinical Applications of Transtelephonic ECG Transmission. Clin Prog in Electrophysiol & Pacing. 1986; 4:168-74.
  669. Antman EM, Smith TW. "Bioavailability of Digitalis Glycosides". Digitalis Glycosides. Smith TW, ed. 1986; 61-4.
  670. Lamas G, Dawley D, Splaine K, Freedman P, Folland E, Antman EM. Does documenting a symptomatic bradycardia increase the likelihood of symptom relief in patients receiving permanent pacemakers?. PACE. 1986; 9:280.
  671. Antman EM, Rutherford JD. Coronary Care Medicine: A Practical Approach. 1986.
  672. Lamas GA, Rebecca GS, Braunwald NS, Antman EM. Pacemaker malfunction after nitrous oxide anesthesia. Am J Cardiol. 1985 Dec 1; 56(15):995.
    View in: PubMed
  673. Kloner RA, Kirshenbaum J, Lange R, Antman EM, Braunwald E. Experimental and clinical observations on the efficacy of esmolol in myocardial ischemia. Am J Cardiol. 1985 Oct 23; 56(11):40F-48F.
    View in: PubMed
  674. Kirshenbaum JM, Kloner RA, Antman EM, Braunwald E. Use of an ultra short-acting beta-blocker in patients with acute myocardial ischemia. Circulation. 1985 Oct; 72(4):873-80.
    View in: PubMed
  675. Nesto RW, White HD, Ganz P, Koslowski J, Wynne J, Holman BL, Antman E. Addition of nifedipine to maximal beta-blocker-nitrate therapy: effects on exercise capacity and global left ventricular performance at rest and during exercise. Am J Cardiol. 1985 May 17; 55(12):3E-8E.
    View in: PubMed
  676. Zoll PM, Zoll RH, Falk RH, Clinton JE, Eitel DR, Antman EM. External noninvasive temporary cardiac pacing: clinical trials. Circulation. 1985 May; 71(5):937-44.
    View in: PubMed
  677. White HD, Polak JF, Wynne J, Holman BL, Antman EM, Nesto RW. Addition of nifedipine to maximal nitrate and beta-adrenoreceptor blocker therapy in coronary artery disease. Am J Cardiol. 1985 May 1; 55(11):1303-7.
    View in: PubMed
  678. Lamas GA, Antman EM. Pacemaker-mediated tachycardia initiated by coincident P-wave undersensing and ventricular blanking period. Pacing Clin Electrophysiol. 1985 May; 8(3 Pt 1):436-9.
    View in: PubMed
  679. Abben RP, Antman EM. Managing bradyarrhythmias. Cardiovascular Medicine. 1985; 10:49-51.
  680. Lee TH, Friedman PL, Goldman L, Stone PH, Antman EM. Sinus arrest and hypotension with combined amiodarone-diltiazem therapy. Am Heart J. 1985 Jan; 109(1):163-4.
    View in: PubMed
  681. Abben RP, Antman EM. Managing tachyarrhythmias. Cardiovascular Medicine. 1985; 10:52-8.
  682. Antman EM, Smith TW. Digitalis toxicity. Annu Rev Med. 1985; 36:357-67.
    View in: PubMed
  683. Kloner RA, Kirshenbaum J, Lange R, Antman EM, Braunwald E. Review of the basic and clinical efficacy of esmolol in ischemic heart disease. American Journal of Cardiology. 1985; 56:40F-48F.
  684. Lamas GA, Koller LR, Antman EM, Smith TW. Electrocardiogram by Einthoven 63 years earlier. Am J Cardiol. 1984 Nov 1; 54(8):1163-5.
    View in: PubMed
  685. White HD, Antman EM, Glynn MA, Collins JJ, Cohn LH, Shemin RJ, Friedman PL. Efficacy and safety of timolol for prevention of supraventricular tachyarrhythmias after coronary artery bypass surgery. Circulation. 1984 Sep; 70(3):479-84.
    View in: PubMed
  686. Smith TW, Antman EM, Friedman PL, Blatt CM, Marsh JD. Digitalis glycosides: mechanisms and manifestations of toxicity. Part III. Prog Cardiovasc Dis. 1984 Jul-Aug; 27(1):21-56.
    View in: PubMed
  687. Smith TW, Antman EM, Friedman PL, Blatt CM, Marsh JD. Digitalis glycosides: mechanisms and manifestations of toxicity. Part II. Prog Cardiovasc Dis. 1984 May-Jun; 26(6):495-540.
    View in: PubMed
  688. Smith TW, Antman EM, Friedman PL, Blatt CM, Marsh JD. Digitalis glycosides: mechanisms and manifestations of toxicity. Part I. Prog Cardiovasc Dis. 1984 Mar-Apr; 26(5):413-58.
    View in: PubMed
  689. Antman EM, Graboys TB. Exercise Testing and Ambulatory Electrocardiographic Monitoring. Manual and Synopsis of Cardiology. Kloner RA, ed. 1984; 111-32.
  690. Smith TW, Antman EW, Friedman PL, Blatt CM, Marsh JD. Digitalis glycosides: mechanisms and manifestations of toxicity. Part III, Progr Cardiovasc Dis. 1984; 27(1):21-56.
  691. Graboys TB, Antman EM. Diagnosis and Management of Cardiac Arrhythmias. Manual and Synopsis of Cardiology. Kloner RA, ed. 1984; 319-37.
  692. Antman EM. "Acute Myocardial Infarction". Current Therapy. Rakel RE, ed. 1984; 190-212.
  693. Smith TW, Antman EM, Friedman PL, Blatt CM, Marsh JD. Digitalis glycosides: mechanisms and manifestations of toxicity. Part II, Progr Cardiovasc Dis. 1984; 26:495-523.
  694. Smith TW, Antman EM, Friedman PL, Blatt CM, Marsh JD. Digitalis glycosides: mechanisms and manifestations of toxicity. Part I, Progr Cardiovasc Dis. 1984; 26:413-41.
  695. Horowitz JD, Antman EM, Lorell BH, Barry WH, Smith TW. Potentiation of the cardiovascular effects of nitroglycerin by N-acetylcysteine. Circulation. 1983 Dec; 68(6):1247-53.
    View in: PubMed
  696. Lee TH, DiSesa VJ, Cohn LH, Lilly LS, Antman EM. Correction of intraoperative diastolic myocardial dysfunction with nifedipine. Clin Cardiol. 1983 Nov; 6(11):549-52.
    View in: PubMed
  697. Lewis BH, Antman EM, Graboys TB. Detailed analysis of 24 hour ambulatory electrocardiographic recordings during ventricular fibrillation or torsade de pointes. J Am Coll Cardiol. 1983 Sep; 2(3):426-36.
    View in: PubMed
  698. Rossi LP, Antman EM. Calcium channel blockers. New treatment for cardiovascular disease. Am J Nurs. 1983 Mar; 83(3):382-7.
    View in: PubMed
  699. Stone PH, Antman EM, Muller JE. Nifedipine therapy for coronary vasospasm. Arch Mal Coeur Vaiss. 1983 Feb; 76 Spec No:137-42.
    View in: PubMed
  700. Schamroth L, Antman EM. "Calcium Channel Blocking Agents in the Treatment of Cardiac Arrhythmias". Calcium Channel Blocking Agents in the Treatment of Cardiovascular Disorders. Stone PH, Antman EM, eds. 1983; 347-75.
  701. Antman EM. "Acute Myocardial Infarction". Current Therapy. Cohn HF, ed. 1983; 205-27.
  702. Stone PH, Antman EM. "Use of Calcium Channel Blocking Agents in Unstable Angina Pectoris and Acute Myocardial Infarction". Calcium Channel Blocking Agents in the Treatment of Cardiovascular Disorders. Stone PH, Antman EM, eds. 1983; 321-46.
  703. Antman EM, Horowitz J, Stone PH. "Clinical Pharmacology of the Calcium Channel Blocking Agents". Calcium Channel Blocking Agents in the Treatment of Cardiovascular Disorders. Stone PH, Antman EM, eds. 1983; 177-202.
  704. Calcium Channel Blocking Agents in the Treatment of Cardiovascular Disorders (P Stone, EM Antman, eds.). 1983.
  705. Antman EM, Grossman W. Clinical Applications of Calcium Channel Blockade: An Overview of the Use of Nifedipine (Japanese). Nifedipine. 1983; 9-27.
  706. Antman EM. "Ambulatory Electrocardiographic Monitoring". Diagnostic Methods in Clinical Cardiology. Cohn PF, Wynne J, eds. 1982; 29-50.
  707. Antman EM. Nifedipine therapy for Prinzmetal's angina. Cardiovascular Reviews & Reports. 1982; 3:54-57.
  708. Antman EM. "Coronary Artery Spasm" (Videocassette). 1982.
  709. Antman EM. New cardiovascular agents. Testimony at Hearing before the Subcommitee on Natural Resources, Agriculture Research and Environment and the Committee on Investigations and Oversight of the Committee on Science and Technology, U.S. House of Representatives. Ninety-Seventh Congress, 1st Sessions. U.S. Government Printing Office. 1982; 145:108-67.
  710. Mueller HS, Antman EM, Ferst JA, Muller JE. Nifedipine in the treatment of cardiovascular disease. Pharmacotherapy. 1981 Sep-Oct; 1(2):78-94.
    View in: PubMed
  711. Antman EM. "Atrial Arrhythmias" (Audiocassette). In: Cohn PF, Smith TW, Braunwald E, eds., Intensive Review of Cardiovascular Disease, Department of Medicine, Cardiovascular Division. 1981.
  712. Antman EM. Supraventricular Arrhythmias. 1981.
  713. Hill NS, Antman EM, Green LH, Alpert JS. Intravenous nitroglycerin. A review of pharmacology, indications, therapeutic effects and complications. Chest. 1981 Jan; 79(1):69-76.
    View in: PubMed
  714. Comprehensive Syllabus Material on Cardiovascular Pharmacology: General Principles, Antiarrhythmic Drugs, Anti-ischemic drugs. 1981.
  715. Stone PH, Antman EM, Muller JE, Braunwald E. Calcium channel blocking agents in the treatment of cardiovascular disorders. Part II: Hemodynamic effects and clinical applications. Ann Intern Med. 1980 Dec; 93(6):886-904.
    View in: PubMed
  716. Antman EM, Stone PH, Muller JE, Braunwald E. Calcium channel blocking agents in the treatment of cardiovascular disorders. Part I: Basic and clinical electrophysiologic effects. Ann Intern Med. 1980 Dec; 93(6):875-85.
    View in: PubMed
  717. Porterfield JG, Antman EM, Lown B. Respiratory difficulty after use of disopyramide. N Engl J Med. 1980 Sep 4; 303(10):584.
    View in: PubMed
  718. Antman EM, Marsh JD, Green LH, Grossman W. Blood oxygen measurements in the assessment of intracardiac left to right shunts: a critical appraisal of methodology. Am J Cardiol. 1980 Aug; 46(2):265-71.
    View in: PubMed
  719. Muller Je, Antman E, Green LH, Koster JK. Salvage of acutely ischemic myocardium by emergency coronary artery bypass grafting. Clin Cardiol. 1980 Aug; 3(4):276-80.
    View in: PubMed
  720. Antman E, Muller J, Goldberg S, MacAlpin R, Rubenfire M, Tabatznik B, Liang CS, Heupler F, Achuff S, Reichek N, Geltman E, Kerin NZ, Neff RK, Braunwald E. Nifedipine therapy for coronary-artery spasm. Experience in 127 patients. N Engl J Med. 1980 Jun 5; 302(23):1269-73.
    View in: PubMed
  721. Syllabus material on Clinical Pharmacology, Acute Coronary Syndromes. 1980.
  722. Antman E, Gunther S, Barry W. Beneficial effects of intravenous glyceryl trinitrate in a case of Prinzmetal angina. Br Heart J. 1980 Jan; 43(1):88-91.
    View in: PubMed
  723. Antman EM, Marsh JD, Green LH, Grossman W. Blood oxygen measurements in the assessment of intracardiac left-to-right shunts -- a critical appraisal of methodology. American Journal of Cardiology. 1980; 46:265-271.
  724. Antman EM, Muller J, Goldberg S, et al. Nifedipine therapy for coronary spasm: experience in 127 patients. New England Journal of Medicine. 1980; 302:1269-1273.
  725. Antman EM, Cargill V, Grossman W. Low-pressure cardiac tamponade. Ann Intern Med. 1979 Sep; 91(3):403-6.
    View in: PubMed
  726. Antman EM, Green LH, Grossman W. Physiologic determinants of the electrocardiographic diagnosis of left ventricular hypertrophy. Circulation. 1979 Aug; 60(2):386-96.
    View in: PubMed
  727. Antman E, Graboys TB, Lown B. Continuous monitoring for ventricular arrhythmias during exercise tests. JAMA. 1979 Jun 29; 241(26):2802-5.
    View in: PubMed
  728. Antman EM, Cargill V, Grossman W. Low pressure cardiac tamponade. Annals of Internal Medicine. 1979; 91:403-406.
  729. Antman EM, Cohn PF. Coronary artery disease - clinical and angiographic correlations. Hosp. Med. 1979; 15:8-22.
  730. Antman EM, Angoff GH, Sloss LJ. Demonstration of the mechanism by which mitral regurgitation mimics aortic stenosis. Am J Cardiol. 1978 Dec; 42(6):1044-8.
    View in: PubMed
  731. Antman E, Jacob G, Volpe B, Finkel S, Savona M. Camphor overdosage. Therapeutic considerations. N Y State J Med. 1978 May; 78(6):896-7.
    View in: PubMed
  732. Antman EM, Jacob G, Volpe B, Finkel S, Savona M. Camphor overdosage: Therapeutic considerations. NYS J Med. 1978; 78:898-907.
  733. Antman EM, Young E. Interpretation of P wave abnormalities on the electrocardiograph. Prac Cardiol. 1978; 4:104-16.
  734. Antman EM, Bilezikian JP. Asymptomatic hyperparathyroidism. JAMA. 1977 May 16; 237(20):2186-7.
    View in: PubMed
  735. Reiffel JA, Antman EM, Casella AJ, Drusin R. Simultaneous intermittent intra-atrial and intraventricular conduction delay. Journal of Electrocardiography. 1977; 10:59-62.
  736. Reiffel JA, Antman EM, Casella AJ, Drusin R. Case studies: Simultaneous intermittent intraatrial and intraventricular conduction defects mimicking trifascicular conduction delay. J Electrocardiol. 1977 Jan; 10(1):59-62.
    View in: PubMed
  737. Kupersmith J, Antman EM, Hoffman BF. In vivo electrophysiological effects of lidocaine in canine acute myocardial infarction. Circ Res. 1975 Jan; 36(1):84-91.
    View in: PubMed
  738. Antman EM. Flooding in vivo for a case of vermiphobia. J Behav Ther. 1973; 4:275-78.
Local representatives can answer questions about the Profiles website or help with editing a profile or issues with profile data. For assistance with this profile: HMS/HSDM faculty should contact Human Resources at faculty_serviceshms.harvard.edu.
Antman's Networks
Click the "See All" links for more information and interactive visualizations!
Concepts
_
Co-Authors
_
Similar People
_
Same Department
Physical Neighbors
_